<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:BTCY="http://biotricity.com/20260331"
  xmlns:country="http://xbrl.sec.gov/country/2026"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2026"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="btcy-20260331.xsd" xlink:type="simple"/>
    <context id="From2025-04-01to2026-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="AsOf2026-07-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <instant>2026-07-14</instant>
        </period>
    </context>
    <context id="From2026-01-012026-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_2026-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:RestatementDateAxis">
                    <ecd:RestatementDateAxis.domain>2026-03-31</ecd:RestatementDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BTCY:SeriesBConvertibleRedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BTCY:SeriesBConvertibleRedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012025-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_ReclassificationOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember_us-gaap_ReclassificationOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:SeriesBConvertibleRedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_MezzanineEquityMember_us-gaap_ReclassificationOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:MezzanineEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:SeriesBConvertibleRedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_MezzanineEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:MezzanineEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationTypeAxis">us-gaap:ReclassificationOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:SeriesBConvertibleRedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_MezzanineEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:MezzanineEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:SeriesBConvertibleRedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_MezzanineEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:MezzanineEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember243855296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:SeriesBConvertibleRedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_MezzanineEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:MezzanineEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SharesToBeIssuedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:SharesToBeIssuedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember243855328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:SeriesBConvertibleRedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_MezzanineEquityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:MezzanineEquityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_TechnologyFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">BTCY:TechnologyFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_TechnologyFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">BTCY:TechnologyFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_DeviceSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">BTCY:DeviceSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_DeviceSalesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">BTCY:DeviceSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_CustomerOneMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">BTCY:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_CustomerTwoMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">BTCY:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_OneCustomerMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">BTCY:OneCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_OneToThirtyDaysMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">BTCY:OneToThirtyDaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_OneToThirtyDaysMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">BTCY:OneToThirtyDaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_ThirtyOneToSixtyDaysMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">BTCY:ThirtyOneToSixtyDaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_ThirtyOneToSixtyDaysMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">BTCY:ThirtyOneToSixtyDaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SixtyOneToNinetyDaysMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">BTCY:SixtyOneToNinetyDaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SixtyOneToNinetyDaysMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">BTCY:SixtyOneToNinetyDaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_NinetyOneToOneEigthyDaysMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">BTCY:NinetyOneToOneEigthyDaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_NinetyOneToOneEigthyDaysMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">BTCY:NinetyOneToOneEigthyDaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_OneEigthyDaysOrMoreMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">BTCY:OneEigthyDaysOrMoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_OneEigthyDaysOrMoreMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">BTCY:OneEigthyDaysOrMoreMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_FairValueInputsLevel1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_FairValueInputsLevel2Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_FairValueInputsLevel3Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesANoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesANoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesANoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesANoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2022-12-30_custom_SeriesANoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesANoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="AsOf2022-12-30_custom_NewConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:NewConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="From2022-12-302022-12-30_custom_NewConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:NewConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-30</startDate>
            <endDate>2022-12-30</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_SeriesANoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesANoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_SeriesANoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesANoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesBNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesBNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_SeriesBNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesBNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesBNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesBNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_SeriesBNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesBNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesCNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesCNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_SeriesCNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesCNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_SeriesCNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesCNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_SeriesCConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesCConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_SeriesCNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesCNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_SeriesCConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesCConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SeriesCNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesCNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_SeriesCNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesCNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_SeriesCNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:SeriesCNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-25_custom_EighteenMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:EighteenMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-25</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_EighteenMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:EighteenMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2023-10-252023-10-25_custom_EighteenMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:EighteenMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-25</startDate>
            <endDate>2023-10-25</endDate>
        </period>
    </context>
    <context id="AsOf2023-10-25_custom_EighteenMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:EighteenMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-25</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_EighteenMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:EighteenMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_EighteenMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:EighteenMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <instant>2024-01-31</instant>
        </period>
    </context>
    <context id="AsOf2024-01-31_custom_TwentyFourMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:TwentyFourMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_TwentyFourMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:TwentyFourMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_TwentyFourMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:TwentyFourMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_SixMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:SixMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_SixMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:SixMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_TwelveMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:TwelveMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_TwelveMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:TwelveMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_EighteenMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:EighteenMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_UnsecuredConvertiblePromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:UnsecuredConvertiblePromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_NineMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:NineMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_NineMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:NineMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_TwentyFourMonthAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:TwentyFourMonthAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_TwentyFourMonthOneAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:TwentyFourMonthOneAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_TwentyFourMonthOneAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:TwentyFourMonthOneAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_TwentyFourMonthTwoAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:TwentyFourMonthTwoAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_TwentyFourMonthTwoAnniversaryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:TwentyFourMonthTwoAnniversaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_UnsecuredConvertiblePromissoryNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:UnsecuredConvertiblePromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_ConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_ConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_ConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_ConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-01-23_custom_OtherConvertibleNotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">BTCY:OtherConvertibleNotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-23</instant>
        </period>
    </context>
    <context id="AsOf2022-12-31_custom_PromissoryNoteAgreementMember_custom_IndividualInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:PromissoryNoteAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BTCY:IndividualInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_PromissoryNoteAgreementMember_custom_IndividualInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:PromissoryNoteAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BTCY:IndividualInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2022-12-012022-12-31_custom_PromissoryNoteAgreementMember_custom_IndividualInvestorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:PromissoryNoteAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BTCY:IndividualInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2022-12-30_custom_NewPromissoryNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:NewPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-30</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_PromissoryNoteAgreementMember_custom_IndividualInvestorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:PromissoryNoteAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BTCY:IndividualInvestorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_PromissoryNoteAgreementMember_custom_IndividualInvestorOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:PromissoryNoteAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BTCY:IndividualInvestorOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-08-11_custom_ShortTermPromissoryNotesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ShortTermPromissoryNotesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-11</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_ShortTermPromissoryNotesOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ShortTermPromissoryNotesOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_ShortTermBridgeLoanAgreementOneMember_custom_CollateralizedMerchantFinanceCompanyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ShortTermBridgeLoanAgreementOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BTCY:CollateralizedMerchantFinanceCompanyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_ShortTermBridgeLoanAgreementOneMember_custom_CollateralizedMerchantFinanceCompanyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ShortTermBridgeLoanAgreementOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">BTCY:CollateralizedMerchantFinanceCompanyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_ShortTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_ShortTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_ShortTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_ShortTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ShortTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <instant>2021-12-21</instant>
        </period>
    </context>
    <context id="From2021-12-212021-12-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <startDate>2021-12-21</startDate>
            <endDate>2021-12-21</endDate>
        </period>
    </context>
    <context id="From2024-11-012024-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2024-11-30</endDate>
        </period>
    </context>
    <context id="AsOf2024-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <instant>2024-11-30</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_ForbearanceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:ForbearanceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:WarrantAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_CreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_CreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_CreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_CreditAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2020-04-012020-04-30_custom_EconomicInjuryDisasterLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:EconomicInjuryDisasterLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="AsOf2020-04-30_custom_EconomicInjuryDisasterLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:EconomicInjuryDisasterLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="From2021-05-012021-05-31_custom_EconomicInjuryDisasterLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:EconomicInjuryDisasterLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_EconomicInjuryDisasterLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:EconomicInjuryDisasterLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_EconomicInjuryDisasterLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:EconomicInjuryDisasterLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_EconomicInjuryDisasterLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:EconomicInjuryDisasterLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_EconomicInjuryDisasterLoanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:EconomicInjuryDisasterLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MinimumMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MaximumMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MinimumMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MaximumMember_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_ConvertibleDebtMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputPriceVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">BTCY:ConvertibleNoteAndWarrantDerivativeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_ShareholdersMember_custom_ExchangeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BTCY:ShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:ExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_ShareholdersMember_custom_ExchangeAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BTCY:ShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:ExchangeAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_ShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BTCY:ShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_ShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BTCY:ShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-09-19_custom_SeriesBConvertiblePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BTCY:SeriesBConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2023-09-19_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-19</instant>
        </period>
    </context>
    <context id="From2023-09-182023-09-19_custom_PurchaseAgreementMember_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-18</startDate>
            <endDate>2023-09-19</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember243863265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BTCY:SeriesBConvertibleRedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-03-312026-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <startDate>2026-03-31</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-01-012026-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-03-31_custom_SeriesCConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BTCY:SeriesCConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_SeriesCConvertibleNoteMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BTCY:SeriesCConvertibleNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-10-012024-10-31_custom_SeriesBConvertibleRedeemablePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BTCY:SeriesBConvertibleRedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-10-31_custom_SeriesBConvertibleRedeemablePreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BTCY:SeriesBConvertibleRedeemablePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="From2024-10-012024-12-31_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012024-12-31_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BTCY:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_srt_ExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_SeriesCPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-05-142024-05-15_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-14</startDate>
            <endDate>2024-05-15</endDate>
        </period>
    </context>
    <context id="From2024-05-142024-05-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
        </entity>
        <period>
            <startDate>2024-05-14</startDate>
            <endDate>2024-05-15</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_CommonStockMember_custom_ConsultantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">BTCY:ConsultantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_CommonStockMember_srt_DirectorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SecondForbearanceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:SecondForbearanceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="From2025-12-012025-12-31_custom_SecondForbearanceAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:SecondForbearanceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SecondForbearanceAgreementMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:SecondForbearanceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SecondForbearanceAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:SecondForbearanceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_SecondForbearanceAgreementMember_us-gaap_MeasurementInputOptionVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:SecondForbearanceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantAgreementMember_us-gaap_MeasurementInputExpectedTermMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:WarrantAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:WarrantAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-12-31_custom_WarrantAgreementMember_us-gaap_MeasurementInputOptionVolatilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:WarrantAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_ExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:SellingGeneralAndAdministrativeExpensesMember</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2016-02-02_custom_TwoThousandAndSixteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BTCY:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-02-02</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_TwoThousandAndSixteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BTCY:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_TwoThousandAndSixteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BTCY:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_TwoThousandAndSixteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BTCY:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember_custom_TwoThousandAndSixteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BTCY:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:SellingGeneralAndAdministrativeExpensesMember</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember_custom_TwoThousandAndSixteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BTCY:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:SellingGeneralAndAdministrativeExpensesMember</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_StockOptionMember_custom_TwoThousandAndSixteenEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BTCY:TwoThousandAndSixteenEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2023-03-31_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">BTCY:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_BrokerWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:BrokerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_ConsultantWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:ConsultantWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_custom_WarrantsIssuedOnConversionOfConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:WarrantsIssuedOnConversionOfConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_BrokerWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:BrokerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_ConsultantWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:ConsultantWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_WarrantsIssuedOnConversionOfConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:WarrantsIssuedOnConversionOfConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_BrokerWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:BrokerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_ConsultantWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:ConsultantWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_custom_WarrantsIssuedOnConversionOfConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:WarrantsIssuedOnConversionOfConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_BrokerWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:BrokerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_ConsultantWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:ConsultantWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_WarrantsIssuedOnConversionOfConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:WarrantsIssuedOnConversionOfConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_BrokerWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:BrokerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_ConsultantWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:ConsultantWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_WarrantsIssuedOnConversionOfConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:WarrantsIssuedOnConversionOfConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_BrokerWarrantsMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:BrokerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_BrokerWarrantsMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:BrokerWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_ConsultantAndNoteholderWarrantsMember_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:ConsultantAndNoteholderWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_ConsultantAndNoteholderWarrantsMember_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:ConsultantAndNoteholderWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2026-03-31_custom_WarrantsIssuedOnConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:WarrantsIssuedOnConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_ConsultantAndNoteholderWarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:ConsultantAndNoteholderWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_WarrantsIssuedOnConvertibleNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">BTCY:WarrantsIssuedOnConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2023-04-012024-03-31_us-gaap_StockOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">BTCY:TwoThousandAndTwentyThreeEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_srt_MinimumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_srt_MaximumMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_country_US">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_country_CA">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_NewLeaseAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:NewLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_SellingGeneralAndAdministrativeExpenses">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:SellingGeneralAndAdministrativeExpenses</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_SellingGeneralAndAdministrativeExpenses">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:StatementOfIncomeLocationBalanceAxis">
                    <us-gaap:QName.domain>us-gaap:SellingGeneralAndAdministrativeExpenses</us-gaap:QName.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="AsOf2024-03-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2024-04-012025-03-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="AsOf2025-03-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_OfficeEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2025-04-012026-03-31_us-gaap_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="From2026-04-012026-07-14_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-07-14</endDate>
        </period>
    </context>
    <context id="From2025-03-312025-03-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-31</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="From2025-03-042025-03-04_us-gaap_SeriesBPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-04</startDate>
            <endDate>2025-03-04</endDate>
        </period>
    </context>
    <context id="From2026-04-012026-07-14_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-07-14</endDate>
        </period>
    </context>
    <context id="AsOf2026-07-14_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-07-14</instant>
        </period>
    </context>
    <context id="From2026-05-012026-05-01_us-gaap_CommonStockMember_custom_ExchangeSharesAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:ExchangeSharesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-01</startDate>
            <endDate>2026-05-01</endDate>
        </period>
    </context>
    <context id="From2026-05-012026-05-01_us-gaap_CommonStockMember_custom_ExchangeOptionsAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:ExchangeOptionsAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-01</startDate>
            <endDate>2026-05-01</endDate>
        </period>
    </context>
    <context id="From2026-05-012026-05-01_us-gaap_CommonStockMember_custom_ExchangeWarrantsAgreementMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:ExchangeWarrantsAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-01</startDate>
            <endDate>2026-05-01</endDate>
        </period>
    </context>
    <context id="From2026-05-012026-05-01_us-gaap_PreferredStockMember_us-gaap_SeriesCPreferredStockMember_custom_ExchangeAgreementsMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:ExchangeAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-01</startDate>
            <endDate>2026-05-01</endDate>
        </period>
    </context>
    <context id="AsOf2026-05-01_us-gaap_PreferredStockMember_us-gaap_SeriesCPreferredStockMember_custom_ExchangeAgreementsMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">BTCY:ExchangeAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-01</instant>
        </period>
    </context>
    <context id="From2026-05-282026-05-28_us-gaap_PreferredStockMember_us-gaap_SeriesCPreferredStockMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-05-28</startDate>
            <endDate>2026-05-28</endDate>
        </period>
    </context>
    <context id="AsOf2026-05-28_us-gaap_PreferredStockMember_us-gaap_SeriesCPreferredStockMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001630113</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-28</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Segment">
        <measure>BTCY:Segment</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2025-04-01to2026-03-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2025-04-01to2026-03-31" id="Fact000004">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2025-04-01to2026-03-31" id="Fact000005">0001630113</dei:EntityCentralIndexKey>
    <BTCY:AdvanceFromCustomers
      contextRef="AsOf2025-03-31"
      id="xdx2ixbrl0123"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LongTermLoansFromBank
      contextRef="AsOf2026-03-31"
      id="xdx2ixbrl0134"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2026-03-31"
      id="xdx2ixbrl0140"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0190"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0191"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0209"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember"
      id="xdx2ixbrl0210"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl0299"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl0300"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:DeemedDividends
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl0308"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AdjustmentsToAdditionalPaidInCapitalIssuancofWarrantsForBrokers
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0356"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AdjustmentsToAdditionalPaidInCapitalIssuancofWarrantsForBrokers
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0357"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AdjustmentsToAdditionalPaidInCapitalIssuancofWarrantsForBrokers
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0358"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AdjustmentsToAdditionalPaidInCapitalIssuancofWarrantsForBrokers
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0360"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AdjustmentsToAdditionalPaidInCapitalIssuancofWarrantsForBrokers
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0361"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0364"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0368"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0369"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-04-012026-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0378"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0384"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0385"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0386"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0387"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0388"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember"
      id="xdx2ixbrl0390"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0398"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0400"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0402"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0403"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0408"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0409"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0410"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0412"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0413"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0416"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0417"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0418"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0419"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0420"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0421"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember"
      id="xdx2ixbrl0422"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0424"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0425"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0426"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0427"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0429"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0432"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0433"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0434"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0435"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0436"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0440"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0441"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0442"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0443"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DividendsPreferredStock
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0444"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AccumulatedDeficitDeemedDividend
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0448"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AccumulatedDeficitDeemedDividend
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_CommonStockMember"
      id="xdx2ixbrl0449"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AccumulatedDeficitDeemedDividend
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0450"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AccumulatedDeficitDeemedDividend
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0451"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AccumulatedDeficitDeemedDividend
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0452"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AccumulatedDeficitDeemedDividend
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0453"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AccumulatedDeficitDeemedDividend
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember"
      id="xdx2ixbrl0454"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-04-012025-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0496"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0497"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0498"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-04-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0499"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-04-012025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0500"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-04-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0501"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl0502"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:IssuanceOfCommonValueFromAtTheMarketTransaction
      contextRef="From2024-04-012025-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0510"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:IssuanceOfCommonValueFromAtTheMarketTransaction
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0512"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:IssuanceOfCommonValueFromAtTheMarketTransaction
      contextRef="From2024-04-012025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0514"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:IssuanceOfCommonValueFromAtTheMarketTransaction
      contextRef="From2024-04-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0515"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-04-012025-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0520"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-04-012025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0524"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-04-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0525"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-04-012025-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0534"
      unitRef="Shares"
      xsi:nil="true"/>
    <BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0542"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne
      contextRef="From2024-04-012025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0544"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne
      contextRef="From2024-04-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0545"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesTwo
      contextRef="From2024-04-012025-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0552"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesTwo
      contextRef="From2024-04-012025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0556"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesTwo
      contextRef="From2024-04-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0557"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-04-012025-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0564"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-04-012025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0568"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-04-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0569"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:StockIssuedDuringPeriodValueForSettlementOfAccountsPayable
      contextRef="From2024-04-012025-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0576"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:StockIssuedDuringPeriodValueForSettlementOfAccountsPayable
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0578"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:StockIssuedDuringPeriodValueForSettlementOfAccountsPayable
      contextRef="From2024-04-012025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0580"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:StockIssuedDuringPeriodValueForSettlementOfAccountsPayable
      contextRef="From2024-04-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0581"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="From2024-04-012025-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0586"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0587"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0588"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="From2024-04-012025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0590"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="From2024-04-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0591"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-04-012025-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0594"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0595"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0596"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-04-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0597"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-04-012025-03-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0599"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012025-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0602"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0603"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0604"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0605"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0606"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:PreferredStockDividends
      contextRef="From2024-04-012025-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0610"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:PreferredStockDividends
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0611"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:PreferredStockDividends
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0612"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:PreferredStockDividends
      contextRef="From2024-04-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0613"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:PreferredStockDividends
      contextRef="From2024-04-012025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0614"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AccumulatedDeficitDeemedDividend
      contextRef="From2024-04-012025-03-31_us-gaap_PreferredStockMember"
      id="xdx2ixbrl0618"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AccumulatedDeficitDeemedDividend
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0619"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AccumulatedDeficitDeemedDividend
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      id="xdx2ixbrl0620"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AccumulatedDeficitDeemedDividend
      contextRef="From2024-04-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0621"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:AccumulatedDeficitDeemedDividend
      contextRef="From2024-04-012025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      id="xdx2ixbrl0622"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:IssuanceOfWarrantsForBrokersAtFairValue
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl0662"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:LossUponSettlementOfAccountsPayable
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl0673"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:LossOnDebtAndWarrantModification
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl0676"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:LossOnDebtAndWarrantModification
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl0677"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl0698"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl0709"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl0712"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl0716"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl0718"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl0725"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl0751"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl0752"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:ConversionOfConvertibleNotesIntoCommonStock
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl0760"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:WarrantsIssuedAndRecordedAsDebtDiscount
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl0764"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl0866"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2026-03-31"
      id="xdx2ixbrl0900"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2026-03-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0902"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2026-03-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0904"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2026-03-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0906"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2026-03-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0910"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2026-03-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0912"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2026-03-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0918"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2026-03-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0920"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2026-03-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0926"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2026-03-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0928"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2025-03-31"
      id="xdx2ixbrl0932"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2025-03-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0934"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2025-03-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0936"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="AsOf2025-03-31_us-gaap_FairValueInputsLevel3Member"
      id="xdx2ixbrl0938"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2025-03-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0942"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2025-03-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0944"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2025-03-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0950"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2025-03-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0952"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2025-03-31_us-gaap_FairValueInputsLevel1Member"
      id="xdx2ixbrl0958"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2025-03-31_us-gaap_FairValueInputsLevel2Member"
      id="xdx2ixbrl0960"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseDebt
      contextRef="From2025-04-012026-03-31_custom_SeriesBNoteMember"
      id="xdx2ixbrl1058"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestExpenseDebt
      contextRef="From2025-04-012026-03-31_custom_SeriesCNotesMember"
      id="xdx2ixbrl1099"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2025-04-012026-03-31_custom_SeriesCNotesMember"
      id="xdx2ixbrl1103"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AccretionExpense
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl1183"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_custom_ShortTermPromissoryNotesOneMember"
      id="xdx2ixbrl1215"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2025-03-31_custom_ShortTermBridgeLoanAgreementOneMember_custom_CollateralizedMerchantFinanceCompanyOneMember"
      id="xdx2ixbrl1219"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2026-03-31_custom_EconomicInjuryDisasterLoanMember"
      id="xdx2ixbrl1296"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2025-03-31_custom_EconomicInjuryDisasterLoanMember"
      id="xdx2ixbrl1298"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssue
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl1311"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
      contextRef="From2025-04-012026-03-31_us-gaap_ConvertibleDebtMember"
      id="xdx2ixbrl1357"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
      contextRef="From2024-04-012025-03-31_us-gaap_ConvertibleDebtMember"
      id="xdx2ixbrl1358"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2025-04-012026-03-31_us-gaap_ConvertibleDebtMember"
      id="xdx2ixbrl1360"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationEndOfDerivativeTreatmentOfWarrants
      contextRef="From2025-04-012026-03-31_us-gaap_ConvertibleDebtMember"
      id="xdx2ixbrl1369"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationEndOfDerivativeTreatmentOfWarrants
      contextRef="From2024-04-012025-03-31_us-gaap_ConvertibleDebtMember"
      id="xdx2ixbrl1370"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationConvertibleNoteModification
      contextRef="From2025-04-012026-03-31_us-gaap_ConvertibleDebtMember"
      id="xdx2ixbrl1372"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationConvertibleNoteModification
      contextRef="From2024-04-012025-03-31_us-gaap_ConvertibleDebtMember"
      id="xdx2ixbrl1373"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2025-04-012026-03-31_us-gaap_SeriesBPreferredStockMember"
      id="xdx2ixbrl1528"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssue
      contextRef="From2025-04-012026-03-31_us-gaap_SeriesBPreferredStockMember"
      id="xdx2ixbrl1531"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock
      contextRef="From2024-04-012025-03-31_us-gaap_SeriesBPreferredStockMember"
      id="xdx2ixbrl1535"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:IssuanceOfCommonSharesFromSharesToBeIssued
      contextRef="From2025-01-012025-03-31_custom_SeriesCConvertibleNoteMember"
      id="xdx2ixbrl1554"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2024-04-012025-03-31_custom_BrokerWarrantsMember"
      id="xdx2ixbrl1670"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2024-04-012025-03-31_custom_WarrantsIssuedOnConversionOfConvertibleNotesMember"
      id="xdx2ixbrl1672"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2024-04-012025-03-31_custom_WarrantsIssuedOnConversionOfConvertibleNotesMember"
      id="xdx2ixbrl1677"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2025-04-012026-03-31_custom_BrokerWarrantsMember"
      id="xdx2ixbrl1690"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2025-04-012026-03-31_custom_ConsultantWarrantsMember"
      id="xdx2ixbrl1691"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2025-04-012026-03-31_custom_WarrantsIssuedOnConversionOfConvertibleNotesMember"
      id="xdx2ixbrl1692"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl1693"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2025-04-012026-03-31_custom_ConsultantWarrantsMember"
      id="xdx2ixbrl1696"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2025-04-012026-03-31_custom_WarrantsIssuedOnConversionOfConvertibleNotesMember"
      id="xdx2ixbrl1697"
      unitRef="Shares"
      xsi:nil="true"/>
    <BTCY:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdjustmentForRoundingEffectOfReverseSplit
      contextRef="From2025-04-012026-03-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl1752"
      unitRef="Shares"
      xsi:nil="true"/>
    <BTCY:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAdjustmentForRoundingEffectOfReverseSplitInPeriodWeightedAverageExercisePrice
      contextRef="From2025-04-012026-03-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl1754"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2025-04-012026-03-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl1756"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2025-04-012026-03-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl1758"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <BTCY:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
      contextRef="From2025-04-012026-03-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl1760"
      unitRef="Shares"
      xsi:nil="true"/>
    <BTCY:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice
      contextRef="From2025-04-012026-03-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl1762"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2025-04-012026-03-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl1766"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2025-04-012026-03-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl1770"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <BTCY:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdjustmentForRoundingEffectOfReverseSplit
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl1808"
      unitRef="Shares"
      xsi:nil="true"/>
    <BTCY:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAdjustmentForRoundingEffectOfReverseSplitInPeriodWeightedAverageExercisePrice
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      id="xdx2ixbrl1810"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:TaxJurisdictionOfDomicileExtensibleEnumeration contextRef="From2025-04-01to2026-03-31" id="xdx2ixbrl1909">http://fasb.org/us-gaap/2026#DomesticCountryMember</us-gaap:TaxJurisdictionOfDomicileExtensibleEnumeration>
    <us-gaap:TaxJurisdictionOfDomicileExtensibleEnumeration contextRef="From2024-04-012025-03-31" id="xdx2ixbrl1910">http://fasb.org/us-gaap/2026#DomesticCountryMember</us-gaap:TaxJurisdictionOfDomicileExtensibleEnumeration>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl1933"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl1934"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2026-03-31"
      id="xdx2ixbrl1951"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="AsOf2025-03-31"
      id="xdx2ixbrl1952"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:OperatingLeaseRightOfUseAssetNewLeases
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl1974"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:OperatingLeaseRightOfUseAssetNewLeases
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl1976"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:OperatingLeaseNewLeases
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl1990"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:OperatingLeaseNewLeases
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl1992"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2026-03-31"
      id="xdx2ixbrl2006"
      unitRef="USD"
      xsi:nil="true"/>
    <BTCY:LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndBeyond
      contextRef="AsOf2026-03-31"
      id="xdx2ixbrl2022"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="From2024-04-012025-03-31_us-gaap_OfficeEquipmentMember"
      id="xdx2ixbrl2050"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="From2024-04-012025-03-31_us-gaap_LeaseholdImprovementsMember"
      id="xdx2ixbrl2052"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="From2024-04-012025-03-31"
      id="xdx2ixbrl2054"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="From2025-04-012026-03-31_us-gaap_OfficeEquipmentMember"
      id="xdx2ixbrl2062"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="From2025-04-012026-03-31_us-gaap_LeaseholdImprovementsMember"
      id="xdx2ixbrl2064"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="From2025-04-01to2026-03-31"
      id="xdx2ixbrl2066"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2025-04-01to2026-03-31" id="Fact000014">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2025-04-01to2026-03-31" id="Fact000015">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2025-04-01to2026-03-31" id="Fact000016">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2025-04-01to2026-03-31" id="Fact000017">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2025-04-01to2026-03-31" id="Fact000018">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="From2025-04-01to2026-03-31" id="Fact000019">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2025-04-01to2026-03-31" id="Fact000020">001-40761</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2025-04-01to2026-03-31" id="Fact000021">BIOTRICITY INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-04-01to2026-03-31" id="Fact000022">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2025-04-01to2026-03-31" id="Fact000023">30-0983531</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2025-04-01to2026-03-31" id="Fact000024">203     Redwood Shores Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2025-04-01to2026-03-31" id="Fact000025">Suite 600</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2025-04-01to2026-03-31" id="Fact000026">Redwood     City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2025-04-01to2026-03-31" id="Fact000027">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2025-04-01to2026-03-31" id="Fact000028">94065 and 75 International Blvd., Suite 300, Toronto, ON, Canada</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2025-04-01to2026-03-31" id="Fact000029">(800)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2025-04-01to2026-03-31" id="Fact000030">590-4155</dei:LocalPhoneNumber>
    <dei:Security12gTitle contextRef="From2025-04-01to2026-03-31" id="Fact000031">Common     Stock, Par Value $0.001</dei:Security12gTitle>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2025-04-01to2026-03-31" id="Fact000032">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2025-04-01to2026-03-31" id="Fact000033">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2025-04-01to2026-03-31" id="Fact000034">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2025-04-01to2026-03-31" id="Fact000035">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2025-04-01to2026-03-31" id="Fact000036">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2025-04-01to2026-03-31" id="Fact000037">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-04-01to2026-03-31" id="Fact000038">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="From2025-04-01to2026-03-31" id="Fact000039">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2025-04-01to2026-03-31" id="Fact000040">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="From2025-04-01to2026-03-31" id="Fact000041">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="AsOf2025-09-30"
      decimals="0"
      id="Fact000042"
      unitRef="USD">13498522</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2026-07-14"
      decimals="INF"
      id="Fact000043"
      unitRef="Shares">20074675</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000044">None</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000048">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="TM_005"&gt;&lt;/span&gt;ITEM
1C. CYBERSECURITY&lt;/b&gt;&lt;/span&gt;&#160;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
have established policies and processes for assessing, identifying, and managing material risk from cybersecurity threats, and have &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90F_ecyd--CybersecurityRiskManagementProcessesIntegratedFlag_dbT_c20250401__20260331_z2YlMYy7u7Tb"&gt;integrated&lt;/span&gt;
these processes into our overall risk management systems and processes. We routinely assess material risks from cybersecurity threats,
including any potential unauthorized occurrence on or conducted through our information systems that may result in adverse effects on
the confidentiality, integrity, or availability of our information systems or any information residing therein.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90E_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_c20250401__20260331_zA1eJGwNctee"&gt;We
conduct periodic risk assessments to identify cybersecurity threats, as well as assessments in the event of a material change in our
business practices that may affect information systems that are vulnerable to such cybersecurity threats. These risk assessments include
identification of reasonably foreseeable internal and external risks, the likelihood and potential damage that could result from such
risks, and the sufficiency of existing policies, procedures, systems, and safeguards in place to manage such risks.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;


    &lt;div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"&gt;&lt;tr style="vertical-align: top; text-align: left"&gt;&lt;td style="text-align: center; width: 100%"&gt;32&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;
    &lt;div style="break-before: page; margin-top: 6pt"&gt;&lt;p style="margin: 0pt"&gt;&#160;&lt;/p&gt;&lt;/div&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
these risk assessments, we re-design, implement, and maintain reasonable safeguards to minimize identified risks; reasonably address
any identified gaps in existing safeguards; and regularly monitor the effectiveness of our safeguards. Primary responsibility for assessing,
monitoring and managing our cybersecurity risks rests with Vice President of Technology, who reports to our Chief Executive Officer,
to manage the risk assessment and mitigation process.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
engage consultants, or other &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20250401__20260331_zWrWa5uvUAx1"&gt;third parties&lt;/span&gt; in connection with our risk assessment processes. These service providers assist us to design
and implement our cybersecurity policies and procedures, as well as to monitor and test our safeguards. We require each third-party service
provider to certify that it has the ability to implement and maintain appropriate security measures, consistent with all applicable laws,
to implement and maintain reasonable security measures in connection with their work with us, and to promptly report any suspected breach
of its security measures that may affect our company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
have &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_901_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20250401__20260331_zhGLwGsJtfHe"&gt;not&lt;/span&gt; encountered cybersecurity challenges that have materially impaired our operations or financial standing.&lt;/span&gt;&lt;/p&gt;

&#160;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="From2025-04-01to2026-03-31" id="Fact000049">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000050">We
conduct periodic risk assessments to identify cybersecurity threats, as well as assessments in the event of a material change in our
business practices that may affect information systems that are vulnerable to such cybersecurity threats. These risk assessments include
identification of reasonably foreseeable internal and external risks, the likelihood and potential damage that could result from such
risks, and the sufficiency of existing policies, procedures, systems, and safeguards in place to manage such risks.</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="From2025-04-01to2026-03-31" id="Fact000051">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="From2025-04-01to2026-03-31" id="Fact000052">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000056">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Governance&lt;/b&gt;&lt;/span&gt;&#160;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_909_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250401__20260331_zHGnOWxQmi87"&gt;Our
board of directors addresses the Company&#x2019;s cybersecurity risk management as part of its general oversight function.&lt;/span&gt; &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag_dbT_c20250401__20260331_zi7MARIylR6"&gt;The board of
directors&#x2019; audit committee is responsible for overseeing Company&#x2019;s cybersecurity risk management processes, including oversight
and mitigation of risks from cybersecurity threats.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
cybersecurity risk assessment and management processes are implemented and maintained by certain Company management, including the information
technology team at the direction of our Vice President of Technology. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90D_ecyd--CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250401__20260331_zv7m5QZGseo4"&gt;Our executive team including our Chief Executive Officer, and Chief
Financial Officer are responsible for hiring appropriate personnel, helping to integrate cybersecurity risk considerations into the Company&#x2019;s
overall risk management strategy, and communicating key priorities to relevant personnel.&lt;/span&gt; This executive team is responsible for approving
budgets, helping prepare for cybersecurity incidents, approving cybersecurity processes, and reviewing security assessments and other
security-related reports.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Our
cybersecurity incident response and vulnerability management policies are designed to escalate certain cybersecurity incidents to members
of management depending on the circumstances, including our Chief Executive Officer, and Chief Financial Officer. In addition, the Company&#x2019;s
incident response and vulnerability management policies include reporting to the audit committee of the board of directors for certain
cybersecurity incidents including significant breaches to the Company&#x2019;s networks or systems. The audit committee receives regular
reports from the information technology team concerning the Company&#x2019;s significant cybersecurity threats and risk and the processes
the Company has implemented to address them. The audit committee also has access to the Vice President of Technology, to receive various
reports, summaries or presentations related to cybersecurity threats, risk and mitigation.&lt;/span&gt;&lt;/p&gt;

&#160;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000057">Our
board of directors addresses the Company&#x2019;s cybersecurity risk management as part of its general oversight function.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="From2025-04-01to2026-03-31" id="Fact000058">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000059">Our executive team including our Chief Executive Officer, and Chief
Financial Officer are responsible for hiring appropriate personnel, helping to integrate cybersecurity risk considerations into the Company&#x2019;s
overall risk management strategy, and communicating key priorities to relevant personnel.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2026-01-012026-03-31" id="Fact000060">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2026-01-012026-03-31" id="Fact000061">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2026-01-012026-03-31" id="Fact000062">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2026-01-012026-03-31" id="Fact000063">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:ErrCompAnalysisTextBlock
      contextRef="From2025-04-012026-03-31_2026-03-31"
      id="Fact000067">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Board has adopted a clawback policy which allows us to recover performance-based compensation, whether cash or equity, from a current
or former executive officer in the event of an Accounting Restatement. The clawback policy defines an Accounting Restatement as an accounting
restatement of our financial statements due to our material noncompliance with any financial reporting requirement under the securities
laws. Under such policy, we may recoup incentive-based compensation previously received by an executive officer that exceeds the amount
of incentive-based compensation that otherwise would have been received had it been determined based on the restated amounts in the Accounting
Restatement.&lt;/span&gt;&#160;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Board has the sole discretion to determine the form and timing of the recovery, which may include repayment, forfeiture and/or an adjustment
to future performance-based compensation payouts or awards. The remedies under the clawback policy are in addition to, and not in lieu
of, any legal and equitable claims available to the Company.&lt;/span&gt;&lt;/p&gt;

&#160;</ecd:ErrCompAnalysisTextBlock>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="From2025-04-01to2026-03-31" id="Fact000068">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <dei:AuditorFirmId contextRef="From2025-04-01to2026-03-31" id="Fact000069">5828</dei:AuditorFirmId>
    <dei:AuditorOpinionTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000070">We
have audited the accompanying consolidated balance sheets of Biotricity Inc. and its subsidiary (the Company) as of March 31, 2026 and
2025 and the related consolidated statements of operations and comprehensive loss, mezzanine equity and stockholders&#x2019; deficiency,
and cash flows for each of the years in the two-year period ended March 31, 2026 and related notes (collectively referred to as the financial
statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of
the Company as at March 31, 2026 and 2025 and the results of its operations and its cash flows for each of the years in the two-year
period ended March 31, 2026, in conformity with accounting principles generally accepted in the United States of America.</dei:AuditorOpinionTextBlock>
    <dei:AuditorName contextRef="From2025-04-01to2026-03-31" id="Fact000071">SRCO Professional Corporation</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2025-04-01to2026-03-31" id="Fact000072">Richmond Hill, Ontario, Canada</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000077"
      unitRef="USD">149789</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000078"
      unitRef="USD">365145</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000080"
      unitRef="USD">2932899</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000081"
      unitRef="USD">1658772</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000083"
      unitRef="USD">1341295</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000084"
      unitRef="USD">1555385</us-gaap:InventoryNet>
    <us-gaap:DepositsAssetsCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000086"
      unitRef="USD">1432501</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000087"
      unitRef="USD">1059990</us-gaap:DepositsAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000089"
      unitRef="USD">5856484</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000090"
      unitRef="USD">4639292</us-gaap:AssetsCurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000092"
      unitRef="USD">109297</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000093"
      unitRef="USD">109297</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:AccountsReceivableNetNoncurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000095"
      unitRef="USD">130847</us-gaap:AccountsReceivableNetNoncurrent>
    <us-gaap:AccountsReceivableNetNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000096"
      unitRef="USD">70713</us-gaap:AccountsReceivableNetNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000098"
      unitRef="USD">3646</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000099"
      unitRef="USD">9599</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000101"
      unitRef="USD">346214</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000102"
      unitRef="USD">812053</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Assets
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000104"
      unitRef="USD">6446488</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000105"
      unitRef="USD">5640954</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000110"
      unitRef="USD">8970870</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000111"
      unitRef="USD">7661924</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000113"
      unitRef="USD">11114209</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000114"
      unitRef="USD">9618738</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:LoansPayableToBankCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000116"
      unitRef="USD">14680914</us-gaap:LoansPayableToBankCurrent>
    <us-gaap:LoansPayableToBankCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000117"
      unitRef="USD">2400000</us-gaap:LoansPayableToBankCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000119"
      unitRef="USD">445893</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000120"
      unitRef="USD">424200</us-gaap:DerivativeLiabilitiesCurrent>
    <BTCY:AdvanceFromCustomers
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000122"
      unitRef="USD">1531530</BTCY:AdvanceFromCustomers>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000125"
      unitRef="USD">397830</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000126"
      unitRef="USD">531286</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000128"
      unitRef="USD">37141246</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000129"
      unitRef="USD">20636148</us-gaap:LiabilitiesCurrent>
    <us-gaap:OtherLoansPayableLongTerm
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000131"
      unitRef="USD">870800</us-gaap:OtherLoansPayableLongTerm>
    <us-gaap:OtherLoansPayableLongTerm
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000132"
      unitRef="USD">870800</us-gaap:OtherLoansPayableLongTerm>
    <us-gaap:LongTermLoansFromBank
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000135"
      unitRef="USD">12271559</us-gaap:LongTermLoansFromBank>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000137"
      unitRef="USD">1396908</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000138"
      unitRef="USD">1478717</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000141"
      unitRef="USD">397830</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000143"
      unitRef="USD">39408954</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000144"
      unitRef="USD">35655054</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact000152"
      unitRef="USDPShares">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact000154"
      unitRef="USDPShares">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact000156"
      unitRef="Shares">600</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact000158"
      unitRef="Shares">600</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact000160"
      unitRef="Shares">335</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact000162"
      unitRef="Shares">335</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact000164"
      unitRef="Shares">385</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact000166"
      unitRef="Shares">385</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000149"
      unitRef="USD">1714476</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000150"
      unitRef="USD">2000290</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000174"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000176"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000178"
      unitRef="Shares">9979400</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000180"
      unitRef="Shares">9979400</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000182"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000184"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000186"
      unitRef="Shares">1</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000188"
      unitRef="Shares">1</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000171"
      unitRef="USD">1</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000172"
      unitRef="USD">1</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000193"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000195"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000197"
      unitRef="Shares">20000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000199"
      unitRef="Shares">20000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000201"
      unitRef="Shares">201</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000203"
      unitRef="Shares">201</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000205"
      unitRef="Shares">201</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact000207"
      unitRef="Shares">201</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000215"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000217"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000219"
      unitRef="Shares">125000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000221"
      unitRef="Shares">125000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000223"
      unitRef="Shares">28597315</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000225"
      unitRef="Shares">28597315</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000227"
      unitRef="Shares">26081295</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000229"
      unitRef="Shares">26081295</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockOtherSharesOutstanding
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000231"
      unitRef="Shares">160672</us-gaap:CommonStockOtherSharesOutstanding>
    <us-gaap:CommonStockOtherSharesOutstanding
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000233"
      unitRef="Shares">160672</us-gaap:CommonStockOtherSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000212"
      unitRef="USD">28759</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000213"
      unitRef="USD">26243</us-gaap:CommonStockValue>
    <BTCY:CommonStockSharesToBeIssued
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact000238"
      unitRef="Shares">1005815</BTCY:CommonStockSharesToBeIssued>
    <BTCY:CommonStockSharesToBeIssued
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact000240"
      unitRef="Shares">324276</BTCY:CommonStockSharesToBeIssued>
    <BTCY:SharesToBeIssued
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000235"
      unitRef="USD">284668</BTCY:SharesToBeIssued>
    <BTCY:SharesToBeIssued
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000236"
      unitRef="USD">284244</BTCY:SharesToBeIssued>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000242"
      unitRef="USD">107621813</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000243"
      unitRef="USD">107123300</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000245"
      unitRef="USD">-41940</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000246"
      unitRef="USD">-6393</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000248"
      unitRef="USD">-142570243</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000249"
      unitRef="USD">-139441785</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000251"
      unitRef="USD">-34676942</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000252"
      unitRef="USD">-32014390</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000254"
      unitRef="USD">6446488</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000255"
      unitRef="USD">5640954</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000257"
      unitRef="USD">15998239</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000258"
      unitRef="USD">13790294</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000260"
      unitRef="USD">3049441</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000261"
      unitRef="USD">3225803</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000263"
      unitRef="USD">12948798</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000264"
      unitRef="USD">10564491</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000269"
      unitRef="USD">8493365</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000270"
      unitRef="USD">10857797</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000272"
      unitRef="USD">2764197</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000273"
      unitRef="USD">2155660</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000275"
      unitRef="USD">11257562</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000276"
      unitRef="USD">13013457</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000278"
      unitRef="USD">1691236</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000279"
      unitRef="USD">-2448966</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000281"
      unitRef="USD">159978</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000282"
      unitRef="USD">-78569</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000284"
      unitRef="USD">3361950</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000285"
      unitRef="USD">3262038</us-gaap:InterestExpenseNonoperating>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000287"
      unitRef="USD">19842</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000288"
      unitRef="USD">-137934</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000290"
      unitRef="USD">-745896</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000291"
      unitRef="USD">-1939816</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000293"
      unitRef="USD">-167349</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000294"
      unitRef="USD">-553856</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000296"
      unitRef="USD">-2404139</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000297"
      unitRef="USD">-8421179</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000302"
      unitRef="USD">-2404139</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000303"
      unitRef="USD">-8421179</us-gaap:NetIncomeLoss>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000305"
      unitRef="USD">724319</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <us-gaap:PreferredStockDividendsIncomeStatementImpact
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000306"
      unitRef="USD">466141</us-gaap:PreferredStockDividendsIncomeStatementImpact>
    <BTCY:DeemedDividends
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000309"
      unitRef="USD">-3054680</BTCY:DeemedDividends>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000311"
      unitRef="USD">-3128458</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000312"
      unitRef="USD">-11942000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000314"
      unitRef="USD">-35547</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000315"
      unitRef="USD">113414</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000317"
      unitRef="USD">-3164005</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000318"
      unitRef="USD">-11828586</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-04-01to2026-03-31"
      decimals="INF"
      id="Fact000320"
      unitRef="USDPShares">-0.115</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-04-01to2026-03-31"
      decimals="INF"
      id="Fact000322"
      unitRef="USDPShares">-0.115</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2024-04-012025-03-31"
      decimals="INF"
      id="Fact000324"
      unitRef="USDPShares">-0.555</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2024-04-012025-03-31"
      decimals="INF"
      id="Fact000326"
      unitRef="USDPShares">-0.555</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-04-01to2026-03-31"
      decimals="INF"
      id="Fact000328"
      unitRef="Shares">27304317</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-04-01to2026-03-31"
      decimals="INF"
      id="Fact000330"
      unitRef="Shares">27304317</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2024-04-012025-03-31"
      decimals="INF"
      id="Fact000332"
      unitRef="Shares">21524884</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2024-04-012025-03-31"
      decimals="INF"
      id="Fact000334"
      unitRef="Shares">21524884</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember_us-gaap_ReclassificationOtherMember"
      decimals="INF"
      id="Fact000344"
      unitRef="Shares">385</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember_us-gaap_ReclassificationOtherMember"
      decimals="INF"
      id="Fact000346"
      unitRef="USD">2000290</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-03-31_custom_MezzanineEquityMember_us-gaap_ReclassificationOtherMember"
      decimals="INF"
      id="Fact000348"
      unitRef="USD">2000290</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000350"
      unitRef="Shares">201</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000336"
      unitRef="USD">1</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000352"
      unitRef="Shares">26241967</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000337"
      unitRef="USD">26243</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_custom_SharesToBeIssuedMember"
      decimals="INF"
      id="Fact000354"
      unitRef="Shares">581599</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_custom_SharesToBeIssuedMember"
      decimals="0"
      id="Fact000338"
      unitRef="USD">284244</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000339"
      unitRef="USD">107123300</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000340"
      unitRef="USD">-6393</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_ReclassificationOtherMember_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000341"
      unitRef="USD">-139441785</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_ReclassificationOtherMember"
      decimals="0"
      id="Fact000342"
      unitRef="USD">-32014390</us-gaap:StockholdersEquity>
    <BTCY:AdjustmentsToAdditionalPaidInCapitalIssuancofWarrantsForBrokers
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000359"
      unitRef="USD">38078</BTCY:AdjustmentsToAdditionalPaidInCapitalIssuancofWarrantsForBrokers>
    <BTCY:AdjustmentsToAdditionalPaidInCapitalIssuancofWarrantsForBrokers
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember"
      decimals="0"
      id="Fact000362"
      unitRef="USD">38078</BTCY:AdjustmentsToAdditionalPaidInCapitalIssuancofWarrantsForBrokers>
    <BTCY:TemporaryEquitySharesConversionOfMezzanineEquityIntoCommonShares
      contextRef="From2025-04-012026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact000372"
      unitRef="Shares">-30</BTCY:TemporaryEquitySharesConversionOfMezzanineEquityIntoCommonShares>
    <BTCY:TemporaryEquitySharesConversionOfMezzanineEquityIntoCommonSharesValue
      contextRef="From2025-04-012026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="0"
      id="Fact000374"
      unitRef="USD">-171488</BTCY:TemporaryEquitySharesConversionOfMezzanineEquityIntoCommonSharesValue>
    <BTCY:TemporaryEquitySharesConversionOfMezzanineEquityIntoCommonSharesValue
      contextRef="From2025-04-012026-03-31_custom_MezzanineEquityMember"
      decimals="0"
      id="Fact000376"
      unitRef="USD">-171488</BTCY:TemporaryEquitySharesConversionOfMezzanineEquityIntoCommonSharesValue>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-04-012026-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000380"
      unitRef="Shares">2506020</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000365"
      unitRef="USD">2506</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-04-012026-03-31_custom_SharesToBeIssuedMember"
      decimals="INF"
      id="Fact000382"
      unitRef="Shares">424216</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_custom_SharesToBeIssuedMember"
      decimals="0"
      id="Fact000366"
      unitRef="USD">424</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000367"
      unitRef="USD">431043</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember"
      decimals="0"
      id="Fact000370"
      unitRef="USD">433973</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <BTCY:TemporaryEquitySharesRedemptionOfConvertiblePreferredShares
      contextRef="From2025-04-012026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact000392"
      unitRef="Shares">-20</BTCY:TemporaryEquitySharesRedemptionOfConvertiblePreferredShares>
    <BTCY:TemporaryEquityRedemptionOfConvertiblePreferredSharesValue
      contextRef="From2025-04-012026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="0"
      id="Fact000394"
      unitRef="USD">-114326</BTCY:TemporaryEquityRedemptionOfConvertiblePreferredSharesValue>
    <BTCY:TemporaryEquityRedemptionOfConvertiblePreferredSharesValue
      contextRef="From2025-04-012026-03-31_custom_MezzanineEquityMember"
      decimals="0"
      id="Fact000396"
      unitRef="USD">-114326</BTCY:TemporaryEquityRedemptionOfConvertiblePreferredSharesValue>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2025-04-012026-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000406"
      unitRef="Shares">10000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000399"
      unitRef="USD">10</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000401"
      unitRef="USD">3760</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember"
      decimals="0"
      id="Fact000404"
      unitRef="USD">3770</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000411"
      unitRef="USD">25632</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember"
      decimals="0"
      id="Fact000414"
      unitRef="USD">25632</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000428"
      unitRef="USD">-35547</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember"
      decimals="0"
      id="Fact000430"
      unitRef="USD">-33547</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000437"
      unitRef="USD">-2404139</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember"
      decimals="0"
      id="Fact000438"
      unitRef="USD">-2404139</us-gaap:NetIncomeLoss>
    <us-gaap:DividendsPreferredStock
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000445"
      unitRef="USD">724319</us-gaap:DividendsPreferredStock>
    <us-gaap:DividendsPreferredStock
      contextRef="From2025-04-012026-03-31_us-gaap_ReclassificationOtherMember"
      decimals="0"
      id="Fact000446"
      unitRef="USD">724319</us-gaap:DividendsPreferredStock>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember243855296"
      decimals="INF"
      id="Fact000464"
      unitRef="Shares">335</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember243855296"
      decimals="INF"
      id="Fact000466"
      unitRef="USD">1714476</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2026-03-31_custom_MezzanineEquityMember"
      decimals="INF"
      id="Fact000468"
      unitRef="USD">1714476</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000470"
      unitRef="Shares">201</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000456"
      unitRef="USD">1</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000472"
      unitRef="Shares">28757987</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000457"
      unitRef="USD">28759</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-03-31_custom_SharesToBeIssuedMember"
      decimals="INF"
      id="Fact000474"
      unitRef="Shares">1005815</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31_custom_SharesToBeIssuedMember"
      decimals="0"
      id="Fact000458"
      unitRef="USD">284668</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000459"
      unitRef="USD">107619813</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000460"
      unitRef="USD">-41940</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000461"
      unitRef="USD">-142570243</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000462"
      unitRef="USD">-34676942</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2024-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact000484"
      unitRef="Shares">265</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2024-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact000486"
      unitRef="USD">1488920</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2024-03-31_custom_MezzanineEquityMember"
      decimals="INF"
      id="Fact000488"
      unitRef="USD">1488920</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000490"
      unitRef="Shares">6305</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000476"
      unitRef="USD">7</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000492"
      unitRef="Shares">9514440</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000477"
      unitRef="USD">9515</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2024-03-31_custom_SharesToBeIssuedMember"
      decimals="INF"
      id="Fact000494"
      unitRef="Shares">344276</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_custom_SharesToBeIssuedMember"
      decimals="0"
      id="Fact000478"
      unitRef="USD">269065</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000479"
      unitRef="USD">95723083</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000480"
      unitRef="USD">32378</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000481"
      unitRef="USD">-127499785</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="Fact000482"
      unitRef="USD">-31465737</us-gaap:StockholdersEquity>
    <BTCY:TemporaryEquityIssuanceOfMezzanineEquity
      contextRef="From2024-04-012025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact000504"
      unitRef="Shares">220</BTCY:TemporaryEquityIssuanceOfMezzanineEquity>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-04-012025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="0"
      id="Fact000506"
      unitRef="USD">1082999</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-04-012025-03-31_custom_MezzanineEquityMember"
      decimals="0"
      id="Fact000508"
      unitRef="USD">1082999</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <BTCY:IssuanceOfCommonSharesFromAtTheMarketTransactionShares
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000518"
      unitRef="Shares">97811</BTCY:IssuanceOfCommonSharesFromAtTheMarketTransactionShares>
    <BTCY:IssuanceOfCommonValueFromAtTheMarketTransaction
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000511"
      unitRef="USD">98</BTCY:IssuanceOfCommonValueFromAtTheMarketTransaction>
    <BTCY:IssuanceOfCommonValueFromAtTheMarketTransaction
      contextRef="From2024-04-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000513"
      unitRef="USD">125129</BTCY:IssuanceOfCommonValueFromAtTheMarketTransaction>
    <BTCY:IssuanceOfCommonValueFromAtTheMarketTransaction
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000516"
      unitRef="USD">125227</BTCY:IssuanceOfCommonValueFromAtTheMarketTransaction>
    <BTCY:TemporaryEquitySharesConversionOfMezzanineEquityIntoCommonShares
      contextRef="From2024-04-012025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact000528"
      unitRef="Shares">-100</BTCY:TemporaryEquitySharesConversionOfMezzanineEquityIntoCommonShares>
    <BTCY:TemporaryEquitySharesConversionOfMezzanineEquityIntoCommonSharesValue
      contextRef="From2024-04-012025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="0"
      id="Fact000530"
      unitRef="USD">-571630</BTCY:TemporaryEquitySharesConversionOfMezzanineEquityIntoCommonSharesValue>
    <BTCY:TemporaryEquitySharesConversionOfMezzanineEquityIntoCommonSharesValue
      contextRef="From2024-04-012025-03-31_custom_MezzanineEquityMember"
      decimals="0"
      id="Fact000532"
      unitRef="USD">-571630</BTCY:TemporaryEquitySharesConversionOfMezzanineEquityIntoCommonSharesValue>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000536"
      unitRef="Shares">4365022</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000521"
      unitRef="USD">4365</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      decimals="INF"
      id="Fact000538"
      unitRef="Shares">-320321</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      decimals="0"
      id="Fact000522"
      unitRef="USD">-228786</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-04-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000523"
      unitRef="USD">1240257</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000526"
      unitRef="USD">1015836</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <BTCY:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne
      contextRef="From2024-04-012025-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000548"
      unitRef="Shares">-6104</BTCY:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne>
    <BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne
      contextRef="From2024-04-012025-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000540"
      unitRef="USD">-6</BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne>
    <BTCY:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000550"
      unitRef="Shares">8952170</BTCY:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesOne>
    <BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000541"
      unitRef="USD">8952</BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne>
    <BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne
      contextRef="From2024-04-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000543"
      unitRef="USD">4925756</BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne>
    <BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000546"
      unitRef="USD">4934702</BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesOne>
    <BTCY:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesTwo
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000560"
      unitRef="Shares">1595445</BTCY:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesTwo>
    <BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesTwo
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000553"
      unitRef="USD">1595</BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesTwo>
    <BTCY:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesTwo
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      decimals="INF"
      id="Fact000562"
      unitRef="Shares">577644</BTCY:StockIssuedDuringPeriodSharesConversionOfConvertibleSecuritiesTwo>
    <BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesTwo
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      decimals="0"
      id="Fact000554"
      unitRef="USD">259245</BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesTwo>
    <BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesTwo
      contextRef="From2024-04-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000555"
      unitRef="USD">2170338</BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesTwo>
    <BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesTwo
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000558"
      unitRef="USD">2431178</BTCY:StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesTwo>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000572"
      unitRef="Shares">716666</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000565"
      unitRef="USD">717</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      decimals="INF"
      id="Fact000574"
      unitRef="Shares">-20000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-04-012025-03-31_custom_SharesToBeIssuedMember"
      decimals="0"
      id="Fact000566"
      unitRef="USD">-15280</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-04-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000567"
      unitRef="USD">335446</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000570"
      unitRef="USD">320883</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <BTCY:StockIssuedDuringPeriodSharesForSettlementOfAccountsPayable
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000584"
      unitRef="Shares">1000413</BTCY:StockIssuedDuringPeriodSharesForSettlementOfAccountsPayable>
    <BTCY:StockIssuedDuringPeriodValueForSettlementOfAccountsPayable
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000577"
      unitRef="USD">1000</BTCY:StockIssuedDuringPeriodValueForSettlementOfAccountsPayable>
    <BTCY:StockIssuedDuringPeriodValueForSettlementOfAccountsPayable
      contextRef="From2024-04-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000579"
      unitRef="USD">989408</BTCY:StockIssuedDuringPeriodValueForSettlementOfAccountsPayable>
    <BTCY:StockIssuedDuringPeriodValueForSettlementOfAccountsPayable
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000582"
      unitRef="USD">990409</BTCY:StockIssuedDuringPeriodValueForSettlementOfAccountsPayable>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="From2024-04-012025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000589"
      unitRef="USD">1461698</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000592"
      unitRef="USD">1461698</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-04-012025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000598"
      unitRef="USD">113414</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000600"
      unitRef="USD">113414</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000607"
      unitRef="USD">-8421179</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000608"
      unitRef="USD">-8421179</us-gaap:NetIncomeLoss>
    <BTCY:PreferredStockDividends
      contextRef="From2024-04-012025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000615"
      unitRef="USD">466141</BTCY:PreferredStockDividends>
    <BTCY:PreferredStockDividends
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000616"
      unitRef="USD">466141</BTCY:PreferredStockDividends>
    <BTCY:AccumulatedDeficitDeemedDividend
      contextRef="From2024-04-012025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000623"
      unitRef="USD">-3054680</BTCY:AccumulatedDeficitDeemedDividend>
    <BTCY:AccumulatedDeficitDeemedDividend
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000624"
      unitRef="USD">-3054680</BTCY:AccumulatedDeficitDeemedDividend>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="AsOf2025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember243855328"
      decimals="INF"
      id="Fact000634"
      unitRef="Shares">385</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember243855328"
      decimals="INF"
      id="Fact000636"
      unitRef="USD">2000290</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-03-31_custom_MezzanineEquityMember"
      decimals="INF"
      id="Fact000638"
      unitRef="USD">2000290</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact000640"
      unitRef="Shares">201</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_PreferredStockMember"
      decimals="0"
      id="Fact000626"
      unitRef="USD">1</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000642"
      unitRef="Shares">26241967</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000627"
      unitRef="USD">26243</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_custom_SharesToBeIssuedMember"
      decimals="INF"
      id="Fact000644"
      unitRef="Shares">581599</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_custom_SharesToBeIssuedMember"
      decimals="0"
      id="Fact000628"
      unitRef="USD">284244</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000629"
      unitRef="USD">106971115</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_AccumulatedOtherComprehensiveIncomeMember"
      decimals="0"
      id="Fact000630"
      unitRef="USD">145792</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000631"
      unitRef="USD">-139441785</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000632"
      unitRef="USD">-32014390</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000649"
      unitRef="USD">-2404139</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000650"
      unitRef="USD">-8421179</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000655"
      unitRef="USD">25632</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000656"
      unitRef="USD">1461698</us-gaap:ShareBasedCompensation>
    <BTCY:IssuanceOfSharesForServices
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000658"
      unitRef="USD">3770</BTCY:IssuanceOfSharesForServices>
    <BTCY:IssuanceOfSharesForServices
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000659"
      unitRef="USD">320883</BTCY:IssuanceOfSharesForServices>
    <BTCY:IssuanceOfWarrantsForBrokersAtFairValue
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000661"
      unitRef="USD">38078</BTCY:IssuanceOfWarrantsForBrokersAtFairValue>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000664"
      unitRef="USD">-745896</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000665"
      unitRef="USD">-1939816</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000667"
      unitRef="USD">-167349</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000668"
      unitRef="USD">-553856</us-gaap:DerivativeGainLossOnDerivativeNet>
    <BTCY:LossGainOnDebtConversionAndRedemption
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000670"
      unitRef="USD">-1252</BTCY:LossGainOnDebtConversionAndRedemption>
    <BTCY:LossGainOnDebtConversionAndRedemption
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000671"
      unitRef="USD">137934</BTCY:LossGainOnDebtConversionAndRedemption>
    <BTCY:LossUponSettlementOfAccountsPayable
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000674"
      unitRef="USD">249093</BTCY:LossUponSettlementOfAccountsPayable>
    <us-gaap:Depreciation
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000679"
      unitRef="USD">5953</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000680"
      unitRef="USD">5953</us-gaap:Depreciation>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000685"
      unitRef="USD">1334260</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000686"
      unitRef="USD">110923</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <BTCY:IncreaseDecreaseInOperatingRightOfUseAssetsAmortization
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000688"
      unitRef="USD">-465839</BTCY:IncreaseDecreaseInOperatingRightOfUseAssetsAmortization>
    <BTCY:IncreaseDecreaseInOperatingRightOfUseAssetsAmortization
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000689"
      unitRef="USD">-409540</BTCY:IncreaseDecreaseInOperatingRightOfUseAssetsAmortization>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000691"
      unitRef="USD">-214090</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000692"
      unitRef="USD">-324017</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000694"
      unitRef="USD">372511</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000695"
      unitRef="USD">747831</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000697"
      unitRef="USD">1531530</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000700"
      unitRef="USD">195070</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000701"
      unitRef="USD">1496966</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000703"
      unitRef="USD">-718955</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000704"
      unitRef="USD">-2380177</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000710"
      unitRef="USD">125227</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000713"
      unitRef="USD">1732532</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <us-gaap:PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000715"
      unitRef="USD">200000</us-gaap:PaymentsForRepurchaseOfPreferredStockAndPreferenceStock>
    <us-gaap:ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000719"
      unitRef="USD">1835000</us-gaap:ProceedsFromRepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000721"
      unitRef="USD">1381769</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000722"
      unitRef="USD">-1733516</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfOtherLongTermDebt
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000724"
      unitRef="USD">600000</us-gaap:RepaymentsOfOtherLongTermDebt>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000727"
      unitRef="USD">24033</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000728"
      unitRef="USD">29984</us-gaap:PaymentsOfDividendsPreferredStockAndPreferenceStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000730"
      unitRef="USD">557736</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000731"
      unitRef="USD">1929259</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000733"
      unitRef="USD">-54137</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000734"
      unitRef="USD">30003</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000736"
      unitRef="USD">-161219</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000737"
      unitRef="USD">-450918</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000739"
      unitRef="USD">365145</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="Fact000740"
      unitRef="USD">786060</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000742"
      unitRef="USD">149789</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000743"
      unitRef="USD">365145</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000748"
      unitRef="USD">2878857</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000749"
      unitRef="USD">3611939</us-gaap:InterestPaidNet>
    <BTCY:ConversionOfSeriesBNotesIntoCommonStock
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000757"
      unitRef="USD">433973</BTCY:ConversionOfSeriesBNotesIntoCommonStock>
    <BTCY:ConversionOfSeriesBNotesIntoCommonStock
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000758"
      unitRef="USD">5950545</BTCY:ConversionOfSeriesBNotesIntoCommonStock>
    <BTCY:ConversionOfConvertibleNotesIntoCommonStock
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000761"
      unitRef="USD">2401735</BTCY:ConversionOfConvertibleNotesIntoCommonStock>
    <BTCY:WarrantsIssuedAndRecordedAsDebtDiscount
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000763"
      unitRef="USD">38078</BTCY:WarrantsIssuedAndRecordedAsDebtDiscount>
    <us-gaap:NatureOfOperations contextRef="From2025-04-01to2026-03-31" id="Fact000766">&lt;p id="xdx_80E_eus-gaap--NatureOfOperations_zDzK4aVV7we9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;1.
&lt;span id="xdx_82A_zwU9bDcAhW0j"&gt;NATURE OF OPERATIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Biotricity
Inc. (formerly MetaSolutions, Inc.) (the &#x201c;Company&#x201d; or &#x201c;Biotricity&#x201d;) was incorporated under the laws of the State
of Nevada on August 29, 2012. iMedical Innovations Inc. (&#x201c;iMedical&#x201d;) was incorporated on July 3, 2014 under the laws of the
Province of Ontario, Canada and became a wholly-owned subsidiary of Biotricity through reverse take-over on February 2, 2016.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company and iMedical are engaged in the research,
development and commercialization of technology-enabled healthcare solutions focused on remote patient monitoring, diagnostics and chronic
disease management. The Company&#x2019;s principal products include the Bioflux&#xae; platform, a mobile cardiac telemetry and remote cardiac
monitoring solution designed to assist healthcare providers in the diagnosis and management of cardiac arrhythmias, and the Biocore&#xae;
platform, a wearable remote monitoring solution that enables the collection, transmission and analysis of physiological data. The Company
is focused on developing and commercializing an ecosystem of connected healthcare technologies that improve patient outcomes while providing
healthcare providers with actionable clinical information.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;To date, the Company&#x2019;s efforts have been primarily
devoted to research and development activities, product commercialization, expanding its customer base, and enhancing its remote monitoring
technology platform and related services.&#160;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:NatureOfOperations>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000768">&lt;p id="xdx_807_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zw4p0lU8K0hk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2.
&lt;span id="xdx_823_zjIEYAMYOpd5"&gt;BASIS OF PRESENTATION, MEASUREMENT AND CONSOLIDATION&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the
United States of America (&#x201c;US GAAP&#x201d;) and are expressed in United States dollars (&#x201c;USD&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements of the Company have been prepared on a historical cost basis except Cash and derivative liabilities
which are carried at fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. Significant intercompany accounts
and transactions have been eliminated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Reclassifications&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Certain
amounts presented in the prior year period have been reclassified to conform to current period consolidated financial statement presentation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Going
Concern, Liquidity and Basis of Presentation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;The accompanying consolidated financial statements
have been prepared assuming that the Company will continue as a going concern. The Company continues to focus on commercialization of
its products, expansion of its customer base and development of additional technologies and services.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;As of March 31, 2026, the Company had cash and cash
equivalents of $&lt;span id="xdx_90C_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20260331_zYKkqilO98Mf" title="Cash and cash equivalents at carrying value"&gt;149,789&lt;/span&gt; (2025: $&lt;span id="xdx_90E_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20250331_zpoEzT6K4JC1" title="Cash and cash equivalents at carrying value"&gt;365,145&lt;/span&gt;), an accumulated deficit of $&lt;span id="xdx_90A_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20260331_zvFZZkZ12aG7" title="Accumulated deficit"&gt;142,570,243&lt;/span&gt; (2025: $&lt;span id="xdx_909_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_di_c20250331_zIZPZBhIGhGl" title="Accumulated deficit"&gt;139,441,785&lt;/span&gt;), and a working capital deficiency
of $&lt;span id="xdx_90F_ecustom--WorkingCapitalDeficiency_iI_c20260331_zNOIeqlKnOoc" title="Working capital deficiency"&gt;31,284,762&lt;/span&gt; (2025: $&lt;span id="xdx_908_ecustom--WorkingCapitalDeficiency_iI_c20250331_zHXFYDMONmTf" title="Working capital deficiency"&gt;15,996,856&lt;/span&gt;). During the year ended March 31, 2026, the Company generated income from operations of $&lt;span id="xdx_90F_eus-gaap--OperatingIncomeLoss_c20250401__20260331_zStS9qtpEGd2" title="Operating income loss"&gt;1,691,236&lt;/span&gt; (2025:
negative $&lt;span id="xdx_908_eus-gaap--OperatingIncomeLoss_iN_di_c20240401__20250331_zHDQse1lNxif" title="Operating income loss"&gt;2,448,966&lt;/span&gt;) but used $&lt;span id="xdx_904_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_di_c20250401__20260331_zW0imlVYqUXe" title="Net cash provided by used in operating activities"&gt;718,955&lt;/span&gt; of cash in operating activities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;The Company&#x2019;s limited cash resources, working capital deficiency and ongoing need for additional financing to support
operations and satisfy debt obligations raise substantial doubt about its ability to continue as a going concern within one year after
the issuance date of these consolidated financial statements. The Company&#x2019;s ability to continue as a going concern is dependent upon its
ability to generate positive cash flows from operations, obtain additional financing and meet its obligations as they become due.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000770"
      unitRef="USD">149789</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000772"
      unitRef="USD">365145</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000774"
      unitRef="USD">-142570243</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000776"
      unitRef="USD">-139441785</us-gaap:RetainedEarningsAccumulatedDeficit>
    <BTCY:WorkingCapitalDeficiency
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000778"
      unitRef="USD">31284762</BTCY:WorkingCapitalDeficiency>
    <BTCY:WorkingCapitalDeficiency
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000780"
      unitRef="USD">15996856</BTCY:WorkingCapitalDeficiency>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000782"
      unitRef="USD">1691236</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000784"
      unitRef="USD">-2448966</us-gaap:OperatingIncomeLoss>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000786"
      unitRef="USD">-718955</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000788">&lt;p id="xdx_807_eus-gaap--SignificantAccountingPoliciesTextBlock_zYdISq3M7yei" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3.
&lt;span id="xdx_828_zolaoNSO90q5"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--RevenueRecognitionPolicyTextBlock_zEIpYOGVyG3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Revenue
Recognition&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopted Accounting Standards Codification Topic 606, &#x201c;Revenue from Contracts with Customers&#x201d; (&#x201c;ASC 606&#x201d;). In accordance with ASC 606, revenue is recognized when promised goods or services are transferred to customers in an
amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services by applying
the core principles &#x2013; (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3)
determine the transaction price, (4) allocate the transaction price to performance obligations in the contract, and (5) recognize revenue
as performance obligations are satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Both
the Bioflux mobile cardiac telemetry device, and the Biocore device are wearable devices. The cardiac data that the devices monitor and
collect is curated and analyzed by the Company&#x2019;s proprietary algorithms and then securely communicated to a remote monitoring facility
for electronic reporting and conveyance to the patient&#x2019;s prescribing physician or other certified cardiac medical professional.
Revenues earned are comprised of device sales revenues and technology fee revenues (technology as a service). The devices, together with
their licensed software, are available for sale to the medical center or physician, who is responsible for the delivery of clinical diagnosis
and therapy. The remote monitoring, data collection and reporting services performed by the technology culminate in a patient study that
is generally billable when it is complete and is issued to the physician. In order to recognize revenue, management considers whether
or not the following criteria are met: persuasive evidence of a commercial arrangement exists, and delivery has occurred or services
have been rendered. For sales of devices, which are invoiced directly, additional revenue recognition criteria include that the price
is fixed and determinable and collectability is reasonably assured; for device sales contracts with terms of more than one year, the
Company recognizes any significant financing component as revenue over the contractual period using the effective interest method, and
the associated interest income is reflected accordingly on the statement of operations and included in other income; for revenue that
is earned based on customer usage of the proprietary software to render a patient&#x2019;s cardiac study, the Company recognizes revenue
when the study ends based on a fixed billing rate. Costs associated with providing the services are recorded as the service is provided
regardless of whether or when revenue is recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company may also earn service-related revenue from contracts with other counterparties with which it consults. This contract work is
separate and distinct from services provided to clinical customers, but may be with a reseller or other counterparties that are working
to establish their operations in foreign jurisdictions or ancillary products or market segments in which the Company has expertise and
may eventually conduct business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_zilMv3XpMDyb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized the following forms of revenue for the fiscal years ended March 31, 2026 and 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B8_zviajit8svF3" style="display: none"&gt;SCHEDULE OF REVENUE RECOGNITION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20250401__20260331_z1LpaHb9G5j2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240401__20250331_zWmXA3A3yGq8" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--TechnologyFeesMember_zRy4YTYV4m6i" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Technology
    fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,440,900&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,591,036&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--DeviceSalesMember_zqTVDAQB8go6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Device
    sales&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,557,339&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,199,258&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zAWMrmmdPmMf" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue recognized&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,998,239&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,790,294&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zNGVjoOUuZyf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--InventoryPolicyTextBlock_zAZ6PLIRVeT5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Inventories&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;Inventory is stated at the lower of cost or net realizable value, with cost determined using the weighted-average cost method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;The cost of raw materials includes purchase costs
and freight-in charges directly attributable to acquiring the inventory. The cost of finished goods includes direct labor, manufacturing
overhead, freight and other costs incurred in bringing the inventory to its present location and condition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;Net realizable value is based on estimated selling prices
in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;The Company evaluates inventory for excess quantities,
obsolescence and slow-moving items based on historical usage, forecasted demand, product life cycles, technological developments and market
conditions. Inventory write-downs are recorded when the carrying value of inventory exceeds its estimated net realizable value. Such write-downs
are recorded within cost of revenues and establish a new cost basis for the inventory.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_ziYXfW5FfTXh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zJwoKbgR7EJc" style="display: none"&gt;SCHEDULE OF INVENTORIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20260331_zfKzfIigfD1" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20250331_zsph66zd5yLe" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzF7M_zsaOqIwtbit3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Raw
    material&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;768,587&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,225,665&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_maINzF7M_zw73xXm2yfe" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Finished
    goods&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;572,708&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;329,720&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--InventoryNet_iTI_mtINzF7M_zC0o3jgTlqk3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,341,295&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,555,385&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AF_znxzFCAQYJc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Accounts
Receivable - Net&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_ecustom--AccountsReceivablesNetPolicyTextBlock_zAj0KnvhUHgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zNNt2Pbr9Rzd"&gt;Accounts
Receivable&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Accounts
receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for expected credit losses
to estimate the amount of receivables that may not be collected. The allowance is determined using a current expected credit loss (&#x201c;CECL&#x201d;)
methodology that incorporates historical loss experience, current economic conditions, aging of receivable balances, customer-specific
risk characteristics and reasonable and supportable forecasts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;The
Company evaluates receivables collectively based on similar risk characteristics, including customer payment history, aging status, customer
significance and other relevant factors. Receivables deemed uncollectible are written off against the allowance when collection efforts
have been exhausted. Recoveries of amounts previously written off are recorded when received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zxZbPA4r6qb8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_z2mDbPX4EYcb" style="display: none"&gt;SCHEDULE
OF ACCOUNTS RECEIVABLE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20260331_z2Bm105OfZg" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal Year 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20250331_zBZZLcLFLu81" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal Year 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccountsReceivableGross_iI_maARGCzzRD_zbCUwQEraQlj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Gross
    Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; font-weight: bold; text-align: right"&gt;1,911,354&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; font-weight: bold; text-align: right"&gt;1,347,417&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_maARGCzzRD_z2i6EbWbQr7e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Other
    Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,092,371&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;382,215&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccountsReceivableGrossCurrent_iTI_mtARGCzzRD_maARNCzQBJ_zszTud9j5pcd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Gross
    Receivables&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,003,725&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,729,632&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_msARNCzQBJ_z0U6jMEqvd6g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Provision&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(70,826&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(70,860&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsReceivableNetCurrent_iTI_mtARNCzQBJ_zBEGfRw49BUk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Balance
    end of year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;2,932,899&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,658,772&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zx0DBFJcjCH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable primarily consist of amounts due from medical facilities, government programs, and patients arising from the Company&#x2019;s normal
course of business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
receivables primarily consist of accrued receivables related to device sales embedded in all-inclusive arrangements, unbilled sales,
accrued technology fees, receivables from third parties, CARES Act payroll tax refund receivables and receivables from e-commerce platforms.
Included in other receivables is a CARES Act payroll tax refund receivable of $&lt;span id="xdx_904_eus-gaap--OtherReceivablesNetCurrent_iI_c20260331_z9o1WsLJpuf8" title="Other receivables net current"&gt;576,000&lt;/span&gt; as of March 31, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
increase in accounts receivable during fiscal 2026 was primarily attributable to increased revenue volume, timing differences in collections
from customers and third-party payors, and the recognition of the CARES Act payroll tax refund receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accounts
Receivable Aging&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--AccountsReceivableNoncurrentPastDueTableTextBlock_z2PxLVc4QQbi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aging analysis below relates only to trade accounts receivable and excludes other receivables.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zvKuQS6dlYgc" style="display: none"&gt;SCHEDULE
OF ACCOUNTS RECEIVABLE AGING&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20260331_z4KBPbz5Yda9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20250331_z1EhOjzS3Jg4" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--OneToThirtyDaysMember_z7xIbjRZx1Aa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Current&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;11,813&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 16%"&gt;189,740&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--ThirtyOneToSixtyDaysMember_zQhud1jbjG1c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;31-60 days&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;852,358&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;13,281&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--SixtyOneToNinetyDaysMember_z96dXg78rwDf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;61-90 days&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;686,298&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;586,218&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--NinetyOneToOneEigthyDaysMember_zh0hMt75rcel" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;91-180 days&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;329,511&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;493,856&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--OneEigthyDaysOrMoreMember_zLKdKy72KMZj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;180 days or more&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;31,372&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;73,321&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NontradeReceivablesCurrent_iI_zhZFiQeUwoG2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;b&gt;1,911,353&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;1,347,417&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zNv66H2KLPn5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Allowance
for Expected Credit Losses&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zcLPEzHRKHcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Changes
in the allowance for expected credit losses for the year ended March 31, 2026 &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
2025 &lt;span style="font-weight: normal"&gt;were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zqJ8pLrHVfzf" style="display: none"&gt;SCHEDULE
OF CHANGE IN ALLOWANCE FOR CREDIT LOSSES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20250401__20260331_zzRZTvd2MXw4" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal Year 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240401__20250331_zxAaCxSvfDKd" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal Year 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iS_z1li0WHPRoq1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; font-weight: bold; font-style: italic; text-align: left"&gt;Balance beginning of year&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; font-weight: bold; text-align: right"&gt;70,860&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; font-weight: bold; text-align: right"&gt;59,546&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_di_zI2mE158P3o" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Write - offs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(74,780&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(48,686&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_z1kbxwFbZaLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Recoveries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0866"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ProvisionForDoubtfulAccounts_zZChzYLZZc9a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Provision during the year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;14,746&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iE_z8JRGa6g96Ai" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt"&gt;Balance end of year&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;70,826&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;70,860&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AA_zszMRWY1olgb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eus-gaap--UseOfEstimates_zJyyN6itMoLh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Significant
accounting estimates and assumptions&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the consolidated financial statements requires the use of estimates and assumptions to be made in applying the accounting
policies that affect the reported amounts of assets, liabilities, revenue and expenses and the disclosure of contingent assets and liabilities.
The estimates and related assumptions are based on previous experiences and other factors considered reasonable under the circumstances,
the results of which form the basis for making the assumptions about the carrying values of assets and liabilities that are not readily
apparent from other sources.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period
in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the
revision affects both current and future periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant
accounts that require estimates as the basis for determining the stated amounts include share-based compensation, impairment analysis
and fair value of warrants, promissory notes, convertible notes and derivative liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Fair
    value of stock options and warrants&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company measures the fair value of stock options and warrants granted to employees, directors, consultants, service
providers and financing counterparties using the Black-Scholes option pricing model. The determination of fair value requires management
to make estimates and assumptions regarding the expected term of the instrument, expected volatility of the Company&#x2019;s common stock, risk-free
interest rate, expected dividend yield and, where applicable, forfeiture rates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;The fair value of stock options
is recognized as stock based compensation expense over the requisite service period. The fair value of warrants issued in
connection with financing transactions or for services is recorded based on the nature of the underlying transaction and classified
as either equity or liability in accordance with applicable accounting guidance.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Fair
    value of derivative liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
determining the fair values of the derivative liabilities from the conversion and redemption features, the Company used Monte-Carlo and
lattice models with the following assumptions: dividend yields, volatility, risk-free rate and the remaining expected life. Changes in
those assumptions and inputs could in turn impact the fair value of the derivative liabilities and can have a material impact on the
reported loss and comprehensive loss for the applicable reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Functional
    currency&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Determining
the appropriate functional currencies for entities in the Company requires analysis of various factors, including the currencies and
country-specific factors that mainly influence labor, materials, and other operating expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Useful
    life of property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company employs significant estimates to determine the estimated useful lives of property and equipment, considering industry trends
such as technological advancements, past experience, expected use and review of asset useful lives. The Company makes estimates when
determining depreciation methods, depreciation rates and asset useful lives, which requires considering industry trends and company-specific
factors. The Company reviews depreciation methods, useful lives and residual values annually or when circumstances change and adjusts
its depreciation methods and assumptions prospectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Provisions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Provisions
are recognized when the Company has a present obligation, legal or constructive, as a result of a previous event, if it is probable that
the Company will be required to settle the obligation and a reliable estimate can be made of the obligation. The amount recognized is
the best estimate of the expenditure required to settle the present obligation at the end of the reporting period, taking into account
the risks and uncertainties surrounding the obligations. Provisions are reviewed at the end of each reporting period and adjusted to
reflect the current best estimate of the expected future cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Contingencies&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Contingencies
can be either possible assets or possible liabilities arising from past events, which, by their nature, will be resolved only when one
or more uncertain future events occur or fail to occur. The assessment of the existence and potential impact of contingencies inherently
involves the exercise of significant judgment and the use of estimates regarding the outcome of future events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Inventory
    obsolescence&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;Inventories are stated at the lower
of cost and net realizable value. Net realizable value of our inventory is generally the selling price less normally predictable costs
of disposal and transportation. The Company estimates net realizable value as the amount at which inventories are expected to be sold,
taking into consideration fluctuations in retail prices less estimated costs necessary to make the sale. Inventories are written down
to net realizable value when the cost of inventories is estimated to be unrecoverable due to obsolescence, damage, or declining selling
prices.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Income
    and other taxes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of current and deferred income taxes requires the Company to make estimates and assumptions and to exercise judgment regarding
the carrying values of assets and liabilities which are subject to accounting estimates inherent in those balances, the interpretation
of income tax legislation across various jurisdictions, expectations about future operating results, the timing of reversal of temporary
differences and possible audits of income tax filings by the tax authorities. In addition, when the Company incurs losses for income
tax purposes, it assesses the probability of taxable income being available in the future based on its budgeted forecasts. These forecasts
are adjusted to take into account certain non-taxable income and expenses and specific rules on the use of unused credits and tax losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the forecasts indicate that sufficient future taxable income will be available to deduct the temporary differences, a deferred tax asset
is recognized for all deductible temporary differences. Changes or differences in underlying estimates or assumptions may result in changes
to the current or deferred income tax balances on the consolidated balance sheets, a charge or credit to income tax expense included
as part of net income (loss) and may result in cash payments or receipts. Judgment includes consideration of the Company&#x2019;s future
cash requirements in its tax jurisdictions. All income, capital and commodity tax filings are subject to audits and reassessments. Changes
in interpretations or judgments may result in a change in the Company&#x2019;s income, capital, or commodity tax provisions in the future.
The amount of such a change cannot be reasonably estimated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Incremental
    borrowing rate for lease&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
determination of the Company&#x2019;s lease obligation and right-of-use asset depends on certain assumptions, which include the selection
of the discount rate. The discount rate is set by reference to the Company&#x2019;s incremental borrowing rate. Significant assumptions
are required to be made when determining which borrowing rates to apply in this determination. Changes in the assumptions used may have
a significant effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zhyE9TiK6Fyj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Earnings
(Loss) Per Share&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has adopted the Financial Accounting Standards Board&#x2019;s (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;)
Topic 260-10 which provides for calculation of &#x201c;basic&#x201d; and &#x201c;diluted&#x201d; earnings per share. Basic loss per share
of common stock is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period.
Diluted earnings or loss per share of common stock is computed similarly to basic earnings or loss per share except the weighted average
shares outstanding are increased to include additional shares from the assumed exercise of any common stock equivalents, if dilutive.
The Company&#x2019;s warrants, options, convertible promissory notes, convertible preferred stock, shares to be issued and restricted
stock awards while outstanding are considered common stock equivalents for this purpose. Diluted earnings is computed utilizing the treasury
method for the warrants, stock options, shares to be issued and restricted stock awards. Diluted earnings with respect to the convertible
promissory notes and convertible preferred stock utilizing the if-converted method was not applicable during the periods presented as
no conditions required for conversion had occurred. No incremental common stock equivalents were included in calculating diluted loss
per share because such inclusion would be anti-dilutive given the net loss reported for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zy0QsNMa3BWa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Cash&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
includes cash on hand and balances with banks.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026, and 2025, cash balance of US$ &lt;span id="xdx_902_eus-gaap--CashFDICInsuredAmount_iI_c20260331_zM4SGhUssSuf" title="US deposit protected"&gt;140,932&lt;/span&gt; and US$ &lt;span id="xdx_909_eus-gaap--CashFDICInsuredAmount_iI_c20250331_zDxpkrtf5XGh" title="US deposit protected"&gt;259,478&lt;/span&gt; were at financial institutions in the United States that were
not covered by the United States Deposit Protection Regulation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zS0OthK9lLB5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Foreign
Currency Translation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
functional currency of the Company&#x2019;s Canadian-based subsidiary is the Canadian dollar and the US-based parent is the U.S. dollar.
Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange
rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated using
the exchange rate prevailing at the consolidated balance sheet date. Non-monetary assets and liabilities are translated using the historical
rate on the date of the transaction. All exchange gains or losses arising from translation of these foreign currency transactions are
included in net income (loss) for the year. In translating the financial statements of the Company&#x2019;s Canadian subsidiary from their
functional currency into the Company&#x2019;s reporting currency of United States dollars, consolidated balance sheet accounts are translated
using the closing exchange rate in effect at the consolidated balance sheet date and income and expense accounts are translated using
an average exchange rate prevailing during the reporting period. Adjustments resulting from the translation, if any, are included in
accumulated other comprehensive loss in stockholders&#x2019; deficiency. The Company has not, to the date of these consolidated financial
statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--TradeAndOtherAccountsReceivablePolicy_z6NNwELwMaAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Accounts
Receivable&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;Accounts receivable consists of amounts due to the Company from medical
facilities, which receive reimbursement from institutions and third-party government and commercial payors and their related patients,
as a result of the Company&#x2019;s normal business activities. Accounts receivable is reported on the consolidated balance sheets net
of an estimated allowance for expected credit losses. The Company establishes an allowance for expected credit losses for estimated uncollectible
receivables based on historical experience, assessment of specific risk, review of outstanding invoices, and various assumptions and estimates
that are believed to be reasonable under the circumstances, and recognizes the provision as a component of selling, general and administrative
expenses. Uncollectible accounts are written off against the allowance after appropriate collection efforts have been exhausted and when
it is deemed that a balance is uncollectible.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zc17brr5uAP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Customer
Concentration&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;For the year ended March 31, 2026,
two customer accounted for &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250401__20260331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zv5hKiTrhfji" title="Concentration risk, percentage"&gt;20&lt;/span&gt;% and &lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250401__20260331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z47W65O5I5M2" title="Concentration risk, percentage"&gt;10&lt;/span&gt;%
of the Company&#x2019;s revenues. For the year ended March 31, 2025, one customer accounted for approximately &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240401__20250331__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zgIObMVAKevc" title="Concentration risk, percentage"&gt;29&lt;/span&gt;%
of the Company&#x2019;s revenues.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zvmaQlTUZC2g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
820 defines fair value, establishes a framework for measuring fair value and expands required disclosure about fair value measurements
of assets and liabilities. ASC 820-10 defines fair value as the exchange price that would be received for an asset or paid to transfer
a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between
market participants on the measurement date. ASC 820-10 also establishes a fair value hierarchy, which requires an entity to maximize
the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels
of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
Level 1 &#x2013; Valuation based on quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
Level 2 &#x2013; Valuation based on quoted market prices for similar assets and liabilities in active markets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
Level 3 &#x2013; Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management&#x2019;s
best estimate of what market participants would use as fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy,
the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is
significant to the fair value measurement in its entirety. The Company&#x2019;s assessment of the significance of a particular input to
the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. The respective
carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these
instruments or interest rates that are comparable to market rates. These financial instruments include cash, accounts receivable, deposits
and other receivables, convertible promissory notes and short term loans, federally guaranteed loans, term loans and accounts payable
and accrued liabilities. The Company&#x2019;s derivative liabilities are carried at fair values and are classified as Level 3 financial
instruments. The Company&#x2019;s bank accounts are maintained with financial institutions of reputable credit, therefore, bear minimal
credit risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_zSUnDrHkjf58" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of financial instruments measured on a recurring basis is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zDPhdlcd3BLc" style="display: none"&gt;SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_c20260331_zAZVWd7seu03" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0900"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zmXE5joUqEnf" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0902"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z2NL45M7f2Kf" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0904"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z9R6wrkSgUoa" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0906"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260331_zvQIS58etaog" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;445,893&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWljQFXTiy2a" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0910"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z60NPywTOE1i" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0912"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_za7j5fAt73Q9" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;445,893&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, long-term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20260331_zBnFVckbdzfk" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,396,908&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z5NyHnbIWi6d" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0918"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zi0y2D2MEhtd" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0920"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBWtEniX0V4l" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,396,908&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    liabilities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20260331_ztuYJLyEGaGd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,842,801&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZjILQbtR8ae" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0926"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zuTJ1lyLzMvi" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0928"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcexZ0PBtz4i" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,842,801&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20250331_zG3HX6D2pw1h" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0932"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2K6HgJCq345" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0934"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKqqpkTEhkB5" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0936"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlE7ifJTOOme" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0938"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20250331_zsaWEWVYpSRe" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;424,200&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zXf2dP17tq93" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0942"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zRwgiy2FOLU" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0944"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z2PdqJrEuOli" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;424,200&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, long-term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20250331_zDfxnnupV5Ca" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,478,717&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zQrE3emYQFMg" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0950"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zy10y8LH25u9" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0952"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWuIc8LRrwXf" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,478,717&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    liabilities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20250331_zEGWyKtElJJg" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,902,917&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zSzxOPlow02h" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0958"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQijVTTLu0Fd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0960"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zqPwESZndUk5" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,902,917&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zpwVGTf3KuI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were no transfers between fair value hierarchy levels during the years ended March 31, 2026 and 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zGuiK0icQz6b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Property
and Equipment&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated
useful lives of the assets. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful lives of
the assets. Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized. Depreciation
of property and equipment is provided using the straight-line method for all assets with estimated lives as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z6WD2tkkPgz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zCILF2UcK4Xk" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 25%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zKCiMm6WaMce" title="Property and equipment, useful life"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold
    improvement&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zaiNtiEsqPl2" title="Property and equipment, useful life"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A1_zuadV11YXQ03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zMhReNtOLA7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Impairment
for Long-Lived Assets&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company applies the provisions of ASC Topic 360, Property, Plant, and Equipment, which addresses financial accounting and reporting for
the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets, including right-of-use
assets, used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those
assets are less than the assets&#x2019; carrying amounts. In that event, a loss is recognized based on the amount by which the carrying
amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner,
except that fair values are reduced for the cost of disposal. Based on its review at March 31, 2026 and 2025, the Company believes there
was &lt;span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20250401__20260331_z7wx1cUa9RGj" title="Impairment of long-lived assets"&gt;&lt;span id="xdx_903_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20240401__20250331_zsFc97DCT6y6" title="Impairment of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt; impairment of its long-lived assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--LesseeLeasesPolicyTextBlock_z0nYF7wJQlCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Leases&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is the lessee in a lease contract when the Company obtains the right to use the asset. Operating leases are included in the line
items Operating right of use assets, Operating lease obligations, current, and Operating lease obligations, long-term in the consolidated
balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right-of-use
(&#x201c;ROU&#x201d;) asset represents the Company&#x2019;s right to use an underlying asset for the lease term and lease obligations represent
the Company&#x2019;s obligations to make lease payments arising from the lease, both of which are recognized based on the present value
of the future minimum lease payments over the lease term at the commencement date. Leases with a lease term of 12 months or less at inception
are not recorded on the consolidated balance sheet and are expensed on a straight-line basis over the lease term in the consolidated
statement of operations and comprehensive loss. The Company determines the lease term by agreement with lessor. As the Company&#x2019;s
lease does not provide implicit interest rate, the Company uses the Company&#x2019;s incremental borrowing rate based on the information
available at commencement date in determining the present value of future payments. Refer to Note 12 for further discussion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_z6fsA1jhGHB6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes in accordance with ASC 740. The Company provides for Federal, State and Provincial income taxes payable,
as well as for those deferred because of the timing differences between reporting income and expenses for consolidated financial statement
purposes versus tax purposes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences
between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.
Deferred tax assets and liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which
those temporary differences are expected to be recoverable or settled. The effect of a change in tax rates is recognized as income or
expense in the period of the change. A valuation allowance is established, when necessary, to reduce deferred income tax assets to the
amount that is more likely than not to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--ResearchAndDevelopmentExpensePolicy_zMAznh6Rrrv2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Research
and Development&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
and development costs, which relate primarily to product and software development, are charged to operations as incurred. Under certain
research and development arrangements with third parties, the Company may be required to make payments that are contingent on the achievement
of specific developmental, regulatory and/or commercial milestones. Before a product receives regulatory approval, milestone payments
made to third parties are expensed when the milestone is achieved&lt;b&gt;. &lt;/b&gt;Milestone payments made to third parties after regulatory approval
is received are capitalized and amortized over the estimated useful life of the approved product.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zvMfxYxlfzS4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Selling,
General and Administrative&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Selling,
general and administrative expenses consist primarily of personnel-related costs including stock based compensation for personnel
in functions not directly associated with research and development activities. Other significant costs include sales and marketing
costs, investor relation and legal costs relating to corporate matters, professional fees for consultants assisting with business
development and financial matters, and office and administrative expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z2cemBB6njNb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Stock
Based Compensation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for share-based payments in accordance with the provision of ASC 718, which requires that all share-based payments issued
to acquire goods or services, including grants of employee stock options, be recognized in the consolidated statements of operations
and comprehensive loss based on their fair values, net of estimated forfeitures. ASC 718 requires forfeitures to be estimated at the
time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Compensation expense
related to share-based awards is recognized over the requisite service period, which is generally the vesting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for stock based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the
fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable,
using the guidelines in ASC 505-50. The Company issues compensatory shares for services including, but not limited to, executive, management,
accounting, operations, corporate communication, financial and administrative consulting services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_841_eus-gaap--DebtPolicyTextBlock_zoPMb1UYAVfj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Convertible
Notes Payable and Derivative Instruments&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has adopted the provisions of ASU 2017-11 to account for the down round features of warrants issued with private placements. In doing so, warrants with a down round feature previously treated as derivative liabilities in the consolidated
balance sheet and measured at fair value are henceforth treated as equity, with no adjustment for changes in fair value at each reporting
period. Previously, the Company accounted for conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally
requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them
as free-standing derivative financial instruments. ASC 815 provides for an exception to this rule when convertible notes, as host instruments,
are deemed to be conventional, as defined by ASC 815-40. The Company accounts for convertible notes deemed conventional and conversion
options embedded in non-conventional convertible notes which qualify as equity under ASC 815, in accordance with the provisions of ASC
470-20, which provides guidance on accounting for convertible securities with beneficial conversion features. Accordingly, the Company
records, as a discount to convertible notes, the intrinsic value of such conversion options based upon the differences between the fair
value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the
note. Debt discounts under these arrangements are amortized over the term of the related debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_ecustom--ConvertiblePreferredStockPolicyTextBlock_zLhpcaSCTxSg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series
B Convertible Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series B convertible preferred stock (&#x201c;Series B Preferred Stock&#x201d;) was accounted for as mezzanine equity and the embedded
conversion and redemption features was accounted for as derivative liabilities with change in fair value at each reporting period end
charged to the consolidated statement of operation and comprehensive loss in accordance with ASC 480 and ASC 815.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_ecustom--PreferredSharesExtinguishmentsPolicyTextBlock_zR60gizXbau7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Preferred
Share Redemption and Conversions&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounted for preferred stock redemptions and conversions in accordance to ASU-260-10-S99. For Series A preferred stock redemptions,
the difference between the fair value of consideration transferred to the holders of the preferred stock and the carrying amount of the
preferred stock is accounted as deemed dividend distribution and subtracted from net loss. For Series B preferred stock conversions,
no gain or loss is recognized upon Series B preferred stock conversion except for the fair value adjustment for the conversion and redemption
feature derivative liabilities on the conversion date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zygy4CVUpzCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Segment
Information&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision
maker in deciding how to allocate resources and assessing performance. The Company has identified its Chief Executive Officer (&#x201c;CEO&#x201d;)
as the chief operating decision maker (&#x201c;CODM&#x201d;). The Company operates in &lt;span id="xdx_90F_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20250401__20260331_zzvwFK0uvT5g" title="Number of operating segment"&gt;one&lt;/span&gt; operating segment. The Company&#x2019;s CODM allocates
resources and assesses performance at the consolidated level. The Company&#x2019;s property and equipment and operating right of use lease
asset are in the United States as of March 31, 2026 and 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
CODM uses net loss for purposes of making operating decisions, allocating resources, and evaluating financial performance.
Significant expenses include non-cash stock based compensation, depreciation and amortization, and write-off of property and
equipment, which are reflected in the Consolidated Statements of Cash Flows for the years ended March 31, 2026 and 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
long-lived assets outside of U.S. are not material as of March 31, 2026. The measure of segment assets is reported on the balance sheet
as total consolidated assets. Refer to the Consolidated Balance Sheets as of March 31, 2026 and 2025 for total consolidated assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zFpO2RbmlMN9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Recently
Issued Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;On November 26, 2024, the FASB issued ASU 2024-04, &lt;i&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic
470-20): Induced Conversions of Convertible Debt Instruments&lt;/i&gt;. This ASU clarifies the accounting for certain settlements of convertible
debt instruments that occur at terms different from the original contractual conversion terms, specifically addressing whether such settlements
should be accounted for as induced conversions or debt extinguishments. The amendments are effective for fiscal years beginning after
December 15, 2025, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating
the impact of adopting ASU 2024-04 on its consolidated financial statements and related disclosures. At this time, the Company has not
determined the effect, if any, that adoption of this standard will have on its consolidated financial position, results of operations,
cash flows, or related disclosures.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In July 2025, the FASB issued ASU 2025-05, which provides
targeted improvements and practical expedients related to the application of the current expected credit loss (&#x201c;CECL&#x201d;) model.
The amendments are intended to simplify certain aspects of estimating expected credit losses while maintaining decision-useful information
for investors. The Company is currently evaluating the impact that adoption of this guidance may have on its consolidated financial statements
and related disclosures.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company continue to evaluate the impact of the new accounting pronouncement, including enhanced disclosure requirements, on our business
processes, controls and systems.&lt;/span&gt;&lt;/p&gt;
&lt;p id="xdx_850_z8YOpOWDEgV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000790">&lt;p id="xdx_840_eus-gaap--RevenueRecognitionPolicyTextBlock_zEIpYOGVyG3g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Revenue
Recognition&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company adopted Accounting Standards Codification Topic 606, &#x201c;Revenue from Contracts with Customers&#x201d; (&#x201c;ASC 606&#x201d;). In accordance with ASC 606, revenue is recognized when promised goods or services are transferred to customers in an
amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services by applying
the core principles &#x2013; (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3)
determine the transaction price, (4) allocate the transaction price to performance obligations in the contract, and (5) recognize revenue
as performance obligations are satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Both
the Bioflux mobile cardiac telemetry device, and the Biocore device are wearable devices. The cardiac data that the devices monitor and
collect is curated and analyzed by the Company&#x2019;s proprietary algorithms and then securely communicated to a remote monitoring facility
for electronic reporting and conveyance to the patient&#x2019;s prescribing physician or other certified cardiac medical professional.
Revenues earned are comprised of device sales revenues and technology fee revenues (technology as a service). The devices, together with
their licensed software, are available for sale to the medical center or physician, who is responsible for the delivery of clinical diagnosis
and therapy. The remote monitoring, data collection and reporting services performed by the technology culminate in a patient study that
is generally billable when it is complete and is issued to the physician. In order to recognize revenue, management considers whether
or not the following criteria are met: persuasive evidence of a commercial arrangement exists, and delivery has occurred or services
have been rendered. For sales of devices, which are invoiced directly, additional revenue recognition criteria include that the price
is fixed and determinable and collectability is reasonably assured; for device sales contracts with terms of more than one year, the
Company recognizes any significant financing component as revenue over the contractual period using the effective interest method, and
the associated interest income is reflected accordingly on the statement of operations and included in other income; for revenue that
is earned based on customer usage of the proprietary software to render a patient&#x2019;s cardiac study, the Company recognizes revenue
when the study ends based on a fixed billing rate. Costs associated with providing the services are recorded as the service is provided
regardless of whether or when revenue is recognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company may also earn service-related revenue from contracts with other counterparties with which it consults. This contract work is
separate and distinct from services provided to clinical customers, but may be with a reseller or other counterparties that are working
to establish their operations in foreign jurisdictions or ancillary products or market segments in which the Company has expertise and
may eventually conduct business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_eus-gaap--ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_zilMv3XpMDyb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized the following forms of revenue for the fiscal years ended March 31, 2026 and 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B8_zviajit8svF3" style="display: none"&gt;SCHEDULE OF REVENUE RECOGNITION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20250401__20260331_z1LpaHb9G5j2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240401__20250331_zWmXA3A3yGq8" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--TechnologyFeesMember_zRy4YTYV4m6i" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Technology
    fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,440,900&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,591,036&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--DeviceSalesMember_zqTVDAQB8go6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Device
    sales&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,557,339&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,199,258&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zAWMrmmdPmMf" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue recognized&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,998,239&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,790,294&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zNGVjoOUuZyf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000792">&lt;p id="xdx_89F_eus-gaap--ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_zilMv3XpMDyb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognized the following forms of revenue for the fiscal years ended March 31, 2026 and 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B8_zviajit8svF3" style="display: none"&gt;SCHEDULE OF REVENUE RECOGNITION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20250401__20260331_z1LpaHb9G5j2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240401__20250331_zWmXA3A3yGq8" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--TechnologyFeesMember_zRy4YTYV4m6i" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Technology
    fees&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,440,900&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,591,036&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--DeviceSalesMember_zqTVDAQB8go6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Device
    sales&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,557,339&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,199,258&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_zAWMrmmdPmMf" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Revenue recognized&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;15,998,239&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,790,294&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-04-012026-03-31_custom_TechnologyFeesMember"
      decimals="0"
      id="Fact000794"
      unitRef="USD">14440900</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-04-012025-03-31_custom_TechnologyFeesMember"
      decimals="0"
      id="Fact000795"
      unitRef="USD">12591036</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-04-012026-03-31_custom_DeviceSalesMember"
      decimals="0"
      id="Fact000797"
      unitRef="USD">1557339</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-04-012025-03-31_custom_DeviceSalesMember"
      decimals="0"
      id="Fact000798"
      unitRef="USD">1199258</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000800"
      unitRef="USD">15998239</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000801"
      unitRef="USD">13790294</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000803">&lt;p id="xdx_84C_eus-gaap--InventoryPolicyTextBlock_zAZ6PLIRVeT5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Inventories&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;Inventory is stated at the lower of cost or net realizable value, with cost determined using the weighted-average cost method.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;The cost of raw materials includes purchase costs
and freight-in charges directly attributable to acquiring the inventory. The cost of finished goods includes direct labor, manufacturing
overhead, freight and other costs incurred in bringing the inventory to its present location and condition.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;Net realizable value is based on estimated selling prices
in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;The Company evaluates inventory for excess quantities,
obsolescence and slow-moving items based on historical usage, forecasted demand, product life cycles, technological developments and market
conditions. Inventory write-downs are recorded when the carrying value of inventory exceeds its estimated net realizable value. Such write-downs
are recorded within cost of revenues and establish a new cost basis for the inventory.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_ziYXfW5FfTXh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zJwoKbgR7EJc" style="display: none"&gt;SCHEDULE OF INVENTORIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20260331_zfKzfIigfD1" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20250331_zsph66zd5yLe" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzF7M_zsaOqIwtbit3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Raw
    material&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;768,587&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,225,665&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_maINzF7M_zw73xXm2yfe" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Finished
    goods&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;572,708&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;329,720&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--InventoryNet_iTI_mtINzF7M_zC0o3jgTlqk3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,341,295&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,555,385&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AF_znxzFCAQYJc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Accounts
Receivable - Net&lt;/span&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000805">&lt;p id="xdx_895_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_ziYXfW5FfTXh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zJwoKbgR7EJc" style="display: none"&gt;SCHEDULE OF INVENTORIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20260331_zfKzfIigfD1" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20250331_zsph66zd5yLe" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--InventoryRawMaterialsAndSupplies_iI_maINzF7M_zsaOqIwtbit3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Raw
    material&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;768,587&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,225,665&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_maINzF7M_zw73xXm2yfe" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Finished
    goods&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;572,708&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;329,720&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--InventoryNet_iTI_mtINzF7M_zC0o3jgTlqk3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Inventories&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,341,295&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,555,385&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSupplies
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000807"
      unitRef="USD">768587</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryRawMaterialsAndSupplies
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000808"
      unitRef="USD">1225665</us-gaap:InventoryRawMaterialsAndSupplies>
    <us-gaap:InventoryFinishedGoods
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000810"
      unitRef="USD">572708</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000811"
      unitRef="USD">329720</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000813"
      unitRef="USD">1341295</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000814"
      unitRef="USD">1555385</us-gaap:InventoryNet>
    <BTCY:AccountsReceivablesNetPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000816">&lt;p id="xdx_842_ecustom--AccountsReceivablesNetPolicyTextBlock_zAj0KnvhUHgf" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;&lt;span id="xdx_864_zNNt2Pbr9Rzd"&gt;Accounts
Receivable&lt;/span&gt;&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Accounts
receivable are recorded at the invoiced amount and do not bear interest. The Company maintains an allowance for expected credit losses
to estimate the amount of receivables that may not be collected. The allowance is determined using a current expected credit loss (&#x201c;CECL&#x201d;)
methodology that incorporates historical loss experience, current economic conditions, aging of receivable balances, customer-specific
risk characteristics and reasonable and supportable forecasts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;The
Company evaluates receivables collectively based on similar risk characteristics, including customer payment history, aging status, customer
significance and other relevant factors. Receivables deemed uncollectible are written off against the allowance when collection efforts
have been exhausted. Recoveries of amounts previously written off are recorded when received.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zxZbPA4r6qb8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_z2mDbPX4EYcb" style="display: none"&gt;SCHEDULE
OF ACCOUNTS RECEIVABLE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20260331_z2Bm105OfZg" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal Year 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20250331_zBZZLcLFLu81" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal Year 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccountsReceivableGross_iI_maARGCzzRD_zbCUwQEraQlj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Gross
    Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; font-weight: bold; text-align: right"&gt;1,911,354&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; font-weight: bold; text-align: right"&gt;1,347,417&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_maARGCzzRD_z2i6EbWbQr7e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Other
    Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,092,371&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;382,215&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccountsReceivableGrossCurrent_iTI_mtARGCzzRD_maARNCzQBJ_zszTud9j5pcd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Gross
    Receivables&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,003,725&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,729,632&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_msARNCzQBJ_z0U6jMEqvd6g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Provision&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(70,826&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(70,860&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsReceivableNetCurrent_iTI_mtARNCzQBJ_zBEGfRw49BUk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Balance
    end of year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;2,932,899&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,658,772&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zx0DBFJcjCH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable primarily consist of amounts due from medical facilities, government programs, and patients arising from the Company&#x2019;s normal
course of business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Other
receivables primarily consist of accrued receivables related to device sales embedded in all-inclusive arrangements, unbilled sales,
accrued technology fees, receivables from third parties, CARES Act payroll tax refund receivables and receivables from e-commerce platforms.
Included in other receivables is a CARES Act payroll tax refund receivable of $&lt;span id="xdx_904_eus-gaap--OtherReceivablesNetCurrent_iI_c20260331_z9o1WsLJpuf8" title="Other receivables net current"&gt;576,000&lt;/span&gt; as of March 31, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
increase in accounts receivable during fiscal 2026 was primarily attributable to increased revenue volume, timing differences in collections
from customers and third-party payors, and the recognition of the CARES Act payroll tax refund receivable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Accounts
Receivable Aging&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--AccountsReceivableNoncurrentPastDueTableTextBlock_z2PxLVc4QQbi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aging analysis below relates only to trade accounts receivable and excludes other receivables.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zvKuQS6dlYgc" style="display: none"&gt;SCHEDULE
OF ACCOUNTS RECEIVABLE AGING&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20260331_z4KBPbz5Yda9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20250331_z1EhOjzS3Jg4" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--OneToThirtyDaysMember_z7xIbjRZx1Aa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Current&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;11,813&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 16%"&gt;189,740&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--ThirtyOneToSixtyDaysMember_zQhud1jbjG1c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;31-60 days&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;852,358&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;13,281&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--SixtyOneToNinetyDaysMember_z96dXg78rwDf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;61-90 days&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;686,298&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;586,218&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--NinetyOneToOneEigthyDaysMember_zh0hMt75rcel" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;91-180 days&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;329,511&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;493,856&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--OneEigthyDaysOrMoreMember_zLKdKy72KMZj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;180 days or more&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;31,372&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;73,321&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NontradeReceivablesCurrent_iI_zhZFiQeUwoG2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;b&gt;1,911,353&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;1,347,417&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AA_zNv66H2KLPn5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Allowance
for Expected Credit Losses&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zcLPEzHRKHcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Changes
in the allowance for expected credit losses for the year ended March 31, 2026 &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
2025 &lt;span style="font-weight: normal"&gt;were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zqJ8pLrHVfzf" style="display: none"&gt;SCHEDULE
OF CHANGE IN ALLOWANCE FOR CREDIT LOSSES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20250401__20260331_zzRZTvd2MXw4" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal Year 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240401__20250331_zxAaCxSvfDKd" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal Year 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iS_z1li0WHPRoq1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; font-weight: bold; font-style: italic; text-align: left"&gt;Balance beginning of year&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; font-weight: bold; text-align: right"&gt;70,860&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; font-weight: bold; text-align: right"&gt;59,546&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_di_zI2mE158P3o" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Write - offs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(74,780&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(48,686&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_z1kbxwFbZaLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Recoveries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0866"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ProvisionForDoubtfulAccounts_zZChzYLZZc9a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Provision during the year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;14,746&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iE_z8JRGa6g96Ai" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt"&gt;Balance end of year&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;70,826&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;70,860&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p id="xdx_8AA_zszMRWY1olgb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BTCY:AccountsReceivablesNetPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000818">&lt;p id="xdx_89E_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zxZbPA4r6qb8" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
receivable consisted of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BF_z2mDbPX4EYcb" style="display: none"&gt;SCHEDULE
OF ACCOUNTS RECEIVABLE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20260331_z2Bm105OfZg" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal Year 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_493_20250331_zBZZLcLFLu81" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal Year 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccountsReceivableGross_iI_maARGCzzRD_zbCUwQEraQlj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; font-weight: bold; font-style: italic; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Gross
    Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; font-weight: bold; text-align: right"&gt;1,911,354&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; font-weight: bold; text-align: right"&gt;1,347,417&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--AccountsAndOtherReceivablesNetCurrent_iI_maARGCzzRD_z2i6EbWbQr7e" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Other
    Receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;1,092,371&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;382,215&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccountsReceivableGrossCurrent_iTI_mtARGCzzRD_maARNCzQBJ_zszTud9j5pcd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Gross
    Receivables&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,003,725&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,729,632&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_msARNCzQBJ_z0U6jMEqvd6g" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Provision&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(70,826&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;(70,860&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AccountsReceivableNetCurrent_iTI_mtARNCzQBJ_zBEGfRw49BUk" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Balance
    end of year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;2,932,899&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;1,658,772&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGross
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000820"
      unitRef="USD">1911354</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000821"
      unitRef="USD">1347417</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000823"
      unitRef="USD">1092371</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsAndOtherReceivablesNetCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000824"
      unitRef="USD">382215</us-gaap:AccountsAndOtherReceivablesNetCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000826"
      unitRef="USD">3003725</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000827"
      unitRef="USD">1729632</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000829"
      unitRef="USD">70826</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000830"
      unitRef="USD">70860</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000832"
      unitRef="USD">2932899</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000833"
      unitRef="USD">1658772</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000835"
      unitRef="USD">576000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:AccountsReceivableNoncurrentPastDueTableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000837">&lt;p id="xdx_89D_eus-gaap--AccountsReceivableNoncurrentPastDueTableTextBlock_z2PxLVc4QQbi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
aging analysis below relates only to trade accounts receivable and excludes other receivables.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B8_zvKuQS6dlYgc" style="display: none"&gt;SCHEDULE
OF ACCOUNTS RECEIVABLE AGING&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20260331_z4KBPbz5Yda9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20250331_z1EhOjzS3Jg4" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--OneToThirtyDaysMember_z7xIbjRZx1Aa" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%"&gt;Current&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;11,813&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="text-align: right; width: 16%"&gt;189,740&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--ThirtyOneToSixtyDaysMember_zQhud1jbjG1c" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;31-60 days&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;852,358&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;13,281&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--SixtyOneToNinetyDaysMember_z96dXg78rwDf" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;61-90 days&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;686,298&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;586,218&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--NinetyOneToOneEigthyDaysMember_zh0hMt75rcel" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;91-180 days&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;329,511&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;493,856&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--NontradeReceivablesCurrent_iI_hus-gaap--FinancialInstrumentAxis__custom--OneEigthyDaysOrMoreMember_zLKdKy72KMZj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;180 days or more&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;31,372&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;73,321&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--NontradeReceivablesCurrent_iI_zhZFiQeUwoG2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;Total&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;&lt;b&gt;1,911,353&lt;/b&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;b&gt;1,347,417&lt;/b&gt;&lt;/td&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:AccountsReceivableNoncurrentPastDueTableTextBlock>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="AsOf2026-03-31_custom_OneToThirtyDaysMember"
      decimals="0"
      id="Fact000839"
      unitRef="USD">11813</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="AsOf2025-03-31_custom_OneToThirtyDaysMember"
      decimals="0"
      id="Fact000840"
      unitRef="USD">189740</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="AsOf2026-03-31_custom_ThirtyOneToSixtyDaysMember"
      decimals="0"
      id="Fact000842"
      unitRef="USD">852358</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="AsOf2025-03-31_custom_ThirtyOneToSixtyDaysMember"
      decimals="0"
      id="Fact000843"
      unitRef="USD">13281</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="AsOf2026-03-31_custom_SixtyOneToNinetyDaysMember"
      decimals="0"
      id="Fact000845"
      unitRef="USD">686298</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="AsOf2025-03-31_custom_SixtyOneToNinetyDaysMember"
      decimals="0"
      id="Fact000846"
      unitRef="USD">586218</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="AsOf2026-03-31_custom_NinetyOneToOneEigthyDaysMember"
      decimals="0"
      id="Fact000848"
      unitRef="USD">329511</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="AsOf2025-03-31_custom_NinetyOneToOneEigthyDaysMember"
      decimals="0"
      id="Fact000849"
      unitRef="USD">493856</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="AsOf2026-03-31_custom_OneEigthyDaysOrMoreMember"
      decimals="0"
      id="Fact000851"
      unitRef="USD">31372</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="AsOf2025-03-31_custom_OneEigthyDaysOrMoreMember"
      decimals="0"
      id="Fact000852"
      unitRef="USD">73321</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000854"
      unitRef="USD">1911353</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:NontradeReceivablesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000855"
      unitRef="USD">1347417</us-gaap:NontradeReceivablesCurrent>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000857">&lt;p id="xdx_895_eus-gaap--AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_zcLPEzHRKHcb" style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;Changes
in the allowance for expected credit losses for the year ended March 31, 2026 &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
2025 &lt;span style="font-weight: normal"&gt;were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B6_zqJ8pLrHVfzf" style="display: none"&gt;SCHEDULE
OF CHANGE IN ALLOWANCE FOR CREDIT LOSSES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20250401__20260331_zzRZTvd2MXw4" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal Year 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240401__20250331_zxAaCxSvfDKd" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal Year 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iS_z1li0WHPRoq1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; font-weight: bold; font-style: italic; text-align: left"&gt;Balance beginning of year&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; font-weight: bold; text-align: right"&gt;70,860&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 16%; font-weight: bold; text-align: right"&gt;59,546&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--AllowanceForDoubtfulAccountsReceivableWriteOffs_iN_di_zI2mE158P3o" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;Write - offs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(74,780&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(48,686&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AllowanceForDoubtfulAccountsReceivableRecoveries_z1kbxwFbZaLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;Recoveries&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0866"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--ProvisionForDoubtfulAccounts_zZChzYLZZc9a" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Provision during the year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;14,746&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;60,000&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iE_z8JRGa6g96Ai" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; font-style: italic; text-align: left; padding-bottom: 2.5pt"&gt;Balance end of year&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;70,826&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"&gt;70,860&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000859"
      unitRef="USD">70860</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="Fact000860"
      unitRef="USD">59546</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000862"
      unitRef="USD">74780</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000863"
      unitRef="USD">48686</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000865"
      unitRef="USD">60000</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000868"
      unitRef="USD">14746</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000869"
      unitRef="USD">60000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000871"
      unitRef="USD">70826</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000872"
      unitRef="USD">70860</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:UseOfEstimates contextRef="From2025-04-01to2026-03-31" id="Fact000874">&lt;p id="xdx_84F_eus-gaap--UseOfEstimates_zJyyN6itMoLh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Significant
accounting estimates and assumptions&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of the consolidated financial statements requires the use of estimates and assumptions to be made in applying the accounting
policies that affect the reported amounts of assets, liabilities, revenue and expenses and the disclosure of contingent assets and liabilities.
The estimates and related assumptions are based on previous experiences and other factors considered reasonable under the circumstances,
the results of which form the basis for making the assumptions about the carrying values of assets and liabilities that are not readily
apparent from other sources.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period
in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the
revision affects both current and future periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Significant
accounts that require estimates as the basis for determining the stated amounts include share-based compensation, impairment analysis
and fair value of warrants, promissory notes, convertible notes and derivative liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Fair
    value of stock options and warrants&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company measures the fair value of stock options and warrants granted to employees, directors, consultants, service
providers and financing counterparties using the Black-Scholes option pricing model. The determination of fair value requires management
to make estimates and assumptions regarding the expected term of the instrument, expected volatility of the Company&#x2019;s common stock, risk-free
interest rate, expected dividend yield and, where applicable, forfeiture rates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;The fair value of stock options
is recognized as stock based compensation expense over the requisite service period. The fair value of warrants issued in
connection with financing transactions or for services is recorded based on the nature of the underlying transaction and classified
as either equity or liability in accordance with applicable accounting guidance.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Fair
    value of derivative liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
determining the fair values of the derivative liabilities from the conversion and redemption features, the Company used Monte-Carlo and
lattice models with the following assumptions: dividend yields, volatility, risk-free rate and the remaining expected life. Changes in
those assumptions and inputs could in turn impact the fair value of the derivative liabilities and can have a material impact on the
reported loss and comprehensive loss for the applicable reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Functional
    currency&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Determining
the appropriate functional currencies for entities in the Company requires analysis of various factors, including the currencies and
country-specific factors that mainly influence labor, materials, and other operating expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Useful
    life of property and equipment&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company employs significant estimates to determine the estimated useful lives of property and equipment, considering industry trends
such as technological advancements, past experience, expected use and review of asset useful lives. The Company makes estimates when
determining depreciation methods, depreciation rates and asset useful lives, which requires considering industry trends and company-specific
factors. The Company reviews depreciation methods, useful lives and residual values annually or when circumstances change and adjusts
its depreciation methods and assumptions prospectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Provisions&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Provisions
are recognized when the Company has a present obligation, legal or constructive, as a result of a previous event, if it is probable that
the Company will be required to settle the obligation and a reliable estimate can be made of the obligation. The amount recognized is
the best estimate of the expenditure required to settle the present obligation at the end of the reporting period, taking into account
the risks and uncertainties surrounding the obligations. Provisions are reviewed at the end of each reporting period and adjusted to
reflect the current best estimate of the expected future cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Contingencies&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Contingencies
can be either possible assets or possible liabilities arising from past events, which, by their nature, will be resolved only when one
or more uncertain future events occur or fail to occur. The assessment of the existence and potential impact of contingencies inherently
involves the exercise of significant judgment and the use of estimates regarding the outcome of future events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Inventory
    obsolescence&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;Inventories are stated at the lower
of cost and net realizable value. Net realizable value of our inventory is generally the selling price less normally predictable costs
of disposal and transportation. The Company estimates net realizable value as the amount at which inventories are expected to be sold,
taking into consideration fluctuations in retail prices less estimated costs necessary to make the sale. Inventories are written down
to net realizable value when the cost of inventories is estimated to be unrecoverable due to obsolescence, damage, or declining selling
prices.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Income
    and other taxes&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of current and deferred income taxes requires the Company to make estimates and assumptions and to exercise judgment regarding
the carrying values of assets and liabilities which are subject to accounting estimates inherent in those balances, the interpretation
of income tax legislation across various jurisdictions, expectations about future operating results, the timing of reversal of temporary
differences and possible audits of income tax filings by the tax authorities. In addition, when the Company incurs losses for income
tax purposes, it assesses the probability of taxable income being available in the future based on its budgeted forecasts. These forecasts
are adjusted to take into account certain non-taxable income and expenses and specific rules on the use of unused credits and tax losses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
the forecasts indicate that sufficient future taxable income will be available to deduct the temporary differences, a deferred tax asset
is recognized for all deductible temporary differences. Changes or differences in underlying estimates or assumptions may result in changes
to the current or deferred income tax balances on the consolidated balance sheets, a charge or credit to income tax expense included
as part of net income (loss) and may result in cash payments or receipts. Judgment includes consideration of the Company&#x2019;s future
cash requirements in its tax jurisdictions. All income, capital and commodity tax filings are subject to audits and reassessments. Changes
in interpretations or judgments may result in a change in the Company&#x2019;s income, capital, or commodity tax provisions in the future.
The amount of such a change cannot be reasonably estimated.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="text-decoration: underline"&gt;Incremental
    borrowing rate for lease&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
determination of the Company&#x2019;s lease obligation and right-of-use asset depends on certain assumptions, which include the selection
of the discount rate. The discount rate is set by reference to the Company&#x2019;s incremental borrowing rate. Significant assumptions
are required to be made when determining which borrowing rates to apply in this determination. Changes in the assumptions used may have
a significant effect on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000876">&lt;p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zhyE9TiK6Fyj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Earnings
(Loss) Per Share&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has adopted the Financial Accounting Standards Board&#x2019;s (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;)
Topic 260-10 which provides for calculation of &#x201c;basic&#x201d; and &#x201c;diluted&#x201d; earnings per share. Basic loss per share
of common stock is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period.
Diluted earnings or loss per share of common stock is computed similarly to basic earnings or loss per share except the weighted average
shares outstanding are increased to include additional shares from the assumed exercise of any common stock equivalents, if dilutive.
The Company&#x2019;s warrants, options, convertible promissory notes, convertible preferred stock, shares to be issued and restricted
stock awards while outstanding are considered common stock equivalents for this purpose. Diluted earnings is computed utilizing the treasury
method for the warrants, stock options, shares to be issued and restricted stock awards. Diluted earnings with respect to the convertible
promissory notes and convertible preferred stock utilizing the if-converted method was not applicable during the periods presented as
no conditions required for conversion had occurred. No incremental common stock equivalents were included in calculating diluted loss
per share because such inclusion would be anti-dilutive given the net loss reported for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000878">&lt;p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zy0QsNMa3BWa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Cash&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Cash
includes cash on hand and balances with banks.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026, and 2025, cash balance of US$ &lt;span id="xdx_902_eus-gaap--CashFDICInsuredAmount_iI_c20260331_zM4SGhUssSuf" title="US deposit protected"&gt;140,932&lt;/span&gt; and US$ &lt;span id="xdx_909_eus-gaap--CashFDICInsuredAmount_iI_c20250331_zDxpkrtf5XGh" title="US deposit protected"&gt;259,478&lt;/span&gt; were at financial institutions in the United States that were
not covered by the United States Deposit Protection Regulation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000880"
      unitRef="USD">140932</us-gaap:CashFDICInsuredAmount>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000882"
      unitRef="USD">259478</us-gaap:CashFDICInsuredAmount>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000884">&lt;p id="xdx_849_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zS0OthK9lLB5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Foreign
Currency Translation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
functional currency of the Company&#x2019;s Canadian-based subsidiary is the Canadian dollar and the US-based parent is the U.S. dollar.
Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange
rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated using
the exchange rate prevailing at the consolidated balance sheet date. Non-monetary assets and liabilities are translated using the historical
rate on the date of the transaction. All exchange gains or losses arising from translation of these foreign currency transactions are
included in net income (loss) for the year. In translating the financial statements of the Company&#x2019;s Canadian subsidiary from their
functional currency into the Company&#x2019;s reporting currency of United States dollars, consolidated balance sheet accounts are translated
using the closing exchange rate in effect at the consolidated balance sheet date and income and expense accounts are translated using
an average exchange rate prevailing during the reporting period. Adjustments resulting from the translation, if any, are included in
accumulated other comprehensive loss in stockholders&#x2019; deficiency. The Company has not, to the date of these consolidated financial
statements, entered into derivative instruments to offset the impact of foreign currency fluctuations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2025-04-01to2026-03-31" id="Fact000886">&lt;p id="xdx_844_eus-gaap--TradeAndOtherAccountsReceivablePolicy_z6NNwELwMaAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Accounts
Receivable&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;Accounts receivable consists of amounts due to the Company from medical
facilities, which receive reimbursement from institutions and third-party government and commercial payors and their related patients,
as a result of the Company&#x2019;s normal business activities. Accounts receivable is reported on the consolidated balance sheets net
of an estimated allowance for expected credit losses. The Company establishes an allowance for expected credit losses for estimated uncollectible
receivables based on historical experience, assessment of specific risk, review of outstanding invoices, and various assumptions and estimates
that are believed to be reasonable under the circumstances, and recognizes the provision as a component of selling, general and administrative
expenses. Uncollectible accounts are written off against the allowance after appropriate collection efforts have been exhausted and when
it is deemed that a balance is uncollectible.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2025-04-01to2026-03-31" id="Fact000888">&lt;p id="xdx_847_eus-gaap--ConcentrationRiskCreditRisk_zc17brr5uAP7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Customer
Concentration&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;For the year ended March 31, 2026,
two customer accounted for &lt;span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250401__20260331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zv5hKiTrhfji" title="Concentration risk, percentage"&gt;20&lt;/span&gt;% and &lt;span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20250401__20260331__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z47W65O5I5M2" title="Concentration risk, percentage"&gt;10&lt;/span&gt;%
of the Company&#x2019;s revenues. For the year ended March 31, 2025, one customer accounted for approximately &lt;span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240401__20250331__srt--MajorCustomersAxis__custom--OneCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zgIObMVAKevc" title="Concentration risk, percentage"&gt;29&lt;/span&gt;%
of the Company&#x2019;s revenues.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-04-012026-03-31_custom_CustomerOneMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      id="Fact000890"
      unitRef="Pure">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2025-04-012026-03-31_custom_CustomerTwoMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      id="Fact000892"
      unitRef="Pure">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="From2024-04-012025-03-31_custom_OneCustomerMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember"
      decimals="INF"
      id="Fact000894"
      unitRef="Pure">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2025-04-01to2026-03-31" id="Fact000896">&lt;p id="xdx_840_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zvmaQlTUZC2g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Fair
Value of Financial Instruments&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
820 defines fair value, establishes a framework for measuring fair value and expands required disclosure about fair value measurements
of assets and liabilities. ASC 820-10 defines fair value as the exchange price that would be received for an asset or paid to transfer
a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between
market participants on the measurement date. ASC 820-10 also establishes a fair value hierarchy, which requires an entity to maximize
the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels
of inputs that may be used to measure fair value:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
Level 1 &#x2013; Valuation based on quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
Level 2 &#x2013; Valuation based on quoted market prices for similar assets and liabilities in active markets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;
Level 3 &#x2013; Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management&#x2019;s
best estimate of what market participants would use as fair value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy,
the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is
significant to the fair value measurement in its entirety. The Company&#x2019;s assessment of the significance of a particular input to
the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Fair
value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. The respective
carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these
instruments or interest rates that are comparable to market rates. These financial instruments include cash, accounts receivable, deposits
and other receivables, convertible promissory notes and short term loans, federally guaranteed loans, term loans and accounts payable
and accrued liabilities. The Company&#x2019;s derivative liabilities are carried at fair values and are classified as Level 3 financial
instruments. The Company&#x2019;s bank accounts are maintained with financial institutions of reputable credit, therefore, bear minimal
credit risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_zSUnDrHkjf58" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of financial instruments measured on a recurring basis is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zDPhdlcd3BLc" style="display: none"&gt;SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_c20260331_zAZVWd7seu03" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0900"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zmXE5joUqEnf" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0902"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z2NL45M7f2Kf" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0904"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z9R6wrkSgUoa" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0906"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260331_zvQIS58etaog" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;445,893&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWljQFXTiy2a" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0910"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z60NPywTOE1i" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0912"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_za7j5fAt73Q9" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;445,893&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, long-term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20260331_zBnFVckbdzfk" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,396,908&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z5NyHnbIWi6d" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0918"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zi0y2D2MEhtd" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0920"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBWtEniX0V4l" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,396,908&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    liabilities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20260331_ztuYJLyEGaGd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,842,801&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZjILQbtR8ae" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0926"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zuTJ1lyLzMvi" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0928"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcexZ0PBtz4i" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,842,801&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20250331_zG3HX6D2pw1h" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0932"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2K6HgJCq345" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0934"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKqqpkTEhkB5" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0936"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlE7ifJTOOme" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0938"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20250331_zsaWEWVYpSRe" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;424,200&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zXf2dP17tq93" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0942"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zRwgiy2FOLU" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0944"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z2PdqJrEuOli" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;424,200&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, long-term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20250331_zDfxnnupV5Ca" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,478,717&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zQrE3emYQFMg" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0950"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zy10y8LH25u9" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0952"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWuIc8LRrwXf" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,478,717&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    liabilities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20250331_zEGWyKtElJJg" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,902,917&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zSzxOPlow02h" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0958"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQijVTTLu0Fd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0960"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zqPwESZndUk5" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,902,917&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zpwVGTf3KuI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
were no transfers between fair value hierarchy levels during the years ended March 31, 2026 and 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000898">&lt;p id="xdx_89C_eus-gaap--ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_zSUnDrHkjf58" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of financial instruments measured on a recurring basis is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BF_zDPhdlcd3BLc" style="display: none"&gt;SCHEDULE OF FAIR VALUE OF FINANCIAL INSTRUMENTS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_c20260331_zAZVWd7seu03" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0900"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zmXE5joUqEnf" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0902"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z2NL45M7f2Kf" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0904"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z9R6wrkSgUoa" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0906"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260331_zvQIS58etaog" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;445,893&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zWljQFXTiy2a" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0910"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z60NPywTOE1i" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0912"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_za7j5fAt73Q9" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;445,893&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, long-term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20260331_zBnFVckbdzfk" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,396,908&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z5NyHnbIWi6d" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0918"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zi0y2D2MEhtd" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0920"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zBWtEniX0V4l" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,396,908&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    liabilities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20260331_ztuYJLyEGaGd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,842,801&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zZjILQbtR8ae" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0926"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zuTJ1lyLzMvi" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0928"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20260331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zcexZ0PBtz4i" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,842,801&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="14" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As
    of March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    1&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    2&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Level
    3&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    assets at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_c20250331_zG3HX6D2pw1h" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0932"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z2K6HgJCq345" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0934"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zKqqpkTEhkB5" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0936"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zlE7ifJTOOme" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Total assets at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0938"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 36%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, short-term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20250331_zsaWEWVYpSRe" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;424,200&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zXf2dP17tq93" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0942"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zRwgiy2FOLU" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0944"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeLiabilitiesCurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z2PdqJrEuOli" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Derivative liabilities, short-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;424,200&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, long-term&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20250331_zDfxnnupV5Ca" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,478,717&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zQrE3emYQFMg" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0950"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zy10y8LH25u9" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0952"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--DerivativeLiabilitiesNoncurrent_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zWuIc8LRrwXf" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Derivative liabilities, long-term"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,478,717&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    liabilities at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20250331_zEGWyKtElJJg" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,902,917&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zSzxOPlow02h" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0958"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zQijVTTLu0Fd" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0960"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20250331__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zqPwESZndUk5" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total liabilities at fair value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,902,917&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000908"
      unitRef="USD">445893</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2026-03-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact000914"
      unitRef="USD">445893</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000916"
      unitRef="USD">1396908</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2026-03-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact000922"
      unitRef="USD">1396908</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact000924"
      unitRef="USD">1842801</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2026-03-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact000930"
      unitRef="USD">1842801</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000940"
      unitRef="USD">424200</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2025-03-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact000946"
      unitRef="USD">424200</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000948"
      unitRef="USD">1478717</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2025-03-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact000954"
      unitRef="USD">1478717</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact000956"
      unitRef="USD">1902917</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="AsOf2025-03-31_us-gaap_FairValueInputsLevel3Member"
      decimals="0"
      id="Fact000962"
      unitRef="USD">1902917</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000964">&lt;p id="xdx_84E_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zGuiK0icQz6b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Property
and Equipment&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Property
and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated
useful lives of the assets. Leasehold improvements are amortized over the shorter of the lease term or the estimated useful lives of
the assets. Maintenance and repairs are charged to expense as incurred, and improvements and betterments are capitalized. Depreciation
of property and equipment is provided using the straight-line method for all assets with estimated lives as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z6WD2tkkPgz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zCILF2UcK4Xk" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 25%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zKCiMm6WaMce" title="Property and equipment, useful life"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold
    improvement&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zaiNtiEsqPl2" title="Property and equipment, useful life"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A1_zuadV11YXQ03" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <BTCY:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000966">&lt;p id="xdx_896_ecustom--ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock_z6WD2tkkPgz5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zCILF2UcK4Xk" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT ESTIMATED USEFUL LIVES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 25%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Office
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zKCiMm6WaMce" title="Property and equipment, useful life"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Leasehold
    improvement&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zaiNtiEsqPl2" title="Property and equipment, useful life"&gt;5&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</BTCY:ScheduleOfPropertyAndEquipmentEstimatedUsefulLivesTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2026-03-31_us-gaap_OfficeEquipmentMember"
      id="Fact000968">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2026-03-31_us-gaap_LeaseholdImprovementsMember"
      id="Fact000970">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000972">&lt;p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zMhReNtOLA7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Impairment
for Long-Lived Assets&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company applies the provisions of ASC Topic 360, Property, Plant, and Equipment, which addresses financial accounting and reporting for
the impairment or disposal of long-lived assets. ASC 360 requires impairment losses to be recorded on long-lived assets, including right-of-use
assets, used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those
assets are less than the assets&#x2019; carrying amounts. In that event, a loss is recognized based on the amount by which the carrying
amount exceeds the fair value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner,
except that fair values are reduced for the cost of disposal. Based on its review at March 31, 2026 and 2025, the Company believes there
was &lt;span id="xdx_907_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20250401__20260331_z7wx1cUa9RGj" title="Impairment of long-lived assets"&gt;&lt;span id="xdx_903_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_do_c20240401__20250331_zsFc97DCT6y6" title="Impairment of long-lived assets"&gt;no&lt;/span&gt;&lt;/span&gt; impairment of its long-lived assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact000974"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact000976"
      unitRef="USD">0</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000978">&lt;p id="xdx_844_eus-gaap--LesseeLeasesPolicyTextBlock_z0nYF7wJQlCd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Leases&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is the lessee in a lease contract when the Company obtains the right to use the asset. Operating leases are included in the line
items Operating right of use assets, Operating lease obligations, current, and Operating lease obligations, long-term in the consolidated
balance sheet.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Right-of-use
(&#x201c;ROU&#x201d;) asset represents the Company&#x2019;s right to use an underlying asset for the lease term and lease obligations represent
the Company&#x2019;s obligations to make lease payments arising from the lease, both of which are recognized based on the present value
of the future minimum lease payments over the lease term at the commencement date. Leases with a lease term of 12 months or less at inception
are not recorded on the consolidated balance sheet and are expensed on a straight-line basis over the lease term in the consolidated
statement of operations and comprehensive loss. The Company determines the lease term by agreement with lessor. As the Company&#x2019;s
lease does not provide implicit interest rate, the Company uses the Company&#x2019;s incremental borrowing rate based on the information
available at commencement date in determining the present value of future payments. Refer to Note 12 for further discussion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000980">&lt;p id="xdx_843_eus-gaap--IncomeTaxPolicyTextBlock_z6fsA1jhGHB6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Income
Taxes&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes in accordance with ASC 740. The Company provides for Federal, State and Provincial income taxes payable,
as well as for those deferred because of the timing differences between reporting income and expenses for consolidated financial statement
purposes versus tax purposes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences
between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.
Deferred tax assets and liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which
those temporary differences are expected to be recoverable or settled. The effect of a change in tax rates is recognized as income or
expense in the period of the change. A valuation allowance is established, when necessary, to reduce deferred income tax assets to the
amount that is more likely than not to be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="From2025-04-01to2026-03-31" id="Fact000982">&lt;p id="xdx_844_eus-gaap--ResearchAndDevelopmentExpensePolicy_zMAznh6Rrrv2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Research
and Development&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Research
and development costs, which relate primarily to product and software development, are charged to operations as incurred. Under certain
research and development arrangements with third parties, the Company may be required to make payments that are contingent on the achievement
of specific developmental, regulatory and/or commercial milestones. Before a product receives regulatory approval, milestone payments
made to third parties are expensed when the milestone is achieved&lt;b&gt;. &lt;/b&gt;Milestone payments made to third parties after regulatory approval
is received are capitalized and amortized over the estimated useful life of the approved product.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000984">&lt;p id="xdx_845_eus-gaap--SellingGeneralAndAdministrativeExpensesPolicyTextBlock_zvMfxYxlfzS4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Selling,
General and Administrative&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Selling,
general and administrative expenses consist primarily of personnel-related costs including stock based compensation for personnel
in functions not directly associated with research and development activities. Other significant costs include sales and marketing
costs, investor relation and legal costs relating to corporate matters, professional fees for consultants assisting with business
development and financial matters, and office and administrative expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2025-04-01to2026-03-31" id="Fact000986">&lt;p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z2cemBB6njNb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Stock
Based Compensation&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for share-based payments in accordance with the provision of ASC 718, which requires that all share-based payments issued
to acquire goods or services, including grants of employee stock options, be recognized in the consolidated statements of operations
and comprehensive loss based on their fair values, net of estimated forfeitures. ASC 718 requires forfeitures to be estimated at the
time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Compensation expense
related to share-based awards is recognized over the requisite service period, which is generally the vesting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for stock based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the
fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable,
using the guidelines in ASC 505-50. The Company issues compensatory shares for services including, but not limited to, executive, management,
accounting, operations, corporate communication, financial and administrative consulting services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:DebtPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000988">&lt;p id="xdx_841_eus-gaap--DebtPolicyTextBlock_zoPMb1UYAVfj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Convertible
Notes Payable and Derivative Instruments&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has adopted the provisions of ASU 2017-11 to account for the down round features of warrants issued with private placements. In doing so, warrants with a down round feature previously treated as derivative liabilities in the consolidated
balance sheet and measured at fair value are henceforth treated as equity, with no adjustment for changes in fair value at each reporting
period. Previously, the Company accounted for conversion options embedded in convertible notes in accordance with ASC 815. ASC 815 generally
requires companies to bifurcate conversion options embedded in convertible notes from their host instruments and to account for them
as free-standing derivative financial instruments. ASC 815 provides for an exception to this rule when convertible notes, as host instruments,
are deemed to be conventional, as defined by ASC 815-40. The Company accounts for convertible notes deemed conventional and conversion
options embedded in non-conventional convertible notes which qualify as equity under ASC 815, in accordance with the provisions of ASC
470-20, which provides guidance on accounting for convertible securities with beneficial conversion features. Accordingly, the Company
records, as a discount to convertible notes, the intrinsic value of such conversion options based upon the differences between the fair
value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the
note. Debt discounts under these arrangements are amortized over the term of the related debt.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtPolicyTextBlock>
    <BTCY:ConvertiblePreferredStockPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000990">&lt;p id="xdx_84C_ecustom--ConvertiblePreferredStockPolicyTextBlock_zLhpcaSCTxSg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Series
B Convertible Preferred Stock&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series B convertible preferred stock (&#x201c;Series B Preferred Stock&#x201d;) was accounted for as mezzanine equity and the embedded
conversion and redemption features was accounted for as derivative liabilities with change in fair value at each reporting period end
charged to the consolidated statement of operation and comprehensive loss in accordance with ASC 480 and ASC 815.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BTCY:ConvertiblePreferredStockPolicyTextBlock>
    <BTCY:PreferredSharesExtinguishmentsPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000992">&lt;p id="xdx_844_ecustom--PreferredSharesExtinguishmentsPolicyTextBlock_zR60gizXbau7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Preferred
Share Redemption and Conversions&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounted for preferred stock redemptions and conversions in accordance to ASU-260-10-S99. For Series A preferred stock redemptions,
the difference between the fair value of consideration transferred to the holders of the preferred stock and the carrying amount of the
preferred stock is accounted as deemed dividend distribution and subtracted from net loss. For Series B preferred stock conversions,
no gain or loss is recognized upon Series B preferred stock conversion except for the fair value adjustment for the conversion and redemption
feature derivative liabilities on the conversion date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BTCY:PreferredSharesExtinguishmentsPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000994">&lt;p id="xdx_84E_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zygy4CVUpzCi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Segment
Information&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Operating
segments are defined as components of an entity where discrete financial information is evaluated regularly by the chief operating decision
maker in deciding how to allocate resources and assessing performance. The Company has identified its Chief Executive Officer (&#x201c;CEO&#x201d;)
as the chief operating decision maker (&#x201c;CODM&#x201d;). The Company operates in &lt;span id="xdx_90F_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20250401__20260331_zzvwFK0uvT5g" title="Number of operating segment"&gt;one&lt;/span&gt; operating segment. The Company&#x2019;s CODM allocates
resources and assesses performance at the consolidated level. The Company&#x2019;s property and equipment and operating right of use lease
asset are in the United States as of March 31, 2026 and 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
CODM uses net loss for purposes of making operating decisions, allocating resources, and evaluating financial performance.
Significant expenses include non-cash stock based compensation, depreciation and amortization, and write-off of property and
equipment, which are reflected in the Consolidated Statements of Cash Flows for the years ended March 31, 2026 and 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
long-lived assets outside of U.S. are not material as of March 31, 2026. The measure of segment assets is reported on the balance sheet
as total consolidated assets. Refer to the Consolidated Balance Sheets as of March 31, 2026 and 2025 for total consolidated assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="From2025-04-01to2026-03-31"
      decimals="INF"
      id="Fact000996"
      unitRef="Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact000998">&lt;p id="xdx_845_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zFpO2RbmlMN9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Recently
Issued Accounting Pronouncements&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;On November 26, 2024, the FASB issued ASU 2024-04, &lt;i&gt;Debt&#x2014;Debt with Conversion and Other Options (Subtopic
470-20): Induced Conversions of Convertible Debt Instruments&lt;/i&gt;. This ASU clarifies the accounting for certain settlements of convertible
debt instruments that occur at terms different from the original contractual conversion terms, specifically addressing whether such settlements
should be accounted for as induced conversions or debt extinguishments. The amendments are effective for fiscal years beginning after
December 15, 2025, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating
the impact of adopting ASU 2024-04 on its consolidated financial statements and related disclosures. At this time, the Company has not
determined the effect, if any, that adoption of this standard will have on its consolidated financial position, results of operations,
cash flows, or related disclosures.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In July 2025, the FASB issued ASU 2025-05, which provides
targeted improvements and practical expedients related to the application of the current expected credit loss (&#x201c;CECL&#x201d;) model.
The amendments are intended to simplify certain aspects of estimating expected credit losses while maintaining decision-useful information
for investors. The Company is currently evaluating the impact that adoption of this guidance may have on its consolidated financial statements
and related disclosures.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company continue to evaluate the impact of the new accounting pronouncement, including enhanced disclosure requirements, on our business
processes, controls and systems.&lt;/span&gt;&lt;/p&gt;
</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001000">&lt;p id="xdx_808_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zy3QvIKxXf8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;4.
&lt;span id="xdx_826_ze30GOTC1xD2"&gt;ACCOUNTS PAYABLE AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zaYQaqwXRcf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zHFSEYinRo17" style="display: none"&gt;SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20260331_ziUYSxiSn763" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
                                            at&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March
                                            31, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20250331_zs5SYN2qdpc2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
                                            at&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March
                                            31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccountsPayableOtherCurrent_iI_maAPAALzJVu_zwrhw59l9Nyb" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Trade
    and other payables&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,402,523&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,602,309&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iI_maAPAALzJVu_zvTwfrhjFxD1" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,534,809&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,034,293&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredRevenue_iI_maAPAALzJVu_z7g4MUExseFd" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
    revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33,538&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,322&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_mtAPAALzJVu_zaYrdGqx5yOj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
    payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,970,870&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,661,924&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_z4tJTnWTRoQk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Trade
and other payables and accrued liabilities as at March 31, 2026 and 2025 included $&lt;span id="xdx_902_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iI_c20260331_zc3c2fD4Ot18" title="Trade and other payables and accrued liabilities"&gt;1,053,228&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iI_c20250331_zNPAR97aQtfd" title="Trade and other payables and accrued liabilities"&gt;373,744&lt;/span&gt;, respectively, due to a shareholder,
who is a director and executive of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001002">&lt;p id="xdx_89D_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zaYQaqwXRcf4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B4_zHFSEYinRo17" style="display: none"&gt;SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20260331_ziUYSxiSn763" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
                                            at&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March
                                            31, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20250331_zs5SYN2qdpc2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;As
                                            at&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March
                                            31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--AccountsPayableOtherCurrent_iI_maAPAALzJVu_zwrhw59l9Nyb" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Trade
    and other payables&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,402,523&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,602,309&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--AccruedLiabilitiesCurrent_iI_maAPAALzJVu_zvTwfrhjFxD1" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accrued
    liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,534,809&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,034,293&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--DeferredRevenue_iI_maAPAALzJVu_z7g4MUExseFd" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Deferred
    revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;33,538&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;25,322&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iTI_mtAPAALzJVu_zaYrdGqx5yOj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Accounts
    payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,970,870&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-family: Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;7,661,924&lt;/span&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableOtherCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001004"
      unitRef="USD">4402523</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccountsPayableOtherCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001005"
      unitRef="USD">4602309</us-gaap:AccountsPayableOtherCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001007"
      unitRef="USD">4534809</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001008"
      unitRef="USD">3034293</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenue
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001010"
      unitRef="USD">33538</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001011"
      unitRef="USD">25322</us-gaap:DeferredRevenue>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001013"
      unitRef="USD">8970870</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001014"
      unitRef="USD">7661924</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001016"
      unitRef="USD">1053228</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001018"
      unitRef="USD">373744</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:DebtDisclosureTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001020">&lt;p id="xdx_800_eus-gaap--DebtDisclosureTextBlock_zZSFT5YEOda7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;5.
&lt;span id="xdx_823_ztHdwFiIxlSc"&gt;CONVERTIBLE PROMISSORY NOTES AND SHORT TERM LOANS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
A Convertible Promissory Notes&lt;/i&gt;&lt;/b&gt;&lt;i&gt;:&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&#x2019;s Series A Convertible Promissory Notes
bear interest at &lt;span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20260331__us-gaap--DebtInstrumentAxis__custom--SeriesANoteMember_zuy7vuqtiiR9" title="Debt instrumental stated percentage"&gt;12&lt;/span&gt;% per annum and are convertible into common shares pursuant to the terms of the respective note agreements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of March 31, 2026, notes held by two investors
remained outstanding with an aggregate principal balance of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20260331__us-gaap--DebtInstrumentAxis__custom--SeriesANoteMember_zxAUJ4gIAqh1" title="Debt face amount"&gt;821,500&lt;/span&gt; (March 31, 2025 &#x2013; $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20250331__us-gaap--DebtInstrumentAxis__custom--SeriesANoteMember_z44VPch5I0Tf" title="Debt face amount"&gt;821,500&lt;/span&gt;). During prior years, substantially
all Series A Notes were converted into common shares, with the exception of these remaining notes.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On December 30, 2022, the Company exchanged $&lt;span id="xdx_906_eus-gaap--DebtInstrumentCarryingAmount_iI_c20221230__us-gaap--DebtInstrumentAxis__custom--SeriesANoteMember_zEi3okh0aIt" title="Carrying amount"&gt;500,000&lt;/span&gt;
of Series A Notes together with accrued interest of $&lt;span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20221230__us-gaap--DebtInstrumentAxis__custom--NewConvertibleNoteMember_zZaK3dHoGmX" title="Debt instrument accrued interest"&gt;121,500&lt;/span&gt; for a new convertible note with principal of $&lt;span id="xdx_909_eus-gaap--DebtInstrumentCarryingAmount_iI_c20221230__us-gaap--DebtInstrumentAxis__custom--NewConvertibleNoteMember_zah9eIxZ4hha" title="DebtInstrumentCarryingAmount"&gt;621,500&lt;/span&gt;. The replacement note
bears interest at &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20221230__us-gaap--DebtInstrumentAxis__custom--NewConvertibleNoteMember_z26ipfwVteWa" title="Interest rate"&gt;12%&lt;/span&gt; per annum and is convertible into common shares at a price equal to &lt;span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20221230__20221230__us-gaap--DebtInstrumentAxis__custom--NewConvertibleNoteMember_zkWif0LmsRBh" title="Debt instrument interest rate"&gt;75%&lt;/span&gt; of the average of the three lowest closing
prices during the ten trading days preceding receipt of a conversion notice.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;As of March 31, 2026 and March 31, 2025, accrued interest
related to the Series A Notes was $&lt;span id="xdx_90F_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20260331__us-gaap--DebtInstrumentAxis__custom--SeriesANoteMember_ziIRS7g1Ll13" title="Interest accruals"&gt;370,922&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250331__us-gaap--DebtInstrumentAxis__custom--SeriesANoteMember_zMFgsDRRYXae" title="Interest accruals"&gt;272,342&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the years ended March 31, 2026 and 2025, the
Company recognized interest expense of $&lt;span id="xdx_904_eus-gaap--InterestExpenseDebt_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--SeriesANoteMember_ztVQWkmr58fl" title="Interest expense"&gt;98,580&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--InterestExpenseDebt_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesANoteMember_zjcOfOAq4nAi" title="Interest expense"&gt;98,580&lt;/span&gt;, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The discount associated with the Series A Notes was
fully amortized in prior years.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
B Convertible Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company previously issued Series B Convertible Promissory Notes that bore interest at &lt;span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20260331__us-gaap--DebtInstrumentAxis__custom--SeriesBNoteMember_zR4yaNe7prTh" title="Debt instrumental stated percentage"&gt;12%&lt;/span&gt; per annum and were convertible into shares
of the Company&#x2019;s common stock pursuant to the terms of the note agreements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2025, the Company redeemed the remaining principal balance of $&lt;span id="xdx_906_ecustom--RedemptionOfConvertibleNotes_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesBNoteMember_zLwJZvlb6R13" title="Redemption of convertible notes"&gt;22,009&lt;/span&gt; through a cash payment of $&lt;span id="xdx_908_eus-gaap--RepaymentsOfOtherDebt_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesBNoteMember_zYLauf8P892i" title="Payment redeemed cash"&gt;25,342&lt;/span&gt;. As
a result of the redemption, the Company recognized a gain on redemption of $&lt;span id="xdx_901_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesBNoteMember_zAs6KuIq4O8l" title="Gains losses on extinguishment of debt"&gt;8,320&lt;/span&gt; during the year ended March 31, 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026 and March 31, 2025, there was no outstanding principal balance related to the Series B Convertible Promissory Notes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026 and March 31, 2025, accrued interest related to the Series B Convertible Promissory Notes was $&lt;span id="xdx_907_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20260331__us-gaap--DebtInstrumentAxis__custom--SeriesBNoteMember_zOajF5zZFJrh" title="Interest payable"&gt;88,881&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250331__us-gaap--DebtInstrumentAxis__custom--SeriesBNoteMember_zrm3m5C8lUbc" title="Interest payable"&gt;88,881&lt;/span&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended March 31, 2026 and 2025, the Company recognized interest expense of $&lt;span id="xdx_907_eus-gaap--InterestExpenseDebt_dxL_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--SeriesBNoteMember_zOfxXCNOP71d" title="Interest expense::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1058"&gt;nil&lt;/span&gt;&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--InterestExpenseDebt_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesBNoteMember_zAacG9Mhcov5" title="Interest expense"&gt;279&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Series
C Convertible Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s Series C Convertible Promissory Notes bear interest at &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20260331__us-gaap--DebtInstrumentAxis__custom--SeriesCNoteMember_zdBjrBzDCSrb" title="Debt instrumental stated percentage"&gt;15&lt;/span&gt;% per annum and are convertible into shares of the Company&#x2019;s common
stock pursuant to the terms of the applicable note agreements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026, one Series C Note remained outstanding with an aggregate principal balance of $&lt;span id="xdx_903_ecustom--RedemptionOfConvertibleNotes_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--SeriesCNoteMember_zgNFwSMTWceb" title="Redemption of convertible notes"&gt;116,667&lt;/span&gt;
(March 31, 2025 &#x2013; $&lt;span id="xdx_906_ecustom--RedemptionOfConvertibleNotes_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCNoteMember_zhTgjkTbFEx5" title="Redemption of convertible notes"&gt;175,000&lt;/span&gt;). The remaining note continues to be subject to the original conversion provisions of the applicable note agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2026, the Company redeemed Series C Notes with a face value of $&lt;span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--SeriesCConvertibleNotesMember_z0SPW8LRhEi5"&gt;58,333&lt;/span&gt; together with accrued interest of
$&lt;span id="xdx_90A_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--SeriesCConvertibleNotesMember_z1cAzdUoMF4l"&gt;18,670&lt;/span&gt; for a cash payment of $&lt;span id="xdx_90F_ecustom--DebtInstrumentRedeemedByCashPayment_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_zIAE15IOIBF3"&gt;77,003&lt;/span&gt;. No gain or loss was recognized on settlement of the host debt. The Company recognized a gain of
$&lt;span id="xdx_902_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_zYNGh8si3BE1"&gt;19,842&lt;/span&gt; upon derecognition of the related derivative liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2026, there were no conversions of Series C Notes into common stock.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended March 31, 2025, Series C Notes
with a face value of $&lt;span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCConvertibleNotesMember_zj5KqCwGpMQc" title="Debt conversion converted instrument amount"&gt;1,487,700&lt;/span&gt; and accrued interest of $&lt;span id="xdx_905_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCConvertibleNotesMember_zBFFZEFR7ZA3" title="Debt instrument increase accrued interest"&gt;237,230&lt;/span&gt; were converted into &lt;span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCConvertibleNotesMember_z3YtvHOXa2L4" title="Debt conversion converted instrument shares issued"&gt;2,173,089&lt;/span&gt; shares of common stock. As of March 31,
2025, &lt;span id="xdx_90E_eus-gaap--SharesPaidForTaxWithholdingForShareBasedCompensation_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCConvertibleNotesMember_zsYwyk3zfHei" title="Shares paid for tax withholding for share based compensation"&gt;577,644&lt;/span&gt; shares were recognized as an obligation for shares to be issued relating to these conversions. The fair value of the common
shares issued and to be issued was $&lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCConvertibleNotesMember_znwn2vAOFko5" title="Stock issued during period value new issues"&gt;2,431,178&lt;/span&gt;, based on the market price of the Company&#x2019;s common stock on the respective conversion
dates.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The total value of debt settled upon conversion was
$&lt;span id="xdx_906_ecustom--SettlementOfDebt_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCConvertibleNotesMember_zNzVioDX0Uc9" title="Settlement of debt"&gt;2,234,232&lt;/span&gt;, consisting of the face value of notes converted, accrued interest of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCConvertibleNotesMember_zglBXJM1gJZi" title="Debt instrument increase accrued interest"&gt;237,230&lt;/span&gt; and related derivative liabilities of $&lt;span id="xdx_905_ecustom--DerivativeLiability_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCConvertibleNotesMember_zk3WTCQlgKpb" title="Derivative liability"&gt;509,303&lt;/span&gt;.
The Company recognized a loss on conversion of $&lt;span id="xdx_901_ecustom--GainLossRecognizedOfDebt_pp2d_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCConvertibleNotesMember_zYMSNrm4ZLIb" title="Gain loss recognized of debt"&gt;196,945&lt;/span&gt;, representing the difference between the fair value of the shares issued and to
be issued and the carrying value of the debt and related derivative liabilities settled.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the year ended March 31, 2025, Series C Notes
with a face value of $&lt;span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_iI_c20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_z90kHKNYKWb5" title="Debt instrument face amount"&gt;150,000&lt;/span&gt; and accrued interest of $&lt;span id="xdx_90B_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCNoteMember_zeEZf6sZrGv3"&gt;34,864&lt;/span&gt; were redeemed for cash payments totaling $&lt;span id="xdx_907_ecustom--DebtInstrumentRedeemedByCashPayment_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_zk6PVBao9BRg" title="Debt instrument redeemed by cash payment"&gt;184,864&lt;/span&gt;. No gain or loss was recognized
on redemption.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026 and March 31, 2025, accrued interest related to the Series C Notes was $&lt;span id="xdx_90D_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20260331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_zP15cPhUxX1j" title="Convertible note issuances"&gt;49,340&lt;/span&gt; and $&lt;span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_zZ3bmejNYxnc" title="Convertible note issuances"&gt;53,188&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;During the years ended March 31, 2026 and 2025, the
Company recognized interest expense of $&lt;span id="xdx_906_eus-gaap--InterestExpenseDebt_dxL_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_zRMX4Jvd1Eu5" title="Interest expense::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1099"&gt;nil&lt;/span&gt;&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--InterestExpenseDebt_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_zRyScBK0u67f" title="Interest expense"&gt;70,712&lt;/span&gt;, respectively.&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended March 31, 2026 and 2025, the Company recognized accretion and amortization expense related to the Series C Notes of $&lt;span id="xdx_906_eus-gaap--AmortizationOfDebtDiscountPremium_dxL_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_z9iea6Hf1wJ4" title="Adjustment for amortization::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1103"&gt;nil&lt;/span&gt;&lt;/span&gt;
and $&lt;span id="xdx_901_eus-gaap--AmortizationOfDebtDiscountPremium_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_zxnElc1hvua6" title="Adjustment for amortization"&gt;1,267,668&lt;/span&gt;, respectively. As of March 31, 2026 and March 31, 2025, all debt discounts associated with the Series C Notes had been
fully amortized.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Convertible
Preferred Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has issued unsecured preferred notes and convertible promissory notes to private investors. Certain notes bear fixed interest
rates ranging from &lt;span id="xdx_904_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20260331__srt--RangeAxis__srt--MinimumMember_zDoIuN9jEF3b" title="Convertible discount percentage"&gt;8&lt;/span&gt;% to &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20260331__srt--RangeAxis__srt--MaximumMember_zSBaVth1RLp1" title="Convertible discount percentage"&gt;20&lt;/span&gt;% per annum and contain conversion features that require the mutual consent of both the investor and the Company.
As the conversion features are not solely within the control of the holder, the Company has not recognized derivative liabilities related
to these conversion options.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company entered into a convertible preferred note
financing on September 25, 2023 and issued a Preferred Note with a principal amount of $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20230925__us-gaap--AwardTypeAxis__custom--EighteenMonthAnniversaryMember_z3nhayBO6bZ2" title="Debt instrument face amount"&gt;1,000,000&lt;/span&gt;. The Preferred Note bears interest at
a fixed rate of &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230925__us-gaap--AwardTypeAxis__custom--EighteenMonthAnniversaryMember_zZKAwlEWHfRb" title="Interest rate"&gt;12&lt;/span&gt;% per annum, payable in cash monthly.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;As of March 31, 2025, the outstanding principal balance of the Preferred Note was $&lt;span id="xdx_90F_eus-gaap--ConvertibleNotesPayable_iI_c20250331__us-gaap--AwardTypeAxis__custom--EighteenMonthAnniversaryMember_zOiZqzkWjDdb" title="Convertible notes payable"&gt;1,000,000&lt;/span&gt;. &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2026, the Company made principal repayments in accordance with the terms of the note, and as of March 31, 2026,
the Preferred Note had been fully repaid with no balance remaining outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;The Company also issued a Preferred Note on October 25, 2023 in the principal amount of $&lt;span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20231025__20231025__us-gaap--AwardTypeAxis__custom--EighteenMonthAnniversaryMember_zroLDGGBGlTh" title="Debt converted amount"&gt;250,000&lt;/span&gt;, bearing
interest at a fixed rate of &lt;span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20231025__us-gaap--AwardTypeAxis__custom--EighteenMonthAnniversaryMember_zyynu1G124Zh" title="Interest rate"&gt;12&lt;/span&gt;% per annum, payable in cash quarterly. During the year ended March 31, 2026, the Company &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;repaid
$&lt;span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20250401__20260331__us-gaap--AwardTypeAxis__custom--EighteenMonthAnniversaryMember_zgybvPu4sxW1" title="Debt conversion converted instrument amount"&gt;100,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of
the principal balance in accordance with the terms of the note. As of March 31, 2026, the outstanding principal balance was $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_iI_c20260331__us-gaap--AwardTypeAxis__custom--EighteenMonthAnniversaryMember_zjSJVEsCasPd"&gt;&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20260331__us-gaap--AwardTypeAxis__custom--EighteenMonthAnniversaryMember_zDgR8ihEvE4b" title="Debt instrument face amount"&gt;150,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(March 31, 2025 - $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20250331__us-gaap--AwardTypeAxis__custom--EighteenMonthAnniversaryMember_z7bC5rAhlaE8" title="Debt instrument face amount"&gt;250,000&lt;/span&gt;)&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company issued a further Preferred Note in January 2024 for a principal amount of $&lt;span id="xdx_908_eus-gaap--ConvertibleNotesPayable_iI_c20240131_zU0nKrLxfCod" title="Convertible notes payble"&gt;114,303&lt;/span&gt;, bearing interest at a fixed rate of &lt;span id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20240131__us-gaap--AwardTypeAxis__custom--TwentyFourMonthAnniversaryMember_zUcy2gcexHb5" title="Debt instrument interest rate stated percentage"&gt;8&lt;/span&gt;% per annum, payable in cash quarterly. As of March 31, 2026, the outstanding principal balance remained $&lt;span id="xdx_90C_eus-gaap--ConvertibleNotesPayable_iI_c20260331__us-gaap--AwardTypeAxis__custom--TwentyFourMonthAnniversaryMember_zM5yQ38U5npc" title="Convertible notes payble"&gt;114,303&lt;/span&gt; (March 31, 2025 - $&lt;span id="xdx_901_eus-gaap--ConvertibleNotesPayable_iI_c20250331__us-gaap--AwardTypeAxis__custom--TwentyFourMonthAnniversaryMember_zMeOd84EY8if" title="Convertible notes payble"&gt;114,303&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2025, the Company issued $&lt;span id="xdx_908_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20240401__20250331_zs8LzbLYWlC1" title="Unsecured convertible promissory notes"&gt;1,985,000&lt;/span&gt; in unsecured convertible promissory notes to private investors: $&lt;span id="xdx_90D_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20240401__20250331__us-gaap--AwardTypeAxis__custom--SixMonthAnniversaryMember_zcGUqfN6u0v3" title="Unsecured convertible promissory notes"&gt;100,000&lt;/span&gt;
of the notes matured on their six-month anniversary of issuance and bore interest at &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20250331__us-gaap--AwardTypeAxis__custom--SixMonthAnniversaryMember_zuFKgCRsPodc" title="Convertible discount percentage"&gt;20&lt;/span&gt;% per annum; $&lt;span id="xdx_908_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20240401__20250331__us-gaap--AwardTypeAxis__custom--TwelveMonthAnniversaryMember_zckrLt2ZJKK7" title="Unsecured convertible promissory notes"&gt;710,000&lt;/span&gt; of the notes mature on their
twenty-four month anniversary of issuance and bear interest at &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20250331__us-gaap--AwardTypeAxis__custom--TwelveMonthAnniversaryMember_z1L20RaL5BVe" title="Convertible discount percentage"&gt;10&lt;/span&gt;% per annum; and $&lt;span id="xdx_902_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20240401__20250331__us-gaap--AwardTypeAxis__custom--EighteenMonthAnniversaryMember_zDGHiyTcqkVi" title="Unsecured convertible promissory notes"&gt;1,175,000&lt;/span&gt; of the notes mature on their eighteen-month
anniversary of issuance and bear no interest. All of the notes contain conversion features that require the mutual consent of the investor
and the Company, and as the conversion is not solely within the control of the holder, the Company did not recognize a derivative liability
in connection with these conversion options. During the year ended March 31, 2026, the Company repaid in full the $&lt;span id="xdx_909_eus-gaap--RepaymentsOfConvertibleDebt_c20250401__20260331_zTlGQVSLwwUa" title="Repayments of convertible debt"&gt;100,000&lt;/span&gt; note that
matured on its six-month anniversary of issuance, together with all accrued interest thereon, the outstanding principal balance remained
$&lt;span id="xdx_903_eus-gaap--ConvertibleNotesPayable_iI_c20260331_zQJYyApBbQOf" title="Convertible notes payble"&gt;1,885,000&lt;/span&gt; ( March 31, 2025 $&lt;span id="xdx_909_eus-gaap--ConvertibleNotesPayable_iI_c20250331_zD4iDRZXBwZe" title="Convertible notes payble"&gt;1,985,000&lt;/span&gt;)&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2026, the Company issued $&lt;span id="xdx_90E_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--UnsecuredConvertiblePromissoryNotesMember_zL2QaJWm9N2j"&gt;1,395,000&lt;/span&gt;
in unsecured convertible promissory notes to private investors. The notes bear interest at rates ranging from &lt;span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20260331__us-gaap--AwardTypeAxis__custom--NineMonthAnniversaryMember_zLDXXEN0UEca"&gt;10.0%&lt;/span&gt;
to &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20260331__us-gaap--AwardTypeAxis__custom--TwentyFourMonthAnniversaryMember_zmPrTf7Ruaog"&gt;12.0&lt;/span&gt;% per annum and mature between nine and twenty-four months from issuance. Specifically, $&lt;span id="xdx_90C_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20250401__20260331__us-gaap--AwardTypeAxis__custom--NineMonthAnniversaryMember_zFZMCASPMnp2" title="Unsecured convertible promissory notes"&gt;65,000&lt;/span&gt; of the notes mature
on their nine-month anniversary and bear interest at &lt;span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20260331__us-gaap--AwardTypeAxis__custom--NineMonthAnniversaryMember_z1AygJwbxmJk" title="Convertible discount percentage"&gt;10.0&lt;/span&gt;% per annum; $&lt;span id="xdx_904_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20250401__20260331__us-gaap--AwardTypeAxis__custom--TwentyFourMonthAnniversaryMember_zn8xpjQWmBql" title="Unsecured convertible promissory notes"&gt;500,000&lt;/span&gt; mature on their twenty-four month anniversary and bear
interest at &lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20260331__us-gaap--AwardTypeAxis__custom--TwentyFourMonthAnniversaryMember_zg0QY1CZKadl" title="Convertible discount percentage"&gt;12.0&lt;/span&gt;% per annum; $&lt;span id="xdx_903_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20250401__20260331__us-gaap--AwardTypeAxis__custom--TwentyFourMonthOneAnniversaryMember_zPGCA21Ehupl" title="Unsecured convertible promissory notes"&gt;730,000&lt;/span&gt; mature on their twenty-four month anniversary and bear interest at &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20260331__us-gaap--AwardTypeAxis__custom--TwentyFourMonthOneAnniversaryMember_zECaZ4D2era3" title="Convertible discount percentage"&gt;10.0&lt;/span&gt;% per annum; and $&lt;span id="xdx_90F_eus-gaap--ProceedsFromUnsecuredNotesPayable_c20250401__20260331__us-gaap--AwardTypeAxis__custom--TwentyFourMonthTwoAnniversaryMember_zWXGr4MpFpd1" title="Unsecured convertible promissory notes"&gt;100,000&lt;/span&gt;
mature on their twenty-four month anniversary and bear interest at &lt;span id="xdx_907_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_c20260331__us-gaap--AwardTypeAxis__custom--TwentyFourMonthTwoAnniversaryMember_ztyOfv1Rodr8" title="Convertible discount percentage"&gt;10.5&lt;/span&gt;% per annum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;The Company received gross proceeds of $&lt;span id="xdx_900_eus-gaap--ProceedsFromIssuanceOfDebt_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--UnsecuredConvertiblePromissoryNotesMember_zRK7LJepJPz7" title="Proceeds from issuance of debt"&gt;1,395,000&lt;/span&gt; from these issuances. &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
connection with the financings, the Company incurred financing fees of $&lt;span id="xdx_904_eus-gaap--DeferredCosts_iI_c20260331__us-gaap--DebtInstrumentAxis__custom--UnsecuredConvertiblePromissoryNotesMember_zb1UYdCc35Id" title="Deferred costs"&gt;46,500&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;,
&lt;/span&gt;resulting in net proceeds of $&lt;span id="xdx_902_eus-gaap--ProceedsFromNotesPayable_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--UnsecuredConvertiblePromissoryNotesMember_zrzrEcp4Wpyl" title="Proceeds from note payable"&gt;1,348,500&lt;/span&gt;. As the conversion features of these notes are not solely within the control of the holder,
the Company did not recognize a derivative liability associated with the conversion options. As of March 31, 2026, the aggregate outstanding
principal balance of these notes was $&lt;span id="xdx_906_eus-gaap--ProceedsFromIssuanceOfDebt_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--UnsecuredConvertiblePromissoryNotesMember_zP87dDnpxaEi" title="Proceeds from issuance of debt"&gt;1,395,000&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="margin: 0; text-align: justify"&gt;The financing fees &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;were
capitalized as deferred financing costs and are presented as a reduction of the related debt balances in the consolidated balance sheet
in accordance with ASC 835-30 and ASC 470-10. These costs are amortized over the contractual terms of the respective notes using a method
that approximates the effective interest method. During the year ended March 31, 2026, the Company recognized amortization expense of
$&lt;span id="xdx_90A_eus-gaap--CostOfGoodsAndServicesSoldAmortization_c20250401__20260331_zmd0MZ1gGrOd" title="Cost of goods and services sold amortization"&gt;17,973&lt;/span&gt; related to these deferred financing costs (2025 &#x2013; $&lt;span id="xdx_90A_eus-gaap--AccretionExpense_dxL_c20240401__20250331_zDeyu7r44v44" title="Accretion expense::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1183"&gt;nil&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026 and March 31, 2025, accrued interest related to the Preferred Notes and convertible promissory notes was $&lt;span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20260331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteMember_zEz4p3l636Vk" title="Interest accruals"&gt;56,309&lt;/span&gt; and
$&lt;span id="xdx_901_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteMember_znGyg44s2Kvg" title="Interest accruals"&gt;36,163&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended March 31, 2026 and 2025, the Company recognized interest expense of $&lt;span id="xdx_900_eus-gaap--InterestExpenseDebt_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteMember_zSNW6CUioDFc" title="Interest expense"&gt;246,110&lt;/span&gt; and $&lt;span id="xdx_90D_eus-gaap--InterestExpenseDebt_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteMember_zUa64zKEVgS7" title="Interest expense"&gt;180,888&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Other
Convertible Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;On January 23, 2023, the Company
issued a convertible preferred note with a principal amount of $&lt;span id="xdx_907_eus-gaap--ConvertibleNotesPayable_iI_c20230123__us-gaap--ShortTermDebtTypeAxis__custom--OtherConvertibleNotesPayableMember_z9H0q83L8pbc"&gt;2,000,000&lt;/span&gt;
to an accredited investor. The note bears interest at a fixed rate of &lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20230123__us-gaap--ShortTermDebtTypeAxis__custom--OtherConvertibleNotesPayableMember_zY8J6DMrtq11"&gt;10&lt;/span&gt;% per annum and contains conversion features that become effective upon a qualified financing or upon mutual agreement
of the Company and the noteholder. As the conversion feature is not solely within the control of the holder, the Company has not recognized
a derivative liability related to the conversion option.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026 and March 31, 2025, the outstanding principal balance of the note was $&lt;span id="xdx_903_eus-gaap--NotesPayable_iI_c20260331_zMXEIvPPnwHe" title="Notes payable"&gt;&lt;span id="xdx_905_eus-gaap--NotesPayable_iI_c20250331_zO8j1BThfElg" title="Notes payable"&gt;2,000,000&lt;/span&gt;&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026 and March 31, 2025, the discount associated with the note was fully amortized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Other
Short-term loans and Promissory Notes&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company maintains various debt arrangements, including promissory notes, a revolving financing facility, bridge loans and other financing
arrangements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026, the Company had the following principal balances outstanding:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
    promissory note issued in December 2022 with principal outstanding of $&lt;span id="xdx_90D_eus-gaap--DebtInstrumentCarryingAmount_iI_c20221231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteAgreementMember__dei--LegalEntityAxis__custom--IndividualInvestorMember_z1oDCuq1wWf6"&gt;600,000&lt;/span&gt;
    (March 31, 2025 $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteAgreementMember__dei--LegalEntityAxis__custom--IndividualInvestorMember_zQ6UgyfM7xF6"&gt;600,000&lt;/span&gt;) bearing interest at &lt;span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20221201__20221231__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteAgreementMember__dei--LegalEntityAxis__custom--IndividualInvestorMember_zQsozoJBfS29"&gt;25%&lt;/span&gt;
    per annum.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
    promissory note issued in December 2022 in connection with the extinguishment of warrants, with principal outstanding of $&lt;span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_c20221230__us-gaap--DebtInstrumentAxis__custom--NewPromissoryNoteMember_zqMosbJ26Awl"&gt;270,000&lt;/span&gt; (March 31, 2025, $ &lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20221230__us-gaap--DebtInstrumentAxis__custom--NewPromissoryNoteMember_zWqzwg6kii2j" title="Debt instrument face amount"&gt;270,000&lt;/span&gt;).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
    revolving accounts receivable and inventory financing facility with aggregate principal outstanding of $&lt;span id="xdx_90F_eus-gaap--LineOfCreditFacilityAnnualPrincipalPayment_c20250401__20260331_zA6uCY1Jhle8" title="Principal outstanding"&gt;2,108,109&lt;/span&gt; (March 31, 2025, $&lt;span id="xdx_901_eus-gaap--LineOfCreditFacilityAnnualPrincipalPayment_c20240401__20250331_zyr5Hp17sLh2" title="Principal outstanding"&gt;1,699,796&lt;/span&gt;).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
    promissory note issued in February 2024, including subsequent advances, with principal outstanding of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentCarryingAmount_iI_c20260331__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteAgreementMember__dei--LegalEntityAxis__custom--IndividualInvestorOneMember_zUr0zQD3I3wk" title="Outstanding amount"&gt;1,263,768&lt;/span&gt; (March 31, 2025, $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentCarryingAmount_iI_c20250331__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteAgreementMember__dei--LegalEntityAxis__custom--IndividualInvestorOneMember_zPe5320jujy8" title="Outstanding amount"&gt;660,932&lt;/span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;An
    unsecured loan issued in July 2025 with principal outstanding of $&lt;span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_c20230811__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesOneMember_zsLT22Nsvlrf" title="Debt face amount"&gt;250,000&lt;/span&gt; (March 31, 2025, $ &lt;span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_dxL_c20250331__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesOneMember_zRXDd9dnkdcb" title="Debt face amount::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1215"&gt;Nil&lt;/span&gt;&lt;/span&gt;).&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
    short-term bridge loan entered into during December 2025 with principal outstanding of $&lt;span id="xdx_907_eus-gaap--DebtInstrumentCarryingAmount_iI_c20260331__us-gaap--DebtInstrumentAxis__custom--ShortTermBridgeLoanAgreementOneMember__dei--LegalEntityAxis__custom--CollateralizedMerchantFinanceCompanyOneMember_zdkRdCujkLO2" title="Principal outstanding amount"&gt;177,226&lt;/span&gt; (March 31, 2025, $ &lt;span id="xdx_904_eus-gaap--DebtInstrumentCarryingAmount_iI_dxL_c20250331__us-gaap--DebtInstrumentAxis__custom--ShortTermBridgeLoanAgreementOneMember__dei--LegalEntityAxis__custom--CollateralizedMerchantFinanceCompanyOneMember_zOOBWQ78ckWb" title="Principal outstanding amount::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1219"&gt;Nil&lt;/span&gt;&lt;/span&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026, accrued interest related to these arrangements totaled $&lt;span id="xdx_90A_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20260331__us-gaap--DebtInstrumentAxis__custom--ShortTermMember_zcGJV9jmDtYj" title="Interest accruals"&gt;311,033&lt;/span&gt;
(March 31, 2025, $&lt;span id="xdx_908_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20250331__us-gaap--DebtInstrumentAxis__custom--ShortTermMember_zKgZ56EkZaMa" title="Interest accruals"&gt;196,837&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2026, the Company recognized interest expense of $&lt;span id="xdx_90C_eus-gaap--InterestExpenseDebt_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--ShortTermMember_zDC84zKzG89i" title="Interest expense"&gt;729,912&lt;/span&gt;
(March 31, 2025, $&lt;span id="xdx_907_eus-gaap--InterestExpenseDebt_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--ShortTermMember_zZZnCP1WoMLe" title="Interest expense"&gt;698,028&lt;/span&gt;) related to these debt arrangements, including financing costs, accretion and facility charges. Deferred
financing costs are recorded as a reduction of the related debt balances and amortized over the contractual terms of the respective
arrangements.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_SeriesANoteMember"
      decimals="INF"
      id="Fact001022"
      unitRef="Pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_custom_SeriesANoteMember"
      decimals="0"
      id="Fact001024"
      unitRef="USD">821500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_custom_SeriesANoteMember"
      decimals="0"
      id="Fact001026"
      unitRef="USD">821500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2022-12-30_custom_SeriesANoteMember"
      decimals="0"
      id="Fact001028"
      unitRef="USD">500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2022-12-30_custom_NewConvertibleNoteMember"
      decimals="0"
      id="Fact001030"
      unitRef="USD">121500</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2022-12-30_custom_NewConvertibleNoteMember"
      decimals="0"
      id="Fact001032"
      unitRef="USD">621500</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2022-12-30_custom_NewConvertibleNoteMember"
      decimals="INF"
      id="Fact001034"
      unitRef="Pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-12-302022-12-30_custom_NewConvertibleNoteMember"
      decimals="INF"
      id="Fact001036"
      unitRef="Pure">0.75</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2026-03-31_custom_SeriesANoteMember"
      decimals="0"
      id="Fact001038"
      unitRef="USD">370922</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2025-03-31_custom_SeriesANoteMember"
      decimals="0"
      id="Fact001040"
      unitRef="USD">272342</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestExpenseDebt
      contextRef="From2025-04-012026-03-31_custom_SeriesANoteMember"
      decimals="0"
      id="Fact001042"
      unitRef="USD">98580</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-04-012025-03-31_custom_SeriesANoteMember"
      decimals="0"
      id="Fact001044"
      unitRef="USD">98580</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_SeriesBNoteMember"
      decimals="INF"
      id="Fact001046"
      unitRef="Pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <BTCY:RedemptionOfConvertibleNotes
      contextRef="From2024-04-012025-03-31_custom_SeriesBNoteMember"
      decimals="0"
      id="Fact001048"
      unitRef="USD">22009</BTCY:RedemptionOfConvertibleNotes>
    <us-gaap:RepaymentsOfOtherDebt
      contextRef="From2024-04-012025-03-31_custom_SeriesBNoteMember"
      decimals="0"
      id="Fact001050"
      unitRef="USD">25342</us-gaap:RepaymentsOfOtherDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2024-04-012025-03-31_custom_SeriesBNoteMember"
      decimals="0"
      id="Fact001052"
      unitRef="USD">8320</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2026-03-31_custom_SeriesBNoteMember"
      decimals="0"
      id="Fact001054"
      unitRef="USD">88881</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2025-03-31_custom_SeriesBNoteMember"
      decimals="0"
      id="Fact001056"
      unitRef="USD">88881</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-04-012025-03-31_custom_SeriesBNoteMember"
      decimals="0"
      id="Fact001060"
      unitRef="USD">279</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_SeriesCNoteMember"
      decimals="INF"
      id="Fact001062"
      unitRef="Pure">0.15</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <BTCY:RedemptionOfConvertibleNotes
      contextRef="From2025-04-012026-03-31_custom_SeriesCNoteMember"
      decimals="0"
      id="Fact001064"
      unitRef="USD">116667</BTCY:RedemptionOfConvertibleNotes>
    <BTCY:RedemptionOfConvertibleNotes
      contextRef="From2024-04-012025-03-31_custom_SeriesCNoteMember"
      decimals="0"
      id="Fact001066"
      unitRef="USD">175000</BTCY:RedemptionOfConvertibleNotes>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-04-012026-03-31_custom_SeriesCConvertibleNotesMember"
      decimals="0"
      id="Fact001067"
      unitRef="USD">58333</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2025-04-012026-03-31_custom_SeriesCConvertibleNotesMember"
      decimals="0"
      id="Fact001068"
      unitRef="USD">18670</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <BTCY:DebtInstrumentRedeemedByCashPayment
      contextRef="From2025-04-012026-03-31_custom_SeriesCNotesMember"
      decimals="0"
      id="Fact001069"
      unitRef="USD">77003</BTCY:DebtInstrumentRedeemedByCashPayment>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="From2025-04-012026-03-31_custom_SeriesCNotesMember"
      decimals="0"
      id="Fact001070"
      unitRef="USD">19842</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2024-04-012025-03-31_custom_SeriesCConvertibleNotesMember"
      decimals="0"
      id="Fact001072"
      unitRef="USD">1487700</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2024-04-012025-03-31_custom_SeriesCConvertibleNotesMember"
      decimals="0"
      id="Fact001074"
      unitRef="USD">237230</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2024-04-012025-03-31_custom_SeriesCConvertibleNotesMember"
      decimals="INF"
      id="Fact001076"
      unitRef="Shares">2173089</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="From2024-04-012025-03-31_custom_SeriesCConvertibleNotesMember"
      decimals="INF"
      id="Fact001078"
      unitRef="Shares">577644</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-04-012025-03-31_custom_SeriesCConvertibleNotesMember"
      decimals="0"
      id="Fact001080"
      unitRef="USD">2431178</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <BTCY:SettlementOfDebt
      contextRef="From2024-04-012025-03-31_custom_SeriesCConvertibleNotesMember"
      decimals="0"
      id="Fact001082"
      unitRef="USD">2234232</BTCY:SettlementOfDebt>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2024-04-012025-03-31_custom_SeriesCConvertibleNotesMember"
      decimals="0"
      id="Fact001084"
      unitRef="USD">237230</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <BTCY:DerivativeLiability
      contextRef="From2024-04-012025-03-31_custom_SeriesCConvertibleNotesMember"
      decimals="0"
      id="Fact001086"
      unitRef="USD">509303</BTCY:DerivativeLiability>
    <BTCY:GainLossRecognizedOfDebt
      contextRef="From2024-04-012025-03-31_custom_SeriesCConvertibleNotesMember"
      decimals="2"
      id="Fact001088"
      unitRef="USD">196945</BTCY:GainLossRecognizedOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_custom_SeriesCNotesMember"
      decimals="0"
      id="Fact001090"
      unitRef="USD">150000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2024-04-012025-03-31_custom_SeriesCNoteMember"
      decimals="0"
      id="Fact001091"
      unitRef="USD">34864</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <BTCY:DebtInstrumentRedeemedByCashPayment
      contextRef="From2024-04-012025-03-31_custom_SeriesCNotesMember"
      decimals="0"
      id="Fact001093"
      unitRef="USD">184864</BTCY:DebtInstrumentRedeemedByCashPayment>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2026-03-31_custom_SeriesCNotesMember"
      decimals="0"
      id="Fact001095"
      unitRef="USD">49340</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2025-03-31_custom_SeriesCNotesMember"
      decimals="0"
      id="Fact001097"
      unitRef="USD">53188</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-04-012025-03-31_custom_SeriesCNotesMember"
      decimals="0"
      id="Fact001101"
      unitRef="USD">70712</us-gaap:InterestExpenseDebt>
    <us-gaap:AmortizationOfDebtDiscountPremium
      contextRef="From2024-04-012025-03-31_custom_SeriesCNotesMember"
      decimals="0"
      id="Fact001105"
      unitRef="USD">1267668</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_srt_MinimumMember"
      decimals="INF"
      id="Fact001107"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_srt_MaximumMember"
      decimals="INF"
      id="Fact001109"
      unitRef="Pure">0.20</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-09-25_custom_EighteenMonthAnniversaryMember"
      decimals="0"
      id="Fact001111"
      unitRef="USD">1000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-09-25_custom_EighteenMonthAnniversaryMember"
      decimals="INF"
      id="Fact001113"
      unitRef="Pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2025-03-31_custom_EighteenMonthAnniversaryMember"
      decimals="0"
      id="Fact001115"
      unitRef="USD">1000000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2023-10-252023-10-25_custom_EighteenMonthAnniversaryMember"
      decimals="0"
      id="Fact001117"
      unitRef="USD">250000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-10-25_custom_EighteenMonthAnniversaryMember"
      decimals="INF"
      id="Fact001119"
      unitRef="Pure">0.12</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2025-04-012026-03-31_custom_EighteenMonthAnniversaryMember"
      decimals="0"
      id="Fact001121"
      unitRef="USD">100000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_custom_EighteenMonthAnniversaryMember"
      decimals="0"
      id="Fact001122"
      unitRef="USD">150000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_custom_EighteenMonthAnniversaryMember"
      decimals="0"
      id="Fact001124"
      unitRef="USD">150000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_custom_EighteenMonthAnniversaryMember"
      decimals="0"
      id="Fact001126"
      unitRef="USD">250000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2024-01-31"
      decimals="0"
      id="Fact001128"
      unitRef="USD">114303</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2024-01-31_custom_TwentyFourMonthAnniversaryMember"
      decimals="INF"
      id="Fact001130"
      unitRef="Pure">0.08</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2026-03-31_custom_TwentyFourMonthAnniversaryMember"
      decimals="0"
      id="Fact001132"
      unitRef="USD">114303</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2025-03-31_custom_TwentyFourMonthAnniversaryMember"
      decimals="0"
      id="Fact001134"
      unitRef="USD">114303</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ProceedsFromUnsecuredNotesPayable
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact001136"
      unitRef="USD">1985000</us-gaap:ProceedsFromUnsecuredNotesPayable>
    <us-gaap:ProceedsFromUnsecuredNotesPayable
      contextRef="From2024-04-012025-03-31_custom_SixMonthAnniversaryMember"
      decimals="0"
      id="Fact001138"
      unitRef="USD">100000</us-gaap:ProceedsFromUnsecuredNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-03-31_custom_SixMonthAnniversaryMember"
      decimals="INF"
      id="Fact001140"
      unitRef="Pure">0.20</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromUnsecuredNotesPayable
      contextRef="From2024-04-012025-03-31_custom_TwelveMonthAnniversaryMember"
      decimals="0"
      id="Fact001142"
      unitRef="USD">710000</us-gaap:ProceedsFromUnsecuredNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2025-03-31_custom_TwelveMonthAnniversaryMember"
      decimals="INF"
      id="Fact001144"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromUnsecuredNotesPayable
      contextRef="From2024-04-012025-03-31_custom_EighteenMonthAnniversaryMember"
      decimals="0"
      id="Fact001146"
      unitRef="USD">1175000</us-gaap:ProceedsFromUnsecuredNotesPayable>
    <us-gaap:RepaymentsOfConvertibleDebt
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001148"
      unitRef="USD">100000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001150"
      unitRef="USD">1885000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001152"
      unitRef="USD">1985000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ProceedsFromUnsecuredNotesPayable
      contextRef="From2025-04-012026-03-31_custom_UnsecuredConvertiblePromissoryNotesMember"
      decimals="0"
      id="Fact001153"
      unitRef="USD">1395000</us-gaap:ProceedsFromUnsecuredNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_NineMonthAnniversaryMember"
      decimals="INF"
      id="Fact001154"
      unitRef="Pure">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_TwentyFourMonthAnniversaryMember"
      decimals="INF"
      id="Fact001155"
      unitRef="Pure">0.120</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromUnsecuredNotesPayable
      contextRef="From2025-04-012026-03-31_custom_NineMonthAnniversaryMember"
      decimals="0"
      id="Fact001157"
      unitRef="USD">65000</us-gaap:ProceedsFromUnsecuredNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_NineMonthAnniversaryMember"
      decimals="INF"
      id="Fact001159"
      unitRef="Pure">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromUnsecuredNotesPayable
      contextRef="From2025-04-012026-03-31_custom_TwentyFourMonthAnniversaryMember"
      decimals="0"
      id="Fact001161"
      unitRef="USD">500000</us-gaap:ProceedsFromUnsecuredNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_TwentyFourMonthAnniversaryMember"
      decimals="INF"
      id="Fact001163"
      unitRef="Pure">0.120</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromUnsecuredNotesPayable
      contextRef="From2025-04-012026-03-31_custom_TwentyFourMonthOneAnniversaryMember"
      decimals="0"
      id="Fact001165"
      unitRef="USD">730000</us-gaap:ProceedsFromUnsecuredNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_TwentyFourMonthOneAnniversaryMember"
      decimals="INF"
      id="Fact001167"
      unitRef="Pure">0.100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromUnsecuredNotesPayable
      contextRef="From2025-04-012026-03-31_custom_TwentyFourMonthTwoAnniversaryMember"
      decimals="0"
      id="Fact001169"
      unitRef="USD">100000</us-gaap:ProceedsFromUnsecuredNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2026-03-31_custom_TwentyFourMonthTwoAnniversaryMember"
      decimals="INF"
      id="Fact001171"
      unitRef="Pure">0.105</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2025-04-012026-03-31_custom_UnsecuredConvertiblePromissoryNotesMember"
      decimals="0"
      id="Fact001173"
      unitRef="USD">1395000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DeferredCosts
      contextRef="AsOf2026-03-31_custom_UnsecuredConvertiblePromissoryNotesMember"
      decimals="0"
      id="Fact001175"
      unitRef="USD">46500</us-gaap:DeferredCosts>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="From2025-04-012026-03-31_custom_UnsecuredConvertiblePromissoryNotesMember"
      decimals="0"
      id="Fact001177"
      unitRef="USD">1348500</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="From2025-04-012026-03-31_custom_UnsecuredConvertiblePromissoryNotesMember"
      decimals="0"
      id="Fact001179"
      unitRef="USD">1395000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001181"
      unitRef="USD">17973</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2026-03-31_custom_ConvertibleNoteMember"
      decimals="0"
      id="Fact001185"
      unitRef="USD">56309</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2025-03-31_custom_ConvertibleNoteMember"
      decimals="0"
      id="Fact001187"
      unitRef="USD">36163</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestExpenseDebt
      contextRef="From2025-04-012026-03-31_custom_ConvertibleNoteMember"
      decimals="0"
      id="Fact001189"
      unitRef="USD">246110</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-04-012025-03-31_custom_ConvertibleNoteMember"
      decimals="0"
      id="Fact001191"
      unitRef="USD">180888</us-gaap:InterestExpenseDebt>
    <us-gaap:ConvertibleNotesPayable
      contextRef="AsOf2023-01-23_custom_OtherConvertibleNotesPayableMember"
      decimals="0"
      id="Fact001192"
      unitRef="USD">2000000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2023-01-23_custom_OtherConvertibleNotesPayableMember"
      decimals="INF"
      id="Fact001193"
      unitRef="Pure">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:NotesPayable
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001195"
      unitRef="USD">2000000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001197"
      unitRef="USD">2000000</us-gaap:NotesPayable>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2022-12-31_custom_PromissoryNoteAgreementMember_custom_IndividualInvestorMember"
      decimals="0"
      id="Fact001198"
      unitRef="USD">600000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2025-03-31_custom_PromissoryNoteAgreementMember_custom_IndividualInvestorMember"
      decimals="0"
      id="Fact001199"
      unitRef="USD">600000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2022-12-012022-12-31_custom_PromissoryNoteAgreementMember_custom_IndividualInvestorMember"
      decimals="INF"
      id="Fact001200"
      unitRef="Pure">0.25</us-gaap:DebtInstrumentInterestRateDuringPeriod>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-12-30_custom_NewPromissoryNoteMember"
      decimals="0"
      id="Fact001201"
      unitRef="USD">270000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2022-12-30_custom_NewPromissoryNoteMember"
      decimals="0"
      id="Fact001203"
      unitRef="USD">270000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityAnnualPrincipalPayment
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001205"
      unitRef="USD">2108109</us-gaap:LineOfCreditFacilityAnnualPrincipalPayment>
    <us-gaap:LineOfCreditFacilityAnnualPrincipalPayment
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact001207"
      unitRef="USD">1699796</us-gaap:LineOfCreditFacilityAnnualPrincipalPayment>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2026-03-31_custom_PromissoryNoteAgreementMember_custom_IndividualInvestorOneMember"
      decimals="0"
      id="Fact001209"
      unitRef="USD">1263768</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2025-03-31_custom_PromissoryNoteAgreementMember_custom_IndividualInvestorOneMember"
      decimals="0"
      id="Fact001211"
      unitRef="USD">660932</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2023-08-11_custom_ShortTermPromissoryNotesOneMember"
      decimals="0"
      id="Fact001213"
      unitRef="USD">250000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="AsOf2026-03-31_custom_ShortTermBridgeLoanAgreementOneMember_custom_CollateralizedMerchantFinanceCompanyOneMember"
      decimals="0"
      id="Fact001217"
      unitRef="USD">177226</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2026-03-31_custom_ShortTermMember"
      decimals="0"
      id="Fact001221"
      unitRef="USD">311033</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent
      contextRef="AsOf2025-03-31_custom_ShortTermMember"
      decimals="0"
      id="Fact001223"
      unitRef="USD">196837</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestExpenseDebt
      contextRef="From2025-04-012026-03-31_custom_ShortTermMember"
      decimals="0"
      id="Fact001225"
      unitRef="USD">729912</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="From2024-04-012025-03-31_custom_ShortTermMember"
      decimals="0"
      id="Fact001227"
      unitRef="USD">698028</us-gaap:InterestExpenseDebt>
    <BTCY:BankLoanCreditAgreementTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001229">&lt;p id="xdx_80F_ecustom--BankLoanCreditAgreementTextBlock_zvyB2uk1O55f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;6.
&lt;span id="xdx_829_zZGq7ciElIO"&gt;TERM LOAN AND CREDIT AGREEMENT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Term
Loan&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
December 21, 2021, the Company entered into a Credit Agreement (the &#x201c;Credit Agreement&#x201d;) with SWK Funding LLC (the &#x201c;Lender&#x201d;),
pursuant to which the Company borrowed approximately $&lt;span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_pn5n6_c20211221_zjIlSbiSW348" title="Debt instrument, face amount"&gt;12.4&lt;/span&gt; million. The term loan matures on &lt;span id="xdx_908_eus-gaap--DebtInstrumentMaturityDate_dd_c20211221__20211221_zbcdnTgPTGrl" title="Maturity date"&gt;February 15, 2027&lt;/span&gt; and bears interest at
a variable rate equal to the applicable benchmark rate plus &lt;span id="xdx_906_eus-gaap--SubordinatedBorrowingInterestRate_pid_dp_uPure_c20211221__20211221_zogYQDMcDVyk" title="Interest rate"&gt;10.5&lt;/span&gt;% per annum, subject to the terms of the Credit Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
loan is secured by substantially all of the Company&#x2019;s assets, including certain intellectual property. Interest payments are payable
quarterly in accordance with the terms of the Credit Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Pursuant
to amendments negotiated with the Lender, principal repayments of $&lt;span id="xdx_909_eus-gaap--ProceedsFromRepaymentsOfDebt_pn5n6_c20250401__20260331_zmjXXA7ee6oc" title="Principal repayments"&gt;2.4&lt;/span&gt; million ($&lt;span id="xdx_90C_eus-gaap--ProceedsFromRepaymentsOfDebt_c20211221__20211221_zqIwJW1m2OJi" title="Principal repayments"&gt;600,000&lt;/span&gt; per quarter) are scheduled during the final
two years of the loan term. Accordingly, as of March 31, 2026, $&lt;span id="xdx_90E_eus-gaap--LoansPayableToBankCurrent_iI_pn4n6_c20260331_z2aNlE40XyN1" title="Current liability"&gt;14.68&lt;/span&gt; million of the outstanding principal balance was classified as a
current liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2024, the Company entered into an amendment with the Lender pursuant to which it received additional term loan proceeds of approximately
$&lt;span id="xdx_904_eus-gaap--ProceedsFromShortTermDebt_pn3n3_c20241101__20241130_zuTfc6rnzKm8"&gt;635,000&lt;/span&gt;&lt;/span&gt; &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and
capitalized approximately $&lt;span id="xdx_907_ecustom--DebtInstrumentInterestAmount_iI_pn5n6_c20241130_z7qgowC9mo8i" title="Accrued interest amount"&gt;1.5&lt;/span&gt; &lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;million
of accrued interest into the outstanding principal balance. In connection with this amendment, the Company issued &lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20241130_zOuxCD53EFFj"&gt;600,000&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;warrants exercisable at $&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20241130_zdV9gw5voXf1"&gt;0.50
&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per share and agreed to increase the exit fee
payable upon maturity of the facility. The Company also received waiver and forbearance relief relating to certain covenant defaults.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;In
December 2025, the Company entered into an additional forbearance agreement with the Lender and issued &lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20251231__us-gaap--TypeOfArrangementAxis__custom--ForbearanceAgreementMember_zUozVRWPJkN7" title="Warrants shares issued"&gt;120,000&lt;/span&gt;&lt;/span&gt;
&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;warrants exercisable
at $&lt;span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20251231__us-gaap--TypeOfArrangementAxis__custom--ForbearanceAgreementMember_zpOjE9VW0xA3" title="Warrants exercisable price"&gt;0.37&lt;/span&gt;&lt;/span&gt;
&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;per share. Additionally,
the Company issued &lt;span id="xdx_901_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20251231__us-gaap--TypeOfArrangementAxis__custom--WarrantAgreementMember_zMo2f3RFe0Jh" title="Warrants shares issued"&gt;27,150&lt;/span&gt; warrants exercisable at $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20251231__us-gaap--TypeOfArrangementAxis__custom--WarrantAgreementMember_zwFWYAzUI9J5" title="Warrants exercisable price"&gt;2.21&lt;/span&gt; per share in accordance with the terms of a previously executed warrant agreement.
The warrants had an aggregate fair value of $&lt;span id="xdx_906_eus-gaap--WarrantsAndRightsOutstanding_iI_c20251231_zJHwG2Tyeq2c" title="Warrants fair value"&gt;38,078&lt;/span&gt; &lt;/span&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;and
were recorded as additional debt discount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2026, the Company made a scheduled principal repayment of $&lt;span id="xdx_909_eus-gaap--ProceedsFromRepaymentsOfDebt_c20250401__20260331__us-gaap--TypeOfArrangementAxis__custom--CreditAgreementMember_zX1Fi5BJkLSg" title="Principal repayments"&gt;600,000&lt;/span&gt; under the Credit Agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026, the outstanding principal balance under the Credit Agreement was $&lt;span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20260331__us-gaap--TypeOfArrangementAxis__custom--CreditAgreementMember_zXZdjaKuRME9" title="Debt instrument face amount"&gt;15,270,932&lt;/span&gt; (March 31, 2025 &#x2013; $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20250331__us-gaap--TypeOfArrangementAxis__custom--CreditAgreementMember_zHWGTnvThgCd" title="Debt instrument face amount"&gt;15,870,932&lt;/span&gt;).
The related unamortized debt discount was $&lt;span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20260331_z8Mgu5EooNw4" title="Unamortized debt discount"&gt;590,018&lt;/span&gt; (March 31, 2025 &#x2013; $&lt;span id="xdx_90A_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_c20250331_zYSDafYlbs62" title="Unamortized debt discount"&gt;1,199,372&lt;/span&gt;), resulting in a net carrying amount of $&lt;span id="xdx_90F_ecustom--DebtInstrumentIncreaseDecreaseInNet_iI_c20260331_z3DyBCRLE3J1" title="Net carrying amount"&gt;14,680,914&lt;/span&gt;
(March 31, 2025 &#x2013; $&lt;span id="xdx_900_ecustom--DebtInstrumentIncreaseDecreaseInNet_iI_c20250331_zNwHaZmOgGSh" title="Net carrying amount"&gt;14,671,560&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Debt
discounts, including deferred financing costs, warrant-related discounts and other financing costs associated with the Credit Agreement,
are amortized over the remaining term of the loan using the effective interest method. During the years ended March 31, 2026 and 2025,
the Company recognized accretion and amortization expense of $&lt;span id="xdx_90D_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_c20250401__20260331_zZ7acRCHIGRd" title="Accretion and amortization expenses"&gt;647,433&lt;/span&gt; and $&lt;span id="xdx_909_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_c20240401__20250331_zRabNc7vSZy8" title="Accretion and amortization expenses"&gt;356,778&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the years ended March 31, 2026 and 2025, the Company recognized interest expense related to the Credit Agreement of $&lt;span id="xdx_907_eus-gaap--InterestExpense_c20250401__20260331__us-gaap--TypeOfArrangementAxis__custom--CreditAgreementMember_z2cwvR6S03Cf" title="Interest expense"&gt;2,248,835&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--InterestExpense_c20240401__20250331__us-gaap--TypeOfArrangementAxis__custom--CreditAgreementMember_zbNxbc2pxTO" title="Interest expense,"&gt;2,180,897&lt;/span&gt;,
respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026 and March 31, 2025, accrued interest payable related to the Credit Agreement was $&lt;span id="xdx_90B_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iI_c20260331__us-gaap--TypeOfArrangementAxis__custom--CreditAgreementMember_zlMzyIERjmY9" title="Accrued interest payable"&gt;677,310&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iI_c20250331__us-gaap--TypeOfArrangementAxis__custom--CreditAgreementMember_z18PDu19PbGd" title="Accrued interest payable"&gt;404,621&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;



&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;
&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</BTCY:BankLoanCreditAgreementTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2021-12-21"
      decimals="-5"
      id="Fact001231"
      unitRef="USD">12400000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2021-12-212021-12-21" id="Fact001233">2027-02-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:SubordinatedBorrowingInterestRate
      contextRef="From2021-12-212021-12-21"
      decimals="INF"
      id="Fact001235"
      unitRef="Pure">0.105</us-gaap:SubordinatedBorrowingInterestRate>
    <us-gaap:ProceedsFromRepaymentsOfDebt
      contextRef="From2025-04-01to2026-03-31"
      decimals="-5"
      id="Fact001237"
      unitRef="USD">2400000</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:ProceedsFromRepaymentsOfDebt
      contextRef="From2021-12-212021-12-21"
      decimals="0"
      id="Fact001239"
      unitRef="USD">600000</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:LoansPayableToBankCurrent
      contextRef="AsOf2026-03-31"
      decimals="-4"
      id="Fact001241"
      unitRef="USD">14680000</us-gaap:LoansPayableToBankCurrent>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="From2024-11-012024-11-30"
      decimals="-3"
      id="Fact001242"
      unitRef="USD">635000000</us-gaap:ProceedsFromShortTermDebt>
    <BTCY:DebtInstrumentInterestAmount
      contextRef="AsOf2024-11-30"
      decimals="-5"
      id="Fact001244"
      unitRef="USD">1500000</BTCY:DebtInstrumentInterestAmount>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact001245"
      unitRef="Shares">600000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact001246"
      unitRef="USDPShares">0.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-12-31_custom_ForbearanceAgreementMember"
      decimals="INF"
      id="Fact001248"
      unitRef="Shares">120000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-31_custom_ForbearanceAgreementMember"
      decimals="INF"
      id="Fact001250"
      unitRef="USDPShares">0.37</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-12-31_custom_WarrantAgreementMember"
      decimals="INF"
      id="Fact001252"
      unitRef="Shares">27150</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-31_custom_WarrantAgreementMember"
      decimals="INF"
      id="Fact001254"
      unitRef="USDPShares">2.21</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="AsOf2025-12-31"
      decimals="0"
      id="Fact001256"
      unitRef="USD">38078</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ProceedsFromRepaymentsOfDebt
      contextRef="From2025-04-012026-03-31_custom_CreditAgreementMember"
      decimals="0"
      id="Fact001258"
      unitRef="USD">600000</us-gaap:ProceedsFromRepaymentsOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2026-03-31_custom_CreditAgreementMember"
      decimals="0"
      id="Fact001260"
      unitRef="USD">15270932</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_custom_CreditAgreementMember"
      decimals="0"
      id="Fact001262"
      unitRef="USD">15870932</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001264"
      unitRef="USD">590018</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001266"
      unitRef="USD">1199372</us-gaap:DebtInstrumentUnamortizedDiscount>
    <BTCY:DebtInstrumentIncreaseDecreaseInNet
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001268"
      unitRef="USD">14680914</BTCY:DebtInstrumentIncreaseDecreaseInNet>
    <BTCY:DebtInstrumentIncreaseDecreaseInNet
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001270"
      unitRef="USD">14671560</BTCY:DebtInstrumentIncreaseDecreaseInNet>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001272"
      unitRef="USD">647433</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact001274"
      unitRef="USD">356778</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:InterestExpense
      contextRef="From2025-04-012026-03-31_custom_CreditAgreementMember"
      decimals="0"
      id="Fact001276"
      unitRef="USD">2248835</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2024-04-012025-03-31_custom_CreditAgreementMember"
      decimals="0"
      id="Fact001278"
      unitRef="USD">2180897</us-gaap:InterestExpense>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities
      contextRef="AsOf2026-03-31_custom_CreditAgreementMember"
      decimals="0"
      id="Fact001280"
      unitRef="USD">677310</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <us-gaap:OtherAccountsPayableAndAccruedLiabilities
      contextRef="AsOf2025-03-31_custom_CreditAgreementMember"
      decimals="0"
      id="Fact001282"
      unitRef="USD">404621</us-gaap:OtherAccountsPayableAndAccruedLiabilities>
    <BTCY:FederallyGuaranteedLoansTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001284">&lt;p id="xdx_805_ecustom--FederallyGuaranteedLoansTextBlock_zpJDK5EEzoe5" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;7.
&lt;span id="xdx_826_zqM0xQ7Mn7Yc"&gt;FEDERALLY GUARANTEED LOANS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Economic
Injury Disaster Loan (&#x201c;EIDL&#x201d;)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
April 2020, the Company received $&lt;span id="xdx_909_eus-gaap--ProceedsFromLoans_c20200401__20200430__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_zAbfzp2qOx9h" title="Proceeds from loan"&gt;370,900&lt;/span&gt; from the U.S. Small Business Administration (SBA) under the captioned program. &lt;span id="xdx_902_eus-gaap--DebtInstrumentDescription_c20200401__20200430__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_z2pGiXrsrLwb" title="Debt instrument description"&gt;The loan has
a term of &lt;span id="xdx_904_eus-gaap--DebtInstrumentTerm_dtY_c20200401__20200430__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_z3ga9sEY8aVd" title="Debt instrument term"&gt;30&lt;/span&gt; years and an interest rate of &lt;span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200430__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_zlPAZYfNAZK9" title="Debt interest rate"&gt;3.75&lt;/span&gt;% per annum, without the requirement for payment in its first 12 months&lt;/span&gt;. The Company may
prepay the loan without penalty at will.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
May 2021, the Company received an additional $&lt;span id="xdx_908_eus-gaap--ProceedsFromLoans_c20210501__20210531__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_zmNPedZmb4I7" title="Proceeds from loan"&gt;499,900&lt;/span&gt; from the SBA under the same terms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026, the Company recorded accrued interest of $&lt;span id="xdx_900_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_dxL_c20260331__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_zWZVAqfw1Ra7" title="Accrued interest::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1296"&gt;nil&lt;/span&gt;&lt;/span&gt; for the EIDL loan (March 31, 2025: $ &lt;span id="xdx_906_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_dxL_c20250331__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_zOUB1fSaeSK7" title="Accrued interest::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1298"&gt;Nil&lt;/span&gt;&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Interest
expense on the above loan was $&lt;span id="xdx_90A_eus-gaap--InterestExpense_c20250401__20260331__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_zkNMrbBMQT99" title="Interest expense"&gt;43,610&lt;/span&gt; and $&lt;span id="xdx_90B_eus-gaap--InterestExpense_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--EconomicInjuryDisasterLoanMember_zs6B9V24Wr0e" title="Interest expense"&gt;32,655&lt;/span&gt; for the years ended March 31, 2026 and 2025, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</BTCY:FederallyGuaranteedLoansTextBlock>
    <us-gaap:ProceedsFromLoans
      contextRef="From2020-04-012020-04-30_custom_EconomicInjuryDisasterLoanMember"
      decimals="0"
      id="Fact001286"
      unitRef="USD">370900</us-gaap:ProceedsFromLoans>
    <us-gaap:DebtInstrumentDescription
      contextRef="From2020-04-012020-04-30_custom_EconomicInjuryDisasterLoanMember"
      id="Fact001288">The loan has
a term of 30 years and an interest rate of 3.75% per annum, without the requirement for payment in its first 12 months</us-gaap:DebtInstrumentDescription>
    <us-gaap:DebtInstrumentTerm
      contextRef="From2020-04-012020-04-30_custom_EconomicInjuryDisasterLoanMember"
      id="Fact001290">P30Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="AsOf2020-04-30_custom_EconomicInjuryDisasterLoanMember"
      decimals="INF"
      id="Fact001292"
      unitRef="Pure">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromLoans
      contextRef="From2021-05-012021-05-31_custom_EconomicInjuryDisasterLoanMember"
      decimals="0"
      id="Fact001294"
      unitRef="USD">499900</us-gaap:ProceedsFromLoans>
    <us-gaap:InterestExpense
      contextRef="From2025-04-012026-03-31_custom_EconomicInjuryDisasterLoanMember"
      decimals="0"
      id="Fact001300"
      unitRef="USD">43610</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="From2024-04-012025-03-31_custom_EconomicInjuryDisasterLoanMember"
      decimals="0"
      id="Fact001302"
      unitRef="USD">32655</us-gaap:InterestExpense>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001304">&lt;p id="xdx_808_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zros1pIzd5ui" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;8.
&lt;span id="xdx_824_z4TRrepwdwZ3"&gt;DERIVATIVE LIABILITIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company analyzed the compound features of variable conversion and redemption embedded in the preferred shares instrument, for potential
derivative accounting treatment on the basis of ASC 820 (Fair Value in Financial Instruments), ASC 815 (Accounting for Derivative Instruments
and Hedging Activities), Emerging Issues Task Force (&#x201c;EITF&#x201d;) Issue No. 00&#x2013;19 and EITF 07&#x2013;05, and determined that
the embedded derivatives should be bundled and valued as a single, compound embedded derivative, bifurcated from the underlying equity
instrument, treated as a derivative liability, and measured at fair value. A roll-forward of activity is presented below for the year
ended March 31, 2026 and 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zlG9rOtJtgpk" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zFflDtcWQJp4" style="display: none"&gt;SCHEDULE OF DERIVATIVE LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20250401__20260331_zXMtnExZd6ng" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
                                            Year 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240401__20250331_z9y65jd4N6O2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
                                            Year 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DerivativeLiabilitiesNoncurrent_iS_zH5E03xkH4l6" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,478,717&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,435,668&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssue_zroXeRB0gBre" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;New
    issuance &lt;i&gt;[Note 9]&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1311"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;649,533&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_zJKzbi1vUvi8" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change
    in fair value of derivatives during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;125,814&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;553,208&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ReductionDueToPreferredSharesConverted_zeVzGA4B44Ua" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Reduction
    due to preferred shares redeemed &lt;i&gt;[Note 9]&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(207,623&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,159,692&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DerivativeLiabilitiesNoncurrent_iE_zaoNMpqF3PC5" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,396,908&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,478,717&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zIRGq29vbSj" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zdqg8HXxmIPb" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
lattice methodology was used to value the derivative components, using the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zhQjhsanKZkf" style="display: none"&gt;SCHEDULE OF DERIVATIVE COMPONENTS VALUATION ASSUMPTIONS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Fiscal
    Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Fiscal
    Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dividend
    yield (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; font-weight: normal; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z0ztCZNihyx1" style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;12&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_ztHyYhAM801c" title="Derivative liability, measurement input"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk-free
    rate for term (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zUpF16I2Pvqj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3.5&lt;/b&gt;&lt;/span&gt;&lt;b&gt;
                                            &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013; &lt;span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z36KBCDJRFai"&gt;4.1&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z9LmWgC3eQx6" title="Derivative liability, measurement input"&gt;3.7&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zBM6PT4DeZhi" title="Derivative liability, measurement input"&gt;5.1&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Volatility (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zc4qhEyI92Oi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;104.7&lt;/b&gt;&lt;/span&gt;&lt;b&gt;
                                            &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013; &lt;span id="xdx_906_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z2KqlneolqRg"&gt;156.4&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zkO6XXAMLdE7" title="Derivative liability, measurement input"&gt;91.2&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zb43rkLx25p3" title="Derivative liability, measurement input"&gt;194.2&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining
    terms (Years)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20250401__20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zdkq5GSCSgG" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;0.25&lt;/b&gt;&lt;/span&gt;&lt;b&gt;
                                            &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013; &lt;span id="xdx_90A_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20250401__20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zetEDpT4VYXi"&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20240401__20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zH6zVlx8iLGe" title="Derivative liability remaining term"&gt;0.17&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90E_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20240401__20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z1QeMFVDDIil" title="Derivative liability remaining term"&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock price ($ per
    share)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right"&gt;&lt;span id="xdx_901_ecustom--DerivativeStockPrice_iI_pid_c20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_ztqro8ylzPk1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;0.24&lt;/b&gt;&lt;/span&gt;&lt;b&gt;
                                            &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013; &lt;span id="xdx_904_ecustom--DerivativeStockPrice_iI_pid_c20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zp6j4uvxYIA4"&gt;0.53&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--DerivativeStockPrice_iI_pid_c20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z2AzTDNh9mU8" title="Stock price"&gt;0.24&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_905_ecustom--DerivativeStockPrice_iI_pid_c20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zR7uaioSjSi5" title="Stock price"&gt;1.34&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A1_zmVmJLe6BsSg" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, the Company recorded derivative liabilities related to the conversion and redemption features of the convertible notes, as
well as warrants that were issued in connection with the convertible notes (Note 5). Any noteholder and placement agent warrants that
were issued after the finalization of exercise price was accounted for as equity.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfDerivativeInstrumentsTextBlock_hus-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zPa5NcDIDKob" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B5_zcocuIyRqo4c" style="display: none"&gt;SCHEDULE OF CONVERTIBLE NOTE AND WARRANT DERIVATIVE LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20250401__20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z3UNHbfszySj" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
                                            Year 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240401__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_ziW3uNyDkZCd" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
                                            Year 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DerivativeLiabilitiesCurrent_iS_zThRbj5b6Zh8" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Balance
    beginning of year&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;424,200&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;991,866&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_zbXxjTgF9Akh" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;New
    Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1357"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1358"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ConversionOfStockAmountConverted1_iN_di_zvF84Hxg62O5" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion
    to common shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1360"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(509,303&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationConvertibleNoteRedemption_zqM08TyocuXd" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible
    note redemption&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(19,842&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(59,011&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_zgDr6AbTauQk" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change
    in fair value of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,535&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;648&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationEndOfDerivativeTreatmentOfWarrants_z1dCfFDLTSAe" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;End
    of derivative treatment of warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1369"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1370"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationConvertibleNoteModification_z6uhaYjKNxzd" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible
    note modification&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1372"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1373"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DerivativeLiabilitiesCurrent_iE_zQrPqbdZpCQj" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Balance
    end of year&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;445,893&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;424,200&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zmpJL3Dto5d2" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_hus-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zwF7Zjf4L7tl" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Monte-Carlo methodology was used to value the convertible note and warrant derivative components, using the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zneZeIuS6fUf" style="display: none"&gt;SCHEDULE OF CONVERTIBLE NOTE AND WARRANT DERIVATIVE COMPONENTS VALUATION ASSUMPTIONS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
                                            Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
                                            Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk-free
    rate for term (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zlVYHY1313Y3" title="Derivative liability, measurement input"&gt;0.2&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_907_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zNnsDn3GJGr2" title="Derivative liability, measurement input"&gt;4.1&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_z0YVIf8LRRB2" title="Derivative liability, measurement input"&gt;0.1&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zcCDogfiCBHh" title="Derivative liability, measurement input"&gt;5.2&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Volatility (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_ziVCPNEHXGie" title="Derivative liability, measurement input"&gt;104.7&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zKhmOLKV7DQa" title="Derivative liability, measurement input"&gt;172.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z8jHbo7mfM1d" title="Derivative liability, measurement input"&gt;91.2&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zVP9B8yenIH" title="Derivative liability, measurement input"&gt;194.4&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining
    terms (Years)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20250401__20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zQdgSoiQ1TZk" title="Remaining terms"&gt;0.25&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_908_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20250401__20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z2ebrAjDMiSb" title="Remaining terms"&gt;0.47&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20240401__20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zdIUgMi6jtrk" title="Remaining terms"&gt;0.25&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90A_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20240401__20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zitJk3rNhSqg" title="Remaining terms"&gt;0.5&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock price ($ per
    share)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--DerivativeStockPrice_iI_pid_c20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember_zqpVvOvJuaX5" title="Stock price"&gt;0.24&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90A_ecustom--DerivativeStockPrice_iI_pid_c20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember_zuG1qVKNXGS8" title="Stock price"&gt;0.71&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--DerivativeStockPrice_iI_pid_c20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember_z2hdswz5eKLg" title="Stock price"&gt;0.24&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90F_ecustom--DerivativeStockPrice_iI_pid_c20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember_ziuZuqf4lva4" title="Stock price"&gt;1.45&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_z7DGTgNztEr7" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001306">&lt;p id="xdx_895_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zlG9rOtJtgpk" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zFflDtcWQJp4" style="display: none"&gt;SCHEDULE OF DERIVATIVE LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20250401__20260331_zXMtnExZd6ng" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
                                            Year 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20240401__20250331_z9y65jd4N6O2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
                                            Year 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--DerivativeLiabilitiesNoncurrent_iS_zH5E03xkH4l6" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,478,717&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,435,668&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssue_zroXeRB0gBre" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;New
    issuance &lt;i&gt;[Note 9]&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1311"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;649,533&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_zJKzbi1vUvi8" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change
    in fair value of derivatives during the year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;125,814&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;553,208&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--ReductionDueToPreferredSharesConverted_zeVzGA4B44Ua" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Reduction
    due to preferred shares redeemed &lt;i&gt;[Note 9]&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(207,623&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,159,692&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DerivativeLiabilitiesNoncurrent_iE_zaoNMpqF3PC5" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Derivative
    liabilities, end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,396,908&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,478,717&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001308"
      unitRef="USD">1478717</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="Fact001309"
      unitRef="USD">1435668</us-gaap:DerivativeLiabilitiesNoncurrent>
    <BTCY:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssue
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact001312"
      unitRef="USD">649533</BTCY:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001314"
      unitRef="USD">125814</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact001315"
      unitRef="USD">553208</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <BTCY:ReductionDueToPreferredSharesConverted
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001317"
      unitRef="USD">-207623</BTCY:ReductionDueToPreferredSharesConverted>
    <BTCY:ReductionDueToPreferredSharesConverted
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact001318"
      unitRef="USD">-1159692</BTCY:ReductionDueToPreferredSharesConverted>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001320"
      unitRef="USD">1396908</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001321"
      unitRef="USD">1478717</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="From2025-04-012026-03-31_us-gaap_SeriesAPreferredStockMember"
      id="Fact001323">&lt;p id="xdx_899_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zdqg8HXxmIPb" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
lattice methodology was used to value the derivative components, using the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BC_zhQjhsanKZkf" style="display: none"&gt;SCHEDULE OF DERIVATIVE COMPONENTS VALUATION ASSUMPTIONS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Fiscal
    Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Fiscal
    Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Dividend
    yield (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; font-weight: normal; text-align: right"&gt;&lt;span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z0ztCZNihyx1" style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;12&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_ztHyYhAM801c" title="Derivative liability, measurement input"&gt;12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk-free
    rate for term (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right"&gt;&lt;span id="xdx_90B_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zUpF16I2Pvqj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;3.5&lt;/b&gt;&lt;/span&gt;&lt;b&gt;
                                            &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013; &lt;span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z36KBCDJRFai"&gt;4.1&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z9LmWgC3eQx6" title="Derivative liability, measurement input"&gt;3.7&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90E_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zBM6PT4DeZhi" title="Derivative liability, measurement input"&gt;5.1&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Volatility (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right"&gt;&lt;span id="xdx_904_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zc4qhEyI92Oi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;104.7&lt;/b&gt;&lt;/span&gt;&lt;b&gt;
                                            &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013; &lt;span id="xdx_906_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z2KqlneolqRg"&gt;156.4&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zkO6XXAMLdE7" title="Derivative liability, measurement input"&gt;91.2&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_901_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zb43rkLx25p3" title="Derivative liability, measurement input"&gt;194.2&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining
    terms (Years)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right"&gt;&lt;span id="xdx_90D_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20250401__20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zdkq5GSCSgG" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;0.25&lt;/b&gt;&lt;/span&gt;&lt;b&gt;
                                            &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013; &lt;span id="xdx_90A_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20250401__20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zetEDpT4VYXi"&gt;0.5&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20240401__20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zH6zVlx8iLGe" title="Derivative liability remaining term"&gt;0.17&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90E_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20240401__20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z1QeMFVDDIil" title="Derivative liability remaining term"&gt;2.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock price ($ per
    share)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right"&gt;&lt;span id="xdx_901_ecustom--DerivativeStockPrice_iI_pid_c20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_ztqro8ylzPk1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;0.24&lt;/b&gt;&lt;/span&gt;&lt;b&gt;
                                            &lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x2013; &lt;span id="xdx_904_ecustom--DerivativeStockPrice_iI_pid_c20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zp6j4uvxYIA4"&gt;0.53&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--DerivativeStockPrice_iI_pid_c20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z2AzTDNh9mU8" title="Stock price"&gt;0.24&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_905_ecustom--DerivativeStockPrice_iI_pid_c20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zR7uaioSjSi5" title="Stock price"&gt;1.34&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2026-03-31_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001324"
      unitRef="Pure">12</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2025-03-31_us-gaap_MeasurementInputExpectedDividendRateMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001326"
      unitRef="Pure">12</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2026-03-31_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001327"
      unitRef="Pure">3.5</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2026-03-31_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001328"
      unitRef="Pure">4.1</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2025-03-31_srt_MinimumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001330"
      unitRef="Pure">3.7</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2025-03-31_srt_MaximumMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001332"
      unitRef="Pure">5.1</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2026-03-31_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001333"
      unitRef="Pure">104.7</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2026-03-31_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001334"
      unitRef="Pure">156.4</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2025-03-31_srt_MinimumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001336"
      unitRef="Pure">91.2</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2025-03-31_srt_MaximumMember_us-gaap_MeasurementInputPriceVolatilityMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001338"
      unitRef="Pure">194.2</us-gaap:DerivativeLiabilityMeasurementInput>
    <BTCY:DerivativeLiabilityRemainingTerm
      contextRef="From2025-04-012026-03-31_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_SeriesAPreferredStockMember"
      id="Fact001339">P0Y3M</BTCY:DerivativeLiabilityRemainingTerm>
    <BTCY:DerivativeLiabilityRemainingTerm
      contextRef="From2025-04-012026-03-31_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_SeriesAPreferredStockMember"
      id="Fact001340">P0Y6M</BTCY:DerivativeLiabilityRemainingTerm>
    <BTCY:DerivativeLiabilityRemainingTerm
      contextRef="From2024-04-012025-03-31_srt_MinimumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_SeriesAPreferredStockMember"
      id="Fact001342">P0Y2M1D</BTCY:DerivativeLiabilityRemainingTerm>
    <BTCY:DerivativeLiabilityRemainingTerm
      contextRef="From2024-04-012025-03-31_srt_MaximumMember_us-gaap_MeasurementInputExpectedTermMember_us-gaap_SeriesAPreferredStockMember"
      id="Fact001344">P2Y</BTCY:DerivativeLiabilityRemainingTerm>
    <BTCY:DerivativeStockPrice
      contextRef="AsOf2026-03-31_srt_MinimumMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001345"
      unitRef="USDPShares">0.24</BTCY:DerivativeStockPrice>
    <BTCY:DerivativeStockPrice
      contextRef="AsOf2026-03-31_srt_MaximumMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001346"
      unitRef="USDPShares">0.53</BTCY:DerivativeStockPrice>
    <BTCY:DerivativeStockPrice
      contextRef="AsOf2025-03-31_srt_MinimumMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001348"
      unitRef="USDPShares">0.24</BTCY:DerivativeStockPrice>
    <BTCY:DerivativeStockPrice
      contextRef="AsOf2025-03-31_srt_MaximumMember_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001350"
      unitRef="USDPShares">1.34</BTCY:DerivativeStockPrice>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock
      contextRef="From2025-04-012026-03-31_us-gaap_ConvertibleDebtMember"
      id="Fact001352">&lt;p id="xdx_89C_eus-gaap--ScheduleOfDerivativeInstrumentsTextBlock_hus-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zPa5NcDIDKob" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B5_zcocuIyRqo4c" style="display: none"&gt;SCHEDULE OF CONVERTIBLE NOTE AND WARRANT DERIVATIVE LIABILITIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20250401__20260331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z3UNHbfszySj" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
                                            Year 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240401__20250331__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_ziW3uNyDkZCd" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
                                            Year 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--DerivativeLiabilitiesCurrent_iS_zThRbj5b6Zh8" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; font-weight: normal; font-style: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Balance
    beginning of year&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;424,200&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;991,866&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_zbXxjTgF9Akh" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;New
    Issuance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1357"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1358"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--ConversionOfStockAmountConverted1_iN_di_zvF84Hxg62O5" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion
    to common shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1360"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(509,303&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationConvertibleNoteRedemption_zqM08TyocuXd" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible
    note redemption&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(19,842&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(59,011&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease_zgDr6AbTauQk" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Change
    in fair value of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;41,535&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;648&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationEndOfDerivativeTreatmentOfWarrants_z1dCfFDLTSAe" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;End
    of derivative treatment of warrants&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1369"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1370"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationConvertibleNoteModification_z6uhaYjKNxzd" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Convertible
    note modification&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1372"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1373"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--DerivativeLiabilitiesCurrent_iE_zQrPqbdZpCQj" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Balance
    end of year&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;445,893&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;424,200&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2025-03-31_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001354"
      unitRef="USD">424200</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2024-03-31_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001355"
      unitRef="USD">991866</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2024-04-012025-03-31_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001361"
      unitRef="USD">509303</us-gaap:ConversionOfStockAmountConverted1>
    <BTCY:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationConvertibleNoteRedemption
      contextRef="From2025-04-012026-03-31_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001363"
      unitRef="USD">-19842</BTCY:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationConvertibleNoteRedemption>
    <BTCY:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationConvertibleNoteRedemption
      contextRef="From2024-04-012025-03-31_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001364"
      unitRef="USD">-59011</BTCY:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationConvertibleNoteRedemption>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
      contextRef="From2025-04-012026-03-31_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001366"
      unitRef="USD">41535</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease
      contextRef="From2024-04-012025-03-31_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001367"
      unitRef="USD">648</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2026-03-31_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001375"
      unitRef="USD">445893</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="AsOf2025-03-31_us-gaap_ConvertibleDebtMember"
      decimals="0"
      id="Fact001376"
      unitRef="USD">424200</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:ScheduleOfAssumptionsUsedTableTextBlock
      contextRef="From2025-04-012026-03-31_us-gaap_ConvertibleDebtMember"
      id="Fact001378">&lt;p id="xdx_896_eus-gaap--ScheduleOfAssumptionsUsedTableTextBlock_hus-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zwF7Zjf4L7tl" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Monte-Carlo methodology was used to value the convertible note and warrant derivative components, using the following assumptions:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BE_zneZeIuS6fUf" style="display: none"&gt;SCHEDULE OF CONVERTIBLE NOTE AND WARRANT DERIVATIVE COMPONENTS VALUATION ASSUMPTIONS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
                                            Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
                                            Year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk-free
    rate for term (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zlVYHY1313Y3" title="Derivative liability, measurement input"&gt;0.2&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_907_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zNnsDn3GJGr2" title="Derivative liability, measurement input"&gt;4.1&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_z0YVIf8LRRB2" title="Derivative liability, measurement input"&gt;0.1&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zcCDogfiCBHh" title="Derivative liability, measurement input"&gt;5.2&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Volatility (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_ziVCPNEHXGie" title="Derivative liability, measurement input"&gt;104.7&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90F_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zKhmOLKV7DQa" title="Derivative liability, measurement input"&gt;172.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_902_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_z8jHbo7mfM1d" title="Derivative liability, measurement input"&gt;91.2&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90C_eus-gaap--DerivativeLiabilityMeasurementInput_iI_pid_uPure_c20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zVP9B8yenIH" title="Derivative liability, measurement input"&gt;194.4&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Remaining
    terms (Years)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20250401__20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zQdgSoiQ1TZk" title="Remaining terms"&gt;0.25&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_908_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20250401__20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_z2ebrAjDMiSb" title="Remaining terms"&gt;0.47&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20240401__20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zdIUgMi6jtrk" title="Remaining terms"&gt;0.25&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90A_ecustom--DerivativeLiabilityRemainingTerm_dtY_c20240401__20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zitJk3rNhSqg" title="Remaining terms"&gt;0.5&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Stock price ($ per
    share)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_ecustom--DerivativeStockPrice_iI_pid_c20260331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember_zqpVvOvJuaX5" title="Stock price"&gt;0.24&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90A_ecustom--DerivativeStockPrice_iI_pid_c20260331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember_zuG1qVKNXGS8" title="Stock price"&gt;0.71&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90F_ecustom--DerivativeStockPrice_iI_pid_c20250331__srt--RangeAxis__srt--MinimumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember_z2hdswz5eKLg" title="Stock price"&gt;0.24&lt;/span&gt;
                                            &#x2013; &lt;span id="xdx_90F_ecustom--DerivativeStockPrice_iI_pid_c20250331__srt--RangeAxis__srt--MaximumMember__us-gaap--DebtInstrumentAxis__custom--ConvertibleNoteAndWarrantDerivativeMember_ziuZuqf4lva4" title="Stock price"&gt;1.45&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfAssumptionsUsedTableTextBlock>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2026-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact001380"
      unitRef="Pure">0.2</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2026-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact001382"
      unitRef="Pure">4.1</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2025-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact001384"
      unitRef="Pure">0.1</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2025-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact001386"
      unitRef="Pure">5.2</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2026-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact001388"
      unitRef="Pure">104.7</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2026-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact001390"
      unitRef="Pure">172.5</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2025-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact001392"
      unitRef="Pure">91.2</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="AsOf2025-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputPriceVolatilityMember"
      decimals="INF"
      id="Fact001394"
      unitRef="Pure">194.4</us-gaap:DerivativeLiabilityMeasurementInput>
    <BTCY:DerivativeLiabilityRemainingTerm
      contextRef="From2025-04-012026-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputExpectedTermMember"
      id="Fact001396">P0Y3M</BTCY:DerivativeLiabilityRemainingTerm>
    <BTCY:DerivativeLiabilityRemainingTerm
      contextRef="From2025-04-012026-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputExpectedTermMember"
      id="Fact001398">P0Y5M19D</BTCY:DerivativeLiabilityRemainingTerm>
    <BTCY:DerivativeLiabilityRemainingTerm
      contextRef="From2024-04-012025-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputExpectedTermMember"
      id="Fact001400">P0Y3M</BTCY:DerivativeLiabilityRemainingTerm>
    <BTCY:DerivativeLiabilityRemainingTerm
      contextRef="From2024-04-012025-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember_us-gaap_MeasurementInputExpectedTermMember"
      id="Fact001402">P0Y6M</BTCY:DerivativeLiabilityRemainingTerm>
    <BTCY:DerivativeStockPrice
      contextRef="AsOf2026-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember"
      decimals="INF"
      id="Fact001404"
      unitRef="USDPShares">0.24</BTCY:DerivativeStockPrice>
    <BTCY:DerivativeStockPrice
      contextRef="AsOf2026-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember"
      decimals="INF"
      id="Fact001406"
      unitRef="USDPShares">0.71</BTCY:DerivativeStockPrice>
    <BTCY:DerivativeStockPrice
      contextRef="AsOf2025-03-31_srt_MinimumMember_custom_ConvertibleNoteAndWarrantDerivativeMember"
      decimals="INF"
      id="Fact001408"
      unitRef="USDPShares">0.24</BTCY:DerivativeStockPrice>
    <BTCY:DerivativeStockPrice
      contextRef="AsOf2025-03-31_srt_MaximumMember_custom_ConvertibleNoteAndWarrantDerivativeMember"
      decimals="INF"
      id="Fact001410"
      unitRef="USDPShares">1.45</BTCY:DerivativeStockPrice>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001412">&lt;p id="xdx_80C_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zi4DcjULN1J8" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;9.
&lt;span id="xdx_82A_zzFqpI8vMrU8"&gt;STOCKHOLDERS&#x2019; DEFICIENCY AND MEZZANINE EQUITY&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(a)
&lt;b&gt;&lt;i&gt;Authorized and Issued Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
at March 31, 2026, the Company is authorized to issue &lt;span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20260331_ztgLVToyhQ88" title="Common stock, shares authorized"&gt;125,000,000&lt;/span&gt; (March 31, 2025 &#x2013; &lt;span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250331_zujB1EurVip7" title="Common stock, shares authorized"&gt;125,000,000&lt;/span&gt;) shares of common stock ($&lt;span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20260331_zLNYVH5NiDQa" title="Common stock, par value"&gt;0.001&lt;/span&gt;
par value), and &lt;span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zQlD43pqktQd"&gt;10,000,000&lt;/span&gt; (March 31, 2025 &#x2013; &lt;span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_c20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zE6zDFLOoVw5"&gt;10,000,000&lt;/span&gt;) shares of preferred stock ($&lt;span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zN7fjHY5KHgl"&gt;0.001&lt;/span&gt; par value), &lt;span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zZCSK2MJCUw4" title="Preferred stock, shares authorized"&gt;20,000&lt;/span&gt; of which (March 31,
2025 &#x2013; &lt;span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_c20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zA4NGHVgHtd7" title="Preferred stock, shares authorized"&gt;20,000&lt;/span&gt;) are designated shares of Series A preferred stock ($&lt;span id="xdx_90B_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zV9rqKS94dL3"&gt;0.001&lt;/span&gt; par value) and &lt;span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zG9yqTa6wsE2"&gt;600&lt;/span&gt; (March 31, 2025 &#x2013; &lt;span id="xdx_904_eus-gaap--PreferredStockSharesAuthorized_iI_c20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zzk6uXwmOOme"&gt;600&lt;/span&gt;) are designated
shares of Series B preferred stock ($&lt;span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zUrQgFScPyIj" title="Preferred stock, par value"&gt;0.001&lt;/span&gt; par value).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
March 31, 2026, common shares and shares directly exchangeable into equivalent common shares that were issued and outstanding totaled
&lt;span id="xdx_90F_eus-gaap--SharesIssued_iI_c20260331__srt--TitleOfIndividualAxis__custom--ShareholdersMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zHTSIZDDM4aj" title="Shares issued"&gt;&lt;span id="xdx_90C_eus-gaap--SharesOutstanding_iI_c20260331__srt--TitleOfIndividualAxis__custom--ShareholdersMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_z4sCn2NSec41" title="Shares outstanding"&gt;28,757,987&lt;/span&gt;&lt;/span&gt; (2025 &#x2013; &lt;span id="xdx_908_eus-gaap--SharesIssued_iI_c20250331__srt--TitleOfIndividualAxis__custom--ShareholdersMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_zx22hzzw31I5" title="Shares issued"&gt;&lt;span id="xdx_904_eus-gaap--SharesOutstanding_iI_c20250331__srt--TitleOfIndividualAxis__custom--ShareholdersMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementMember_znChVCxmPok9" title="Shares outstanding"&gt;26,241,967&lt;/span&gt;&lt;/span&gt;) shares; these were comprised of &lt;span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_pid_c20260331__srt--TitleOfIndividualAxis__custom--ShareholdersMember_zviblyLEu73b" title="Common stock, shares issued"&gt;&lt;span id="xdx_90C_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20260331__srt--TitleOfIndividualAxis__custom--ShareholdersMember_znWzIL3Tb4F5" title="Common stock, shares outstanding"&gt;28,597,315&lt;/span&gt;&lt;/span&gt; (2025 &#x2013; &lt;span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pid_c20250331__srt--TitleOfIndividualAxis__custom--ShareholdersMember_zBqTqgD6ujbd" title="Common stock, shares issued"&gt;&lt;span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20250331__srt--TitleOfIndividualAxis__custom--ShareholdersMember_zJaqm9FovAk4" title="Common stock, shares outstanding"&gt;26,081,295&lt;/span&gt;&lt;/span&gt;) shares of common stock and
&lt;span id="xdx_906_eus-gaap--CommonStockOtherSharesOutstanding_iI_c20260331_z0RmbDrI6zH4" title="Common stock, other shares, outstanding"&gt;160,672&lt;/span&gt; (2025 &#x2013; &lt;span id="xdx_90D_eus-gaap--CommonStockOtherSharesOutstanding_iI_c20250331_zkq9FERy67X3" title="Common stock, other shares, outstanding"&gt;160,672&lt;/span&gt;) exchangeable shares. At March 31, 2026, there were &lt;span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zUO244srVxT2" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zTKbJfPm1pL4" title="Preferred stock, shares outstanding"&gt;201&lt;/span&gt;&lt;/span&gt; Series A shares of Preferred Stock that were issued
and outstanding (2025 &#x2013; &lt;span id="xdx_90D_eus-gaap--PreferredStockSharesIssued_iI_c20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zT19rHw8K6s7" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_c20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zCXU7aAK9B6h" title="Preferred stock, shares outstanding"&gt;201&lt;/span&gt;&lt;/span&gt;), and there were &lt;span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zhyc9JDTW0D7" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zzwWTRUsjdlj" title="Preferred stock, shares outstanding"&gt;335&lt;/span&gt;&lt;/span&gt; shares of Series B Preferred Stock that were issued and outstanding (March 31,
2024 &#x2013; &lt;span id="xdx_90A_eus-gaap--PreferredStockSharesIssued_iI_c20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z17tgNtQo2zf" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90F_eus-gaap--PreferredStockSharesOutstanding_iI_c20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_ztq0DKtjFp72" title="Preferred stock, shares outstanding"&gt;385&lt;/span&gt;&lt;/span&gt;). There is also one share of the Special Voting Preferred Stock issued and outstanding held by one holder of record,
which is the Trustee in accordance with the terms of the Trust Agreement and outstanding as at March 31, 2026 and 2025.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(&lt;b&gt;&lt;i&gt;b)
Series A Preferred Stock&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
number of Series A Preferred Stock issued and outstanding as of March 31, 2026 and 2025 was &lt;span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z7dRfLWWsCB" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_901_eus-gaap--PreferredStockSharesOutstanding_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zzEsXMnFHOQf" title="Preferred stock, shares outstanding"&gt;201&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_90B_eus-gaap--PreferredStockSharesIssued_iI_c20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zK06mrNW0SHb" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_c20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zDqGceSVSGCh" title="Preferred stock, shares outstanding"&gt;201&lt;/span&gt;&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series A Preferred Stock is junior to the Company&#x2019;s existing undesignated preferred stock, and unless otherwise set forth in the
applicable certificate of designations, shall be junior to any future issuance of preferred stock. The purchase price (the &#x201c;Purchase
Price&#x201d;) for the Series A Preferred Stock to date has been $&lt;span id="xdx_901_eus-gaap--PreferredStockLiquidationPreference_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zbYMYPg1cJre" title="Preferred stock, liquidation preference"&gt;10,000&lt;/span&gt; per share. Except as otherwise expressly required by law, the
Series A Preferred Stock does not have voting rights and does not have any liquidation rights.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Preferred
Stock Dividends&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Dividends
shall be paid at the rate of &lt;span id="xdx_902_eus-gaap--PreferredStockDividendRatePercentage_pid_dp_uPure_c20250401__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zUmjm7Rv1Ea1" title="Preferred stock dividend rate percentage"&gt;12&lt;/span&gt;% per annum of the amount of the Series A Preferred Stockholder&#x2019;s (the &#x201c;Holder&#x201d;) Purchase
Price. Dividends shall be paid quarterly unless the Holder and the Company mutually agree to accrue and defer any such dividend.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Conversion&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series A Preferred Stock is convertible into shares of common stock commencing 24 months after the issuance date of the Series A Preferred
Stock. Upon which, on a monthly basis, up to &lt;span id="xdx_902_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20250401__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zclrVznhGmic" title="Debt instrument redemption price percentage"&gt;5&lt;/span&gt;% of the aggregate amount of the Purchase Price can be converted (subject to adjustment
for changes in the Holder&#x2019;s ownership of the underlying Series A Preferred Stock). The conversion price is equal to the greater
of $&lt;span id="xdx_907_eus-gaap--PreferredStockConvertibleConversionPrice_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_ztTRmivte77b" title="Preferred stock convertible conversion price"&gt;.001&lt;/span&gt; or a &lt;span id="xdx_90D_ecustom--VolumeWeightedAveragePricePercentage_pid_dp_uPure_c20250401__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z6QqfUTM1Aw7" title="Volume weighted average price percentage"&gt;15&lt;/span&gt;% discount to the volume-weighted average price (&#x201c;VWAP&#x201d;) of the Company&#x2019;s common stock five Trading
Days immediately prior to the conversion date (the &#x201c;Conversion Rate). Additionally, subject to certain provisions, the Holder may
exchange its Series A Preferred Stock into any common stock financing being conducted by the Company at a &lt;span id="xdx_906_ecustom--VolumeWeightedAveragePricePercentage_pid_dp_uPure_c20250401__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zxUSuX4k7lXk" title="Volume weighted average price percentage"&gt;15&lt;/span&gt;% discount to the pricing
of that financing.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Other
Adjustments and Rights&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
    Conversion Rate (and shares issuable upon conversion of the Series A Preferred Stock) will be appropriately adjusted to reflect stock
    splits, stock dividends business combinations and similar recapitalization.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;The
    Holders shall be entitled to a proportionate share of certain qualifying distributions on the same basis as if they were holders
    of the Company&#x2019;s common stock on an as converted basis.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Company
Redemption&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company may redeem all or part of the outstanding Series A Preferred Stock after one year from the date of issuance by paying an amount
equal to the aggregate Purchase Price paid, adjusted for any reduction in Series A Preferred Stock holdings, multiplied by &lt;span id="xdx_90B_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20250401__20260331_zGC5tW2z0Cw2" title="Debt instrument redemption price percentage"&gt;110&lt;/span&gt;% plus
accrued dividends&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;(c)
Series B Preferred Stock and Mezzanine Equity&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
September 19, 2023, the Company entered into a Securities Purchase Agreement with an institutional investor for the issuance of Series
B Convertible Preferred Stock (the &#x201c;Series B Preferred Stock&#x201d;). Each share of Series B Preferred Stock has a stated value
of $&lt;span id="xdx_90E_eus-gaap--PreferredStockValue_iI_c20230919__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertiblePreferredStockMember_z541T2jXsAlj" title="Preferred stock, value"&gt;10,000&lt;/span&gt;. During the years ended March 31, 2025 and 2024, the Company issued an aggregate of &lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250401__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zGloXOoWjwwe" title="Shares, new issues"&gt;550&lt;/span&gt; shares of Series B Preferred Stock
and received net proceeds of approximately $&lt;span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn5n6_c20250401__20260331_zTdwIq6AO732" title="Stock issued"&gt;4.6&lt;/span&gt; million. No Series B Preferred Stock was issued during the year ended March 31, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Series B Preferred Stock ranks senior to the Company&#x2019;s common stock with respect to dividends, distributions and liquidation preferences.
Holders are entitled to cumulative dividends at a rate of &lt;span id="xdx_900_ecustom--DividendsValuePercentage_iI_pid_dp_c20230919__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z3TnHWiGTfh9" title="Dividends value percentage"&gt;8&lt;/span&gt;% per annum, payable in cash or common stock in accordance with the terms
of the Certificate of Designations. The Series B Preferred Stock is convertible into shares of the Company&#x2019;s common stock pursuant
to the terms of the Certificate of Designations and is also subject to redemption provisions. &lt;span title="Debt conversion description"&gt;The Company may redeem outstanding shares
of Series B Preferred Stock at a price equal to &lt;span id="xdx_902_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20230918__20230919__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zt6dPPzpO4m6" title="Debt instrument redemption price percentage"&gt;110&lt;/span&gt;% of the stated value plus accrued but unpaid dividends and other amounts due.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 1, 2024, the Company filed an Amended Certificate of Designations pursuant to which the Series B Preferred Stock became non-voting,
except as otherwise required by law. All other material rights and preferences of the Series B Preferred Stock remained substantially
unchanged.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has determined that the Series B Preferred Stock should be classified as mezzanine equity in accordance with ASC 480, &lt;i&gt;Distinguishing
Liabilities from Equity&lt;/i&gt;. Certain embedded conversion and redemption features are accounted for separately as derivative liabilities
and are remeasured to fair value at each reporting date, with changes in fair value recognized in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2026, the Company reduced the carrying value of mezzanine equity by $&lt;span id="xdx_90C_eus-gaap--TemporaryEquityIssuePeriodIncreaseOrDecrease_c20250401__20260331_zJwHy23vHcKc" title="Temporary equity issue period increase or decrease"&gt;171,488&lt;/span&gt; in connection with the conversion
of &lt;span id="xdx_903_eus-gaap--ConversionOfStockSharesConverted1_c20250401__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zGTDfCMyVP3a"&gt;30&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series B Preferred shares into common stock and by $&lt;span id="xdx_906_ecustom--ConversionIntoCommonShares_c20250401__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_znlULznhg5Q" title="Conversion into common shares"&gt;114,326&lt;/span&gt; in connection with the
redemption of &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250401__20260331__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertibleRedeemablePreferredStockMember_z5K93Kx3mbFf"&gt;20&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Series B Preferred shares. As a result of the conversion and
redemption activity, the Company also reduced its accrued dividend liability by $&lt;span id="xdx_90C_eus-gaap--AccruedLiabilitiesAndOtherLiabilities_iI_c20260331_zyv41fkgcdW3"&gt;121,945&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;and reduced the related derivative liabilities by $&lt;span id="xdx_908_eus-gaap--IncreaseDecreaseInDerivativeLiabilities_c20260331__20260331_zg7lDlBJytEa"&gt;207,623&lt;/span&gt;&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accrued dividends related to the Series B Preferred
Stock, which are included within Accounts Payable and Accrued Liabilities in the accompanying consolidated balance sheets, were $&lt;span id="xdx_90A_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z3DCYjN8cn3" title="Accounts payable and accrued liabilities"&gt;876,256&lt;/span&gt;
and $&lt;span id="xdx_903_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_c20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zSeD1N8I5rk6" title="Accounts payable and accrued liabilities"&gt;297,915&lt;/span&gt; as of March 31, 2026 and 2025, respectively.&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026 and March 31, 2025, &lt;span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zX1H6uwsSYpg" title="Preferred stock, shares outstanding"&gt;335&lt;/span&gt; and &lt;span id="xdx_900_eus-gaap--PreferredStockSharesOutstanding_iI_c20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zhdONxeLO0Eh" title="Preferred stock, shares outstanding"&gt;385&lt;/span&gt; shares of Series B Preferred Stock were outstanding, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
carrying value of the Series B Preferred Stock classified as mezzanine equity was $&lt;span id="xdx_90C_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20260331_zElTwf4A1hnb" title="Temporary equity carrying amount attributable to parent"&gt;1,714,476&lt;/span&gt; and $&lt;span id="xdx_902_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iI_c20250331_zTj4moVGR8Rg" title="Temporary equity carrying amount attributable to parent"&gt;2,000,290&lt;/span&gt; as of March 31, 2026 and
March 31, 2025, respectively.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--ScheduleOfSeriesBPreferredStockForMezzanineEquityTableTextBlock_zfLC9CFRLzU7" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
roll-forward of activity is presented below for the year ended March 31, 2026:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zMGYUG6l12mi" style="display: none"&gt;SCHEDULE OF SERIES B PREFERRED STOCK FOR MEZZANINE EQUITY&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20250401__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zhaSMioZExx9" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240401__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zzPjxgP98iUb" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_zFbmUsDWLgC" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; font-weight: normal; font-style: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Balance
    beginning of year &#x2013; March 31&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,290&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,488,920&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_zOxTslawaYn7" style="font-style: normal; display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,290&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,488,920&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_zvMkDo0EoKDi" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    proceeds received pursuant to the issuance of preferred shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1528"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,732,532&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssue_zLnCVHNYHv7a" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Recognition
    of derivative liabilities (Note 8)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1531"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(649,533&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--PaymentsForRepurchaseOfConvertiblePreferredStock_iN_di_z079A08TY5zd" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption of convertible
    preferred shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(114,326&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1535"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertiblePreferredStockConvertedToOtherSecurities_iN_di_zKCyvLViG9Z8" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion
    into common shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(171,488&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(571,629&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_z8XkTYwB1pIe" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Balance
    end of year &#x2013; March 31&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,714,476&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,290&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zioVqbG7rMm1" style="font-style: normal; display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,714,476&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,290&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_8A7_zFOpkjttpKka" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;(d)
Share issuances&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Share
issuances during the year ended March 31, 2026&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the three months and the year ended March 31, 2026, the Company issued &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260101__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXT4reJbMMP2" title="Conversion of mezzanine equity into common shares"&gt;789,604&lt;/span&gt; and &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250401__20260331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zmZjjqQKM528" title="Conversion of mezzanine equity into common shares"&gt;2,506,020&lt;/span&gt; common shares to Series B preferred shareholders,
respectively, in connection with Series B preferred share conversions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2026, the Company issued &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20250401__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zFBDhDTGp3G7" title="Stock issued during period, shares, issued for services"&gt;10,000&lt;/span&gt; common shares for services received with a fair value of $&lt;span id="xdx_905_ecustom--StockIssuedDuringPeriodValueIssueForServices_c20250401__20260331_zADTLO4A8Vb" title="Stock issued during period, value, issued for services"&gt;3,770&lt;/span&gt;, which was recognized
as a general and administrative expense with a corresponding credit to additional paid-in capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Share
issuances during the year ended March 31, 2025&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the three months and the year ended March 31, 2025, the Company issued &lt;span id="xdx_90D_ecustom--IssuanceOfCommonSharesFromSharesToBeIssued_dxL_c20250101__20250331__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertibleNoteMember_zp4MbQAw7sq1" title="Issuance of common shares from shares to be issued::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1554"&gt;nil&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_90B_ecustom--IssuanceOfCommonSharesFromSharesToBeIssued_c20240401__20250331__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertibleNoteMember_z36jAINhcOa6" title="Issuance of common shares from shares to be issued"&gt;320,321&lt;/span&gt; common shares to Series B preferred shareholders,
respectively, in relation to shares to be issued obligation as of March 2024 for Series B preferred share conversions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
October 2024, the Company issued &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241001__20241031__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertibleRedeemablePreferredStockMember_z0WPp7EMYcmk"&gt;1,197,770&lt;/span&gt;
common shares on partial conversion of &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20241001__20241031__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertibleRedeemablePreferredStockMember_zQnr1j2FeRBi"&gt;25&lt;/span&gt;
shares of Series B Convertible Redeemable Preferred Stock, and a further &lt;span id="xdx_902_eus-gaap--PreferredStockConvertibleSharesIssuable_iI_c20241031__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertibleRedeemablePreferredStockMember_zypTF4v8o3H9" title="Additional common shares conversion"&gt;233,441&lt;/span&gt;
additional common shares required to complete its conversion obligation of a conversion of &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20241001__20241031__us-gaap--StatementClassOfStockAxis__custom--SeriesBConvertibleRedeemablePreferredStockMember_zk2qDlNfrQl7"&gt;25&lt;/span&gt;
shares of Series B Convertible Redeemable Preferred Stock that was triggered on July 11, 2024. During the three and nine months
ended December 31, 2024, the Company issued another &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_z2xE46B927Lc"&gt;1,431,181&lt;/span&gt;
and &lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240401__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zI4JJ6mHOU52"&gt;2,867,448&lt;/span&gt;
common shares to Series B preferred shareholders for an additional request to convert &lt;span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20241001__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zHtkFvicetga"&gt;25&lt;/span&gt;
and &lt;span id="xdx_90D_eus-gaap--ConversionOfStockSharesConverted1_c20240401__20241231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zLTQnDkAoT3a"&gt;75&lt;/span&gt;
Series B preferred shares, respectively. In addition, during the year ended March 31, 2025, the Company issued &lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240401__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zsvPPgOSLHP2" title="Stock issued during period, shares, issued for services"&gt;616,666&lt;/span&gt;
common shares for services received with a fair value of $&lt;span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20240401__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zheLVhzM2i9c" title="Stock issued during period, value, issued for services"&gt;292,596&lt;/span&gt;,
which was recognized as a general and administrative expense with a corresponding credit to additional paid-in capital. During that
same period, the Company issued &lt;span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240401__20250331__srt--TitleOfIndividualAxis__custom--ConsultantMember_zAkMUuLyUSgc" title="Stock issued during period, shares, issued for services"&gt;100,000&lt;/span&gt;
shares of common stock valued at $&lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20240401__20250331__srt--TitleOfIndividualAxis__custom--ConsultantMember_z2IwCkOKmq35" title="Stock issued during period, value, issued for services"&gt;26,000&lt;/span&gt;
to a consultant as part of agreed contract remuneration In addition, the Company issued &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_c20240401__20250331__srt--TitleOfIndividualAxis__srt--ExecutiveOfficerMember_zyBy8WpRxAH5" title="Stock issued during period, shares, issued for services"&gt;480,000&lt;/span&gt;
common shares to an executive as part of a bonus compensation arrangement. The shares were issued in settlement of previously
accrued bonus liabilities, with a total fair value of $&lt;span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_c20240401__20250331__srt--TitleOfIndividualAxis__srt--ExecutiveOfficerMember_z2XPDr0LGBRk" title="Stock issued during period, value, issued for services"&gt;206,400&lt;/span&gt;
recognized in the financial statements. During the year ended March 31, 2025, convertible notes with a face value of $&lt;span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240401__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvcxcdN7zmgi" title="Instrument amount"&gt;1,487,700&lt;/span&gt;
were converted into &lt;span id="xdx_903_eus-gaap--ConversionOfStockSharesConverted1_pid_c20240401__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvcljFsqmhhb" title="Shares converted"&gt;2,173,089&lt;/span&gt;
common shares. The fair value of common shares issued during the year ended March 31, 2025, is $&lt;span id="xdx_904_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_zE6AfFZYmXBa" title="fair value of common shares"&gt;2,431,178&lt;/span&gt;,
and is determined based on market price upon conversion. Total value of debt settled is in the amount of $&lt;span id="xdx_90C_ecustom--DebtSettled_c20240401__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zS1culMFZ0K" title="Debt settled"&gt;2,234,232&lt;/span&gt;,
which consisted of the face value of notes converted, accrued interest of $&lt;span id="xdx_900_eus-gaap--DebtInstrumentIncreaseAccruedInterest_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_zfSmsrgSQz52" title="Debt instrument accrued interest"&gt;237,230&lt;/span&gt;,
and relevant derivative liability of $&lt;span id="xdx_903_eus-gaap--ConversionOfStockAmountConverted1_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_zLSzur5LkGu2" title="Conversion to derivative liability"&gt;509,303&lt;/span&gt;.
The Company recognized a loss upon conversion of $&lt;span id="xdx_901_ecustom--GainLossRecognizedOfDebt_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_z66AJUKimqyg" title="Debt instrument accrued interest"&gt;196,945&lt;/span&gt;,
representing the difference between the value of debt settled and fair value of shares issued and to be issued. (Note 5).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2025, $&lt;span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zxQjPQK7r5k8" title="Face value"&gt;6,104,444&lt;/span&gt; of Series A Preferred Stock (face value) and $&lt;span id="xdx_906_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_c20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zKkgLsh7bkH6" title="Accrued dividends"&gt;1,071,542&lt;/span&gt; relevant accrued dividend were converted
into &lt;span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20240401__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zDOO2Tz4Mtkk" title="Debt conversion converted shares"&gt;8,952,170&lt;/span&gt; common shares. The conversion was accounted as an extinguishment and the difference between the total carrying value of
the preferred shares converted, derivative liabilities derecognized and unpaid dividend at the time of conversion &lt;span id="xdx_90F_eus-gaap--DepositLiabilitiesAccruedInterest_iNI_di_c20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zG5Y7q3WYfTd" title="Deposit liabilities, accrued interest"&gt;($7,984,463)&lt;/span&gt;, and the
fair value of the common shares issued &lt;span id="xdx_90A_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20240401__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zykDNpVmH7Gd" title="Stock redeemed or called during period, value"&gt;($11,039,142)&lt;/span&gt; was $&lt;span id="xdx_90E_eus-gaap--InvestmentCompanyDividendDistribution_c20240401__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_ztArs4uD0xO" title="Investment company, dividend distribution"&gt;3,054,680&lt;/span&gt; and was recognized as deemed dividend expense.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company issued &lt;span id="xdx_903_ecustom--IssuanceOfSharesForSettlementOfAccountsPayable_c20240401__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zq1zlTqmDAI5" title="Issuance of shares for settlement of accounts payable"&gt;1,000,413&lt;/span&gt; common shares in settlement of $&lt;span id="xdx_902_ecustom--IssuanceOfSharesForSettlementOfAccountsPayableValue_c20240401__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziHyk811i5z4" title="Issuance of shares for settlement of accounts payable, value"&gt;741,316&lt;/span&gt; in amount due to a shareholder which was part of the accounts payable.
The Company recognized a loss upon debt extinguishment of $&lt;span id="xdx_90A_ecustom--LossUponSettlementOfAccountsPayable_c20240401__20250331_zy0V7yURec2k" title="Loss upon settlement of accounts payable"&gt;249,093&lt;/span&gt;, which was the difference between the accounts payable settled and
the fair value of common shares issued. The loss was included as part of the other income (expense) in the Condensed Consolidated Statement
of Operations and Comprehensive Loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company issued &lt;span id="xdx_904_ecustom--IssuanceOfCommonSharesFromAtTheMarketTransactionShares_c20240514__20240515__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zwq1Ginmk1sc" title="Issuance of common shares from at-the-market transaction, shares"&gt;97,811&lt;/span&gt; common shares for net proceeds of $&lt;span id="xdx_903_ecustom--IssuanceOfCommonValueFromAtTheMarketTransaction_c20240514__20240515_z2mkV9O5BoN5" title="Issuance of common shares from at-the-market transaction"&gt;125,227&lt;/span&gt; pursuant to a registration statement filed on May 15, 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company issued &lt;span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20240401__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkTg79LdwDOb"&gt;716,666&lt;/span&gt; shares pursuant to the services provided by consultant (&lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20240401__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__custom--ConsultantMember_zq842HquQ9y6"&gt;236,666&lt;/span&gt; shares) and a director of the Company (&lt;span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20240401__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__srt--TitleOfIndividualAxis__srt--DirectorMember_zK9aoZWhRi6e"&gt;480,000&lt;/span&gt;),
and the fair of those shares were determined by using market value relative to the issuance.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;(e)
Shares to be issued&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Activity
during the year ended March 31, 2026&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;As of March 31, 2026, the Company
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;has &lt;span id="xdx_902_eus-gaap--SharesIssued_iI_pid_c20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zq5o5tqavJqf" title="Outstanding shares remaining to be issued"&gt;424,216 &lt;/span&gt;outstanding shares remaining to be issued to Series
B preference shareholders in relation to November 2025 notice for conversion of &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesConversionOfUnits_pid_c20250401__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zkNBCCAiG8sg" title="Preferred shares conversion"&gt;25&lt;/span&gt; preferred shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;Activity
during the year ended March 31, 2025&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2025, the Company issued &lt;span id="xdx_90E_ecustom--IssuanceOfCommonSharesFromSharesToBeIssued_c20240401__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zz1VQn8JANyb" title="Issuance of common shares from shares to be issued"&gt;320,321&lt;/span&gt; common shares to Series B preferred shareholders in relation to shares to be
issued obligation as of March 31, 2024, for Series B preferred share conversions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2025, Series C Notes with a face value of $&lt;span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_zOck32HYIDmk" title="Instrument amount"&gt;1,487,700&lt;/span&gt;, were converted into &lt;span id="xdx_906_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20240401__20250331__us-gaap--DebtInstrumentAxis__custom--SeriesCNotesMember_z56PedYmElM4" title="Converted instrument shares issued"&gt;2,173,089&lt;/span&gt; common shares, respectively.
As of March 31, 2025, &lt;span id="xdx_90F_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20240401__20250331_z3bq33ZQrMmd" title="Converted instrument shares issued"&gt;577,644&lt;/span&gt; shares are recognized as an obligation for shares to be issued relating to the conversion.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;(f)
Warrant issuances, exercises and other activity&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrant
issuances during the year ended March 31, 2026&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;In
December 2025, the Company issued &lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecondForbearanceAgreementMember_zQ6pXR34qNQ2" title="Warrants shares issued"&gt;120,000&lt;/span&gt;&lt;/span&gt;
&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;warrants to its term
lender in connection with a forbearance agreement dated December 12, 2025, with an exercise price of $&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecondForbearanceAgreementMember_zgigJ3R3PZU2" title="Warrants exercise price"&gt;0.37&lt;/span&gt;&lt;/span&gt;
&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;per share. During
the same month, the Company also issued &lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--WarrantAgreementMember_z1TjdaDuDB54" title="Warrants shares issued"&gt;27,150&lt;/span&gt; additional warrants with an exercise price of $&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--WarrantAgreementMember_zfqlUvvQXZe8" title="Warrants exercise price"&gt;2.21&lt;/span&gt; per share pursuant to the terms of
a previously executed warrant agreement. The warrants had an aggregate fair value of $&lt;span id="xdx_906_eus-gaap--FairValueAdjustmentOfWarrants_c20251201__20251231__us-gaap--TypeOfArrangementAxis__custom--SecondForbearanceAgreementMember_zlNGUAA2JJJ9"&gt;38,078&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;,
determined using the Black-Scholes option pricing model. The &lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecondForbearanceAgreementMember_zK3HotRmNI57" title="Warrants shares issued"&gt;120,000&lt;/span&gt; warrants were valued using an expected life of &lt;span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecondForbearanceAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zSVDj5UJxIzh"&gt;7.0&lt;/span&gt;
years, a risk-free interest rate of &lt;span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecondForbearanceAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zYh4WbhCWhYf"&gt;3.95&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;%,
and expected volatility of &lt;span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20251231__us-gaap--TypeOfArrangementAxis__custom--SecondForbearanceAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember_zZGtwZqcoKj1"&gt;103.07&lt;/span&gt;&lt;/span&gt;&lt;span style="font: normal 10pt Times New Roman, Times, Serif"&gt;%.&lt;/span&gt;
&lt;span style="font-style: normal; font-weight: normal"&gt;The &lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20251231__us-gaap--TypeOfArrangementAxis__custom--WarrantAgreementMember_zqia4R2If2qh" title="Warrants shares issued"&gt;27,150&lt;/span&gt; warrants were valued using an expected life of &lt;span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20251231__us-gaap--TypeOfArrangementAxis__custom--WarrantAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zK6KKLRUqmH2"&gt;4.65&lt;/span&gt; years, a risk-free
interest rate of &lt;span id="xdx_904_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20251231__us-gaap--TypeOfArrangementAxis__custom--WarrantAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zn6rJm9T2vph"&gt;3.94&lt;/span&gt;%, and expected volatility of &lt;span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20251231__us-gaap--TypeOfArrangementAxis__custom--WarrantAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember_zFpYNQnyJCvk"&gt;103.07&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrant
issuances during the year ended March 31, 2025&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2025, the Company issued a &lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20250331__srt--TitleOfIndividualAxis__srt--ExecutiveOfficerMember_zN8G6tGMM4aa" title="Warrants shares issues"&gt;1,200,000&lt;/span&gt;
warrant to its executive against the stock options from the Company&#x2019;s 2018 Equity Incentive Plan, with exercise price of &lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20250331__srt--TitleOfIndividualAxis__srt--ExecutiveOfficerMember_zBPPAJp9wXnh" title="Warrants price per share"&gt;0.43&lt;/span&gt;.
The Company recorded stock based compensation of $&lt;span id="xdx_907_eus-gaap--AllocatedShareBasedCompensationExpense_c20240401__20250331__us-gaap--StatementOfIncomeLocationBalanceAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember_zzIaGFcH21H4" title="Stock-based compensation"&gt;422,456&lt;/span&gt;
under selling, general and administrative expenses with corresponding credit to additional paid in capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2024, the Company issued &lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_c20241130_z7YSQvthtGgj" title="Warrants shares issues"&gt;600,000&lt;/span&gt;, &lt;span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20241130_zWKLcwJD53Gd" title="Warrants term"&gt;7&lt;/span&gt;-year share warrants to the term lender with a strike price of $&lt;span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20241130_z0JlILYNiTs" title="Warrants price per share"&gt;0.50&lt;/span&gt; per share with the fair
value of &lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20241130_z2kkg6ErKfYa" title="Fair value of warrants"&gt;152,184&lt;/span&gt; against an additional transaction with its term lender. The Company increased the liability with corresponding credit
to additional paid in Capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Warrant
issuances, exercises and expirations or cancellations during the fiscal years ended March 31, 2026 and 2025 as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z0kJvThGfjB1" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrant
activity during the years ended March 31, 2026 and 2025 is indicated below:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B7_zvKWr1W1ah95" style="display: none"&gt;SCHEDULE OF WARRANTS OUTSTANDING&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_custom--BrokerWarrantsMember_zdcD8hpqqJ65" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Broker
    Warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_custom--ConsultantWarrantsMember_zipoGj4lxBhg" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Consultant
    and Noteholder Warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_custom--WarrantsIssuedOnConversionOfConvertibleNotesMember_zGvZvK7PEnIe" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Warrants
    Issued on Convertible Notes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BD_zbcD8i8Pu3De" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20240401__20250331_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_zAOIMLlkdoci" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 36%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As at
    March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;208,927&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;253,994&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;868,098&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,331,019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_zwEinut82qeb" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired/cancelled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1670"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(15,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1672"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(15,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_zuOx0jnltAZe" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;600,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1677"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,800,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20250401__20260331_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_zsxATIRrCtYf" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;808,927&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,438,994&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;868,098&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,116,019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20250401__20260331_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_zLExyayE1Fd1" style="font-style: normal; display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;Beginning balance&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;808,927&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,438,994&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;868,098&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,116,019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_z03Ag5H6omY4" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired/cancelled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1690"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1691"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1692"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1693"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_z8tV8RbCSQYc" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;147,150&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1696"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1697"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;147,150&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20250401__20260331_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_zW72oWUABIRh" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As at March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;956,077&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,438,994&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;868,098&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,263169&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20250401__20260331_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_zyo4e6PRZeB9" style="font-style: normal; display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;956,077&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,438,994&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;868,098&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,263169&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--StatementEquityComponentsAxis__custom--BrokerWarrantsMember__srt--RangeAxis__srt--MinimumMember_zsDkmaDUU9j4" title="Exercise price"&gt;0.37&lt;/span&gt;
                                            to $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--StatementEquityComponentsAxis__custom--BrokerWarrantsMember__srt--RangeAxis__srt--MaximumMember_zGOgPkQQ1Dgg" title="Exercise price"&gt;37.56&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--StatementEquityComponentsAxis__custom--ConsultantAndNoteholderWarrantsMember__srt--RangeAxis__srt--MinimumMember_zdsKY4IVl1Sh" title="Exercise price"&gt;0.43&lt;/span&gt;
                                            to $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--StatementEquityComponentsAxis__custom--ConsultantAndNoteholderWarrantsMember__srt--RangeAxis__srt--MaximumMember_zFgVV5eCMRIh" title="Exercise price"&gt;14.40&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--StatementEquityComponentsAxis__custom--WarrantsIssuedOnConvertibleNotesMember_zByR3a6puuX3" title="Exercise price"&gt;4.18&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expiration
    Date&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20250401__20260331__us-gaap--StatementEquityComponentsAxis__custom--BrokerWarrantsMember_zZkfbny7FCf4" title="Expiration date"&gt;August
                                            2026 to October 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20250401__20260331__us-gaap--StatementEquityComponentsAxis__custom--ConsultantAndNoteholderWarrantsMember_zigQ8MNP16k7" title="Expiration date"&gt;March
                                            2029 to December 2032&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20250401__20260331__us-gaap--StatementEquityComponentsAxis__custom--WarrantsIssuedOnConvertibleNotesMember_zNnaMtuzm7Gi" title="Expiration date"&gt;October
                                            2027&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;(g)
Stock based compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8A5_zqKEhtNga9q7" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;2016
Equity Incentive Plan&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 2, 2016, the Board of Directors of the Company approved the Company&#x2019;s 2016 Equity Incentive Plan (the
&#x201c;Plan&#x201d;). The purpose of the Plan is to advance the interests of the Company and its stockholders by providing an
incentive to attract, retain and reward persons performing services for the Company and by motivating such persons to contribute to
the growth and profitability of the Company. The Plan seeks to achieve this purpose by providing for awards in the form of options,
stock appreciation rights, restricted stock purchase rights, restricted stock bonuses, restricted stock units, performance shares,
performance units and other stock based awards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Plan shall continue in effect until its termination by the board of directors or committee formed by the board; provided, however, that
all awards shall be granted, if at all, on or before the day immediately preceding the tenth (10th) anniversary of the effective date.
The maximum number of shares of stock that may be issued under the Plan shall be equal to &lt;span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20160202__us-gaap--PlanNameAxis__custom--TwoThousandAndSixteenEquityIncentivePlanMember_zfBFTun82qIj" title="Share based payment award number of shares authorized"&gt;1,241,422&lt;/span&gt; shares ; provided that the maximum
number of shares of stock that may be issued under the Plan pursuant to awards shall automatically and without any further Company or
shareholder approval, increase on January 1 of each year for not more than 10 years from the effective date, so the number of shares
that may be issued is an amount no greater than 20% of the Company&#x2019;s outstanding shares of stock and shares of stock underlying
any outstanding exchangeable shares as of such January 1; provided further that no such increase shall be effective if it would violate
any applicable law or stock exchange rule or regulation, or result in adverse tax consequences to the Company or any participant that
would not otherwise result but for the increase.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the year ended March 31, 2026, the Company granted &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_do_uShares_c20250401__20260331__us-gaap--PlanNameAxis__custom--TwoThousandAndSixteenEquityIncentivePlanMember_z3j4rFac4Ps6" title="Granted shares"&gt;no&lt;/span&gt;
stock options. During the year ended March 31, 2025, the Company granted &lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240401__20250331__us-gaap--PlanNameAxis__custom--TwoThousandAndSixteenEquityIncentivePlanMember_zFiUw20xdzT6" title="Granted shares"&gt;2,836,176&lt;/span&gt;
stock options with a weighted average grant date exercise price of $&lt;span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20250331__us-gaap--PlanNameAxis__custom--TwoThousandAndSixteenEquityIncentivePlanMember_z2E8RvCWuzuh" title="Weighted average exercise price"&gt;0.5&lt;/span&gt;.The
Company recorded stock based compensation of $&lt;span id="xdx_90C_eus-gaap--AllocatedShareBasedCompensationExpense_c20250401__20260331__us-gaap--StatementOfIncomeLocationBalanceAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSixteenEquityIncentivePlanMember_zklYkon3SQh2" title="Stock-based compensation"&gt;25,632&lt;/span&gt;
(2025: $&lt;span id="xdx_90A_eus-gaap--AllocatedShareBasedCompensationExpense_c20240401__20250331__us-gaap--StatementOfIncomeLocationBalanceAxis__us-gaap--SellingGeneralAndAdministrativeExpensesMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSixteenEquityIncentivePlanMember_zeTSgiEUH7q1" title="Stock-based compensation"&gt;1,461,698&lt;/span&gt;)
under selling, general and administrative expenses with corresponding credit to additional paid in capital. The stock based
compensation expense recognized during the period relates to unvested stock options granted in prior periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026, options outstanding were &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSixteenEquityIncentivePlanMember_zYG4T8deua7c" title="Number of options outstanding"&gt;3,048,663&lt;/span&gt; with the weighted average exercise price of $&lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember__us-gaap--PlanNameAxis__custom--TwoThousandAndSixteenEquityIncentivePlanMember_zBPj3ouw4Pd6" title="Weighted average exercise price"&gt;1.14&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zNlCnvfbTYae" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the stock option activities during the fiscal year ended March 31, 2026:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B5_zfN8fdZUZCxf" style="display: none"&gt;SCHEDULE OF STOCK OPTION ACTIVITIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
                                            Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Term
                                            (years)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value&lt;sup&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 36%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zzddj5XrLfT1" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal" title="Number of options, beginning outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,067,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAIjmKSMZsF9" style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal" title="Weighted average exercise price, beginning outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.14&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z3Tk91tRkqwh" title="Weighted average remaining contractual term (years)"&gt;1.77&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEp_zwDlSUtvUMdl" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal" title="Aggregate intrinsic value, beginning outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,078,756&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustment
    for rounding effect of Reverse Split&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdjustmentForRoundingEffectOfReverseSplit_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zFy9mbPIMoBc" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Adjustment for rounding effect of Reverse Split"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1752"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAdjustmentForRoundingEffectOfReverseSplitInPeriodWeightedAverageExercisePrice_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zQ5H1RkaTsvf" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Adjustment for rounding effect of Reverse Split"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1754"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zVjEaTKUySU6" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1756"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zThdwn3jX1n6" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1758"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z6jf8MzfUoq9" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1760"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9om2UBLTajh" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1762"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyl1nuuaj4cj" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(14,192&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zJ2pT6WG4Rm5" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1766"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zHpwBOXW8ixj" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,975&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDELwJz3Dfci" style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1770"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    at March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zI0vuBz3vQfj" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, ending outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,048,663&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zwxdDXfR33p9" style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, ending outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.13&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zS8nReOX4PSe" title="Weighted average remaining contractual term (years)"&gt;6.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEp_zKffgI1ga2d2" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Aggregate intrinsic value, ending outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested
    and expected to vest at March 31, 2026*&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zDetTzh0IdUf" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Vested and expected to vest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,048,663&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____ztQNBKZZ7ba9" style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Vested and expected to vest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.13&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zuYqmHWDQ6Vi" title="Weighted average remaining contractual term, Vested and expected to vest"&gt;6.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEpKg_____zD5lqmaLzwYd" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Aggregate intrinsic value, Vested and expected to vest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested
    and exercisable at March 31, 2026*&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zhtw4ZyZlxSd" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Vested and exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,749,295&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zWgkyofJaWQg" style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Vested and exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.14&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zU3k3wamSa3a" title="Weighted average remaining contractual term, Vested and exercisable"&gt;5.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEpKg_____z6CHObfNu54k" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Aggregate intrinsic value, Vested and exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F0C_z6BywhWyfaP6"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_zrtsjMsdDgz" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value
    of our common stock as of March 31, 2026 and fair value of common stock adjusted.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td id="xdx_F0F_zkREnKxyTlAd" style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1D_z7q10pNCFHYd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
    includes &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBBQ1RJVklUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20250401__20260331__us-gaap--AwardTypeAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember_ztJVfYUhkkW" title="Options granted to employees"&gt;1,200,000&lt;/span&gt; options granted to employees from the 2023 Equity Incentive Plan, discussed below.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the stock option activities during the fiscal year ended March 31, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
                                            Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Term
                                            (years)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value&lt;sup&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 36%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjGJMqzus83l" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal" title="Number of options, beginning outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,239,873&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_ztbgpIUTF5wl" style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 12%; text-align: right; font-weight: normal" title="Weighted average exercise price, beginning outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.39&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 12%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230401__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z7Otgh2jO8yi" title="Weighted average remaining contractual term (years)"&gt;5.35&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEp_zeBDLaPPzzYh" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal" title="Aggregate intrinsic value, beginning outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,705,937&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustment
    for rounding effect of Reverse Split&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdjustmentForRoundingEffectOfReverseSplit_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z3MIl9eK6kp9" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Adjustment for rounding effect of Reverse Split"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1808"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAdjustmentForRoundingEffectOfReverseSplitInPeriodWeightedAverageExercisePrice_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZi4X3tEIC0f" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Adjustment for rounding effect of Reverse Split"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1810"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAY64GV5GULh" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,836,176&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zu9RSEe5JLDa" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted2_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjSiRRoALXIe" title="Weighted average remaining contractual term granted"&gt;0.02&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zlXhKwINLnMd" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(931,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zim0SZj7lBp3" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.32&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermCancelled_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zcUhWsuT9zAf" title="Weighted average remaining contractual term Cancelled"&gt;4.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZSyOCdxEeHj" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(57,582&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zEx5dX2a1X1" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.56&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired2_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zgpU1TCvgfqb" title="Weighted average remaining contractual term, Expired"&gt;0.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zANvfliwGEwb" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(19,637&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z5uJCvQX67Ca" style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right; font-weight: normal" title="Weighted average exercise price, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.37&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited2_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zkVdheeMUGr1" title="Weighted average remaining contractual term, Forfeited"&gt;2.34&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zf7v9xy9yV2e" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, ending outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,067,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zYZH6Wf9MI42" style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right; font-weight: normal" title="Weighted average exercise price, ending outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.14&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9q1l1XzsvPb" title="Weighted average remaining contractual term (years)"&gt;1.77&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEp_zW7iFkZtdGKg" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Aggregate intrinsic value, ending outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,078,756&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested
    and expected to vest at March 31, 2025*&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zQ7jSuTsMACd" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Vested and expected to vest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,067,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zoyZdUnVdfLa" style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right; font-weight: normal" title="Weighted average exercise price, Vested and expected to vest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.14&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____z6QY0bWBzXnb" title="Weighted average remaining contractual term, Vested and expected to vest"&gt;1.77&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEpKg_____zt4hntK0YMAa" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Aggregate intrinsic value, Vested and expected to vest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,078,756&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested
    and exercisable at March 31, 2025*&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____z8JgIwyFAwLi" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Vested and exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,611,411&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zZrqdNvDmtib" style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right; font-weight: normal" title="Weighted average exercise price, Vested and exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.17&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zu0uW1tKYjtc" title="Weighted average remaining contractual term, Vested and exercisable"&gt;0.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEpKg_____zpbqEdxGGqW8" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Aggregate intrinsic value, Vested and exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;805,181&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F02_zkreqy65znHh"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F14_zM1c8tp5zqqe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value
    of our common stock as of March 31, 2025 and fair value of common stock adjusted.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F00_zBMTBKcBs96d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F13_zJCGXbg2wqxk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
    includes &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBBQ1RJVklUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20240401__20250331__us-gaap--AwardTypeAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember_zkZTkJcIwgCi" title="Options granted to employees"&gt;1,200,000&lt;/span&gt; options granted to employees from the 2023 Equity Incentive Plan, discussed below.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AF_zwpIQOsYZ7hh" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zhyUvzOEgKXb" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of each option granted is estimated at the time of grant using multi-nominal lattice model using the following assumptions,
for each of the respective years ended March 31&lt;b&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BB_zalpczyJFqyb" style="display: none"&gt;SCHEDULE OF FAIR VALUE OF OPTION GRANTED USING VALUATION ASSUMPTIONS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: justify; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise
    price ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20250331__srt--RangeAxis__srt--MinimumMember_zPKvM8DvDAH5" title="Exercise price"&gt;0.43&lt;/span&gt;-&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20250331__srt--RangeAxis__srt--MaximumMember_zaJVIBXzfJUd" title="Exercise price"&gt;0.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: justify; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk
    free interest rate (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240401__20250331__srt--RangeAxis__srt--MinimumMember_zAGMUgD1t6Xd" title="Risk free interest rate"&gt;4.24&lt;/span&gt;-&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240401__20250331__srt--RangeAxis__srt--MaximumMember_zBIUnSiBaWcc" title="Risk free interest rate"&gt;4.33&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: justify; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
    term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240401__20250331__srt--RangeAxis__srt--MinimumMember_zatYHNMxIsz1" title="Expected term"&gt;1.46&lt;/span&gt;-&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240401__20250331__srt--RangeAxis__srt--MaximumMember_zXmIqTJKCQ33" title="Expected term"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: justify; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
    volatility (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240401__20250331__srt--RangeAxis__srt--MinimumMember_zaMMQ3a1Lfvc" title="Expected volatility"&gt;113.97&lt;/span&gt;-&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240401__20250331__srt--RangeAxis__srt--MaximumMember_zWXGHnY3KDz8" title="Expected volatility"&gt;142.22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
    dividend yield (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240401__20250331_zQrqNu6gboMh" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal" title="Expected dividend yield"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: justify; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
    value of option ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20250331__srt--RangeAxis__srt--MinimumMember_zvW1gWPaUtC" title="Fair value of option"&gt;1.097&lt;/span&gt;-&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20250331__srt--RangeAxis__srt--MaximumMember_znyA1v23J1nk" title="Fair value of option"&gt;1.360&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: justify; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
    forfeiture (attrition) rate (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ExpectedForfeitureAttritionRates_pid_dp_uPure_c20240401__20250331_zSGT8GrZ65ik" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Expected forfeiture (attrition) rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zfwvDD4YWPz7" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;2023
Equity Incentive Plan and the Employee Stock Purchase Plans&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 31, 2023, the Company adopted the 2023 Equity Incentive Plan (the &#x201c;2023 Plan&#x201d;). The 2023 Plan authorizes grants of
equity-based and incentive cash awards to eligible participants designated by the 2023 Plan&#x2019;s administrator. The 2023 Plan will
be administered by the Compensation Committee of the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). An aggregate of &lt;span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230331__us-gaap--PlanNameAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember_z29EO4u6Ax7k" title="Aggregate shares"&gt;5,000,000&lt;/span&gt;
shares of the Company&#x2019;s common stock (the &#x201c;Common Stock&#x201d;), plus the number of shares available for issuance under the
Company&#x2019;s 2016 Equity Incentive Plan that had not been made subject to outstanding awards, were reserved for issuance under the
2023 Plan. Unless earlier terminated by the Board, the 2023 Plan will remain in effect until all Common Stock reserved for issuance has
been issued, provided, however, that all awards shall be granted, if at all, on or before the day immediately preceding the tenth (10th)
anniversary of the effective date of the 2023 Plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also adopted the Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;). The ESPP allows eligible employees of the Company and
the Company&#x2019;s designated subsidiaries the ability to purchase shares of the Company&#x2019;s Common Stock at a discount, subject
to various limitations. Under the ESPP, employees will be granted the right to purchase Common Stock at a discount during a series of
successive offerings, the duration and timing of which will be determined by the ESPP administrator (the &#x201c;Administrator&#x201d;).
In no event can any single offering period be longer than 27 months. The purchase price (the &#x201c;Purchase Price&#x201d;) for each offering
will be established by the Administrator. With respect to an offering under Section 423 of the Internal Revenue Code of 1986 (&#x201c;Section
423 Offering&#x201d;), in no case may such Purchase Price be less than the lesser of (i) an amount equal to 85 percent of the fair market
value on the commencement date, or (ii) an amount not less than 85 percent of the fair market value the on the purchase date. In the
event of financial hardship, an employee may withdraw from the ESPP by providing a request at least 20 Business Days before the end of
the offering period (the &#x201c;Offering Period&#x201d;). Otherwise, the employee will be deemed to have exercised the purchase right
in full as of such exercise date. Upon exercise, the employee will purchase the number of whole shares that the participant&#x2019;s accumulated
payroll deductions will buy at the Purchase Price. If an employee wants to decrease the rate of contribution, the employee must make
a request at least 20 Business Days before the end of an Offering Period (or such earlier date as determined by the Administrator). An
employee may not transfer any rights under the ESPP other than by will or the laws of descent and distribution. During a participant&#x2019;s
lifetime, purchase rights under the ESPP shall be exercisable only by the participant.&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact001414"
      unitRef="Shares">125000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact001416"
      unitRef="Shares">125000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact001418"
      unitRef="USDPShares">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001419"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001420"
      unitRef="Shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_us-gaap_PreferredStockMember"
      decimals="INF"
      id="Fact001421"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001423"
      unitRef="Shares">20000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001425"
      unitRef="Shares">20000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001426"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001427"
      unitRef="Shares">600</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001428"
      unitRef="Shares">600</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001430"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:SharesIssued
      contextRef="AsOf2026-03-31_custom_ShareholdersMember_custom_ExchangeAgreementMember"
      decimals="INF"
      id="Fact001432"
      unitRef="Shares">28757987</us-gaap:SharesIssued>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-03-31_custom_ShareholdersMember_custom_ExchangeAgreementMember"
      decimals="INF"
      id="Fact001434"
      unitRef="Shares">28757987</us-gaap:SharesOutstanding>
    <us-gaap:SharesIssued
      contextRef="AsOf2025-03-31_custom_ShareholdersMember_custom_ExchangeAgreementMember"
      decimals="INF"
      id="Fact001436"
      unitRef="Shares">26241967</us-gaap:SharesIssued>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-03-31_custom_ShareholdersMember_custom_ExchangeAgreementMember"
      decimals="INF"
      id="Fact001438"
      unitRef="Shares">26241967</us-gaap:SharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-03-31_custom_ShareholdersMember"
      decimals="INF"
      id="Fact001440"
      unitRef="Shares">28597315</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-03-31_custom_ShareholdersMember"
      decimals="INF"
      id="Fact001442"
      unitRef="Shares">28597315</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-03-31_custom_ShareholdersMember"
      decimals="INF"
      id="Fact001444"
      unitRef="Shares">26081295</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-03-31_custom_ShareholdersMember"
      decimals="INF"
      id="Fact001446"
      unitRef="Shares">26081295</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockOtherSharesOutstanding
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact001448"
      unitRef="Shares">160672</us-gaap:CommonStockOtherSharesOutstanding>
    <us-gaap:CommonStockOtherSharesOutstanding
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact001450"
      unitRef="Shares">160672</us-gaap:CommonStockOtherSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001452"
      unitRef="Shares">201</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001454"
      unitRef="Shares">201</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001456"
      unitRef="Shares">201</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001458"
      unitRef="Shares">201</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001460"
      unitRef="Shares">335</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001462"
      unitRef="Shares">335</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001464"
      unitRef="Shares">385</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001466"
      unitRef="Shares">385</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001468"
      unitRef="Shares">201</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001470"
      unitRef="Shares">201</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001472"
      unitRef="Shares">201</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001474"
      unitRef="Shares">201</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockLiquidationPreference
      contextRef="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001476"
      unitRef="USDPShares">10000</us-gaap:PreferredStockLiquidationPreference>
    <us-gaap:PreferredStockDividendRatePercentage
      contextRef="From2025-04-012026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001478"
      unitRef="Pure">0.12</us-gaap:PreferredStockDividendRatePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="From2025-04-012026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001480"
      unitRef="Pure">0.05</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:PreferredStockConvertibleConversionPrice
      contextRef="AsOf2026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001482"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockConvertibleConversionPrice>
    <BTCY:VolumeWeightedAveragePricePercentage
      contextRef="From2025-04-012026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001484"
      unitRef="Pure">0.15</BTCY:VolumeWeightedAveragePricePercentage>
    <BTCY:VolumeWeightedAveragePricePercentage
      contextRef="From2025-04-012026-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001486"
      unitRef="Pure">0.15</BTCY:VolumeWeightedAveragePricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="From2025-04-01to2026-03-31"
      decimals="INF"
      id="Fact001488"
      unitRef="Pure">1.10</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2023-09-19_custom_SeriesBConvertiblePreferredStockMember"
      decimals="0"
      id="Fact001490"
      unitRef="USD">10000</us-gaap:PreferredStockValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-04-012026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001492"
      unitRef="Shares">550</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-04-01to2026-03-31"
      decimals="-5"
      id="Fact001494"
      unitRef="USD">4600000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <BTCY:DividendsValuePercentage
      contextRef="AsOf2023-09-19_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001496"
      unitRef="Pure">0.08</BTCY:DividendsValuePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="From2023-09-182023-09-19_custom_PurchaseAgreementMember_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001498"
      unitRef="Pure">1.10</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001500"
      unitRef="USD">171488</us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2025-04-012026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001501"
      unitRef="Shares">30</us-gaap:ConversionOfStockSharesConverted1>
    <BTCY:ConversionIntoCommonShares
      contextRef="From2025-04-012026-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001503"
      unitRef="USD">114326</BTCY:ConversionIntoCommonShares>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-04-012026-03-31_custom_SeriesBConvertibleRedeemablePreferredStockMember243863265"
      decimals="INF"
      id="Fact001504"
      unitRef="Shares">20</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:AccruedLiabilitiesAndOtherLiabilities
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001505"
      unitRef="USD">121945</us-gaap:AccruedLiabilitiesAndOtherLiabilities>
    <us-gaap:IncreaseDecreaseInDerivativeLiabilities
      contextRef="From2026-03-312026-03-31"
      decimals="0"
      id="Fact001506"
      unitRef="USD">207623</us-gaap:IncreaseDecreaseInDerivativeLiabilities>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001508"
      unitRef="USD">876256</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001510"
      unitRef="USD">297915</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001512"
      unitRef="Shares">335</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001514"
      unitRef="Shares">385</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001516"
      unitRef="USD">1714476</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001518"
      unitRef="USD">2000290</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <BTCY:ScheduleOfSeriesBPreferredStockForMezzanineEquityTableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001520">&lt;p id="xdx_892_ecustom--ScheduleOfSeriesBPreferredStockForMezzanineEquityTableTextBlock_zfLC9CFRLzU7" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;A
roll-forward of activity is presented below for the year ended March 31, 2026:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B0_zMGYUG6l12mi" style="display: none"&gt;SCHEDULE OF SERIES B PREFERRED STOCK FOR MEZZANINE EQUITY&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20250401__20260331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zhaSMioZExx9" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20240401__20250331__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zzPjxgP98iUb" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_zFbmUsDWLgC" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; width: 60%; font-weight: normal; font-style: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Balance
    beginning of year &#x2013; March 31&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,290&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,488,920&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iS_zOxTslawaYn7" style="font-style: normal; display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,290&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,488,920&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40D_eus-gaap--ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_zvMkDo0EoKDi" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net
    proceeds received pursuant to the issuance of preferred shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1528"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,732,532&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssue_zLnCVHNYHv7a" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Recognition
    of derivative liabilities (Note 8)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1531"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(649,533&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--PaymentsForRepurchaseOfConvertiblePreferredStock_iN_di_z079A08TY5zd" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Redemption of convertible
    preferred shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(114,326&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1535"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--ConvertiblePreferredStockConvertedToOtherSecurities_iN_di_zKCyvLViG9Z8" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Conversion
    into common shares&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(171,488&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(571,629&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_z8XkTYwB1pIe" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&lt;i&gt;Balance
    end of year &#x2013; March 31&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,714,476&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,290&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zioVqbG7rMm1" style="font-style: normal; display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-family: Times New Roman, Times, Serif; font-weight: normal; font-style: normal; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,714,476&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,000,290&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</BTCY:ScheduleOfSeriesBPreferredStockForMezzanineEquityTableTextBlock>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001522"
      unitRef="USD">2000290</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2024-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001523"
      unitRef="USD">1488920</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001525"
      unitRef="USD">2000290</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2024-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001526"
      unitRef="USD">1488920</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
      contextRef="From2024-04-012025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001529"
      unitRef="USD">1732532</us-gaap:ProceedsFromIssuanceOfPreferredStockAndPreferenceStock>
    <BTCY:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssue
      contextRef="From2024-04-012025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001532"
      unitRef="USD">-649533</BTCY:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssue>
    <us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock
      contextRef="From2025-04-012026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001534"
      unitRef="USD">114326</us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock>
    <us-gaap:ConvertiblePreferredStockConvertedToOtherSecurities
      contextRef="From2025-04-012026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001537"
      unitRef="USD">171488</us-gaap:ConvertiblePreferredStockConvertedToOtherSecurities>
    <us-gaap:ConvertiblePreferredStockConvertedToOtherSecurities
      contextRef="From2024-04-012025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001538"
      unitRef="USD">571629</us-gaap:ConvertiblePreferredStockConvertedToOtherSecurities>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001540"
      unitRef="USD">1714476</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001541"
      unitRef="USD">2000290</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001543"
      unitRef="USD">1714476</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001544"
      unitRef="USD">2000290</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2026-01-012026-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001546"
      unitRef="Shares">789604</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-04-012026-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001548"
      unitRef="Shares">2506020</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2025-04-012026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001550"
      unitRef="Shares">10000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <BTCY:StockIssuedDuringPeriodValueIssueForServices
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001552"
      unitRef="USD">3770</BTCY:StockIssuedDuringPeriodValueIssueForServices>
    <BTCY:IssuanceOfCommonSharesFromSharesToBeIssued
      contextRef="From2024-04-012025-03-31_custom_SeriesCConvertibleNoteMember"
      decimals="INF"
      id="Fact001556"
      unitRef="Shares">320321</BTCY:IssuanceOfCommonSharesFromSharesToBeIssued>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-10-012024-10-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact001557"
      unitRef="Shares">1197770</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-10-012024-10-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact001558"
      unitRef="Shares">25</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:PreferredStockConvertibleSharesIssuable
      contextRef="AsOf2024-10-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact001560"
      unitRef="Shares">233441</us-gaap:PreferredStockConvertibleSharesIssuable>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2024-10-012024-10-31_custom_SeriesBConvertibleRedeemablePreferredStockMember"
      decimals="INF"
      id="Fact001561"
      unitRef="Shares">25</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-10-012024-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001562"
      unitRef="Shares">1431181</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2024-04-012024-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001563"
      unitRef="Shares">2867448</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-10-012024-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001564"
      unitRef="Shares">25</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-04-012024-12-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001565"
      unitRef="Shares">75</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-04-012025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001567"
      unitRef="Shares">616666</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-04-012025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="0"
      id="Fact001569"
      unitRef="USD">292596</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-04-012025-03-31_custom_ConsultantMember"
      decimals="INF"
      id="Fact001571"
      unitRef="Shares">100000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-04-012025-03-31_custom_ConsultantMember"
      decimals="0"
      id="Fact001573"
      unitRef="USD">26000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-04-012025-03-31_srt_ExecutiveOfficerMember"
      decimals="INF"
      id="Fact001575"
      unitRef="Shares">480000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="From2024-04-012025-03-31_srt_ExecutiveOfficerMember"
      decimals="0"
      id="Fact001577"
      unitRef="USD">206400</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001579"
      unitRef="USD">1487700</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001581"
      unitRef="Shares">2173089</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2024-04-012025-03-31_custom_SeriesCNotesMember"
      decimals="0"
      id="Fact001583"
      unitRef="USD">2431178</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <BTCY:DebtSettled
      contextRef="From2024-04-012025-03-31_us-gaap_SeriesCPreferredStockMember"
      decimals="0"
      id="Fact001585"
      unitRef="USD">2234232</BTCY:DebtSettled>
    <us-gaap:DebtInstrumentIncreaseAccruedInterest
      contextRef="From2024-04-012025-03-31_custom_SeriesCNotesMember"
      decimals="0"
      id="Fact001587"
      unitRef="USD">237230</us-gaap:DebtInstrumentIncreaseAccruedInterest>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="From2024-04-012025-03-31_custom_SeriesCNotesMember"
      decimals="0"
      id="Fact001589"
      unitRef="USD">509303</us-gaap:ConversionOfStockAmountConverted1>
    <BTCY:GainLossRecognizedOfDebt
      contextRef="From2024-04-012025-03-31_custom_SeriesCNotesMember"
      decimals="0"
      id="Fact001591"
      unitRef="USD">196945</BTCY:GainLossRecognizedOfDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact001593"
      unitRef="USD">6104444</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact001595"
      unitRef="USD">1071542</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2024-04-012025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="INF"
      id="Fact001597"
      unitRef="Shares">8952170</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DepositLiabilitiesAccruedInterest
      contextRef="AsOf2025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact001599"
      unitRef="USD">7984463</us-gaap:DepositLiabilitiesAccruedInterest>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="From2024-04-012025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact001601"
      unitRef="USD">-11039142</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:InvestmentCompanyDividendDistribution
      contextRef="From2024-04-012025-03-31_us-gaap_SeriesAPreferredStockMember"
      decimals="0"
      id="Fact001603"
      unitRef="USD">3054680</us-gaap:InvestmentCompanyDividendDistribution>
    <BTCY:IssuanceOfSharesForSettlementOfAccountsPayable
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001605"
      unitRef="Shares">1000413</BTCY:IssuanceOfSharesForSettlementOfAccountsPayable>
    <BTCY:IssuanceOfSharesForSettlementOfAccountsPayableValue
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact001607"
      unitRef="USD">741316</BTCY:IssuanceOfSharesForSettlementOfAccountsPayableValue>
    <BTCY:LossUponSettlementOfAccountsPayable
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact001609"
      unitRef="USD">249093</BTCY:LossUponSettlementOfAccountsPayable>
    <BTCY:IssuanceOfCommonSharesFromAtTheMarketTransactionShares
      contextRef="From2024-05-142024-05-15_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001611"
      unitRef="Shares">97811</BTCY:IssuanceOfCommonSharesFromAtTheMarketTransactionShares>
    <BTCY:IssuanceOfCommonValueFromAtTheMarketTransaction
      contextRef="From2024-05-142024-05-15"
      decimals="0"
      id="Fact001613"
      unitRef="USD">125227</BTCY:IssuanceOfCommonValueFromAtTheMarketTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact001614"
      unitRef="Shares">716666</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember_custom_ConsultantMember"
      decimals="INF"
      id="Fact001615"
      unitRef="Shares">236666</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="From2024-04-012025-03-31_us-gaap_CommonStockMember_srt_DirectorMember"
      decimals="INF"
      id="Fact001616"
      unitRef="Shares">480000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:SharesIssued
      contextRef="AsOf2026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001618"
      unitRef="Shares">424216</us-gaap:SharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="From2025-04-012026-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001620"
      unitRef="Shares">25</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <BTCY:IssuanceOfCommonSharesFromSharesToBeIssued
      contextRef="From2024-04-012025-03-31_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact001622"
      unitRef="Shares">320321</BTCY:IssuanceOfCommonSharesFromSharesToBeIssued>
    <us-gaap:DebtConversionConvertedInstrumentAmount1
      contextRef="From2024-04-012025-03-31_custom_SeriesCNotesMember"
      decimals="0"
      id="Fact001624"
      unitRef="USD">1487700</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2024-04-012025-03-31_custom_SeriesCNotesMember"
      decimals="INF"
      id="Fact001626"
      unitRef="Shares">2173089</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="From2024-04-012025-03-31"
      decimals="INF"
      id="Fact001628"
      unitRef="Shares">577644</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-12-31_custom_SecondForbearanceAgreementMember"
      decimals="INF"
      id="Fact001630"
      unitRef="Shares">120000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-31_custom_SecondForbearanceAgreementMember"
      decimals="INF"
      id="Fact001632"
      unitRef="USDPShares">0.37</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-12-31_custom_WarrantAgreementMember"
      decimals="INF"
      id="Fact001634"
      unitRef="Shares">27150</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-12-31_custom_WarrantAgreementMember"
      decimals="INF"
      id="Fact001636"
      unitRef="USDPShares">2.21</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="From2025-12-012025-12-31_custom_SecondForbearanceAgreementMember"
      decimals="0"
      id="Fact001637"
      unitRef="USD">38078</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-12-31_custom_SecondForbearanceAgreementMember"
      decimals="INF"
      id="Fact001639"
      unitRef="Shares">120000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2025-12-31_custom_SecondForbearanceAgreementMember_us-gaap_MeasurementInputExpectedTermMember"
      id="Fact001640">P7Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2025-12-31_custom_SecondForbearanceAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact001641"
      unitRef="Pure">3.95</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2025-12-31_custom_SecondForbearanceAgreementMember_us-gaap_MeasurementInputOptionVolatilityMember"
      decimals="INF"
      id="Fact001642"
      unitRef="Pure">103.07</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-12-31_custom_WarrantAgreementMember"
      decimals="INF"
      id="Fact001644"
      unitRef="Shares">27150</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="AsOf2025-12-31_custom_WarrantAgreementMember_us-gaap_MeasurementInputExpectedTermMember"
      id="Fact001645">P4Y7M24D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2025-12-31_custom_WarrantAgreementMember_us-gaap_MeasurementInputRiskFreeInterestRateMember"
      decimals="INF"
      id="Fact001646"
      unitRef="Pure">3.94</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="AsOf2025-12-31_custom_WarrantAgreementMember_us-gaap_MeasurementInputOptionVolatilityMember"
      decimals="INF"
      id="Fact001647"
      unitRef="Pure">103.07</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-03-31_srt_ExecutiveOfficerMember"
      decimals="INF"
      id="Fact001649"
      unitRef="Shares">1200000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2025-03-31_srt_ExecutiveOfficerMember"
      decimals="INF"
      id="Fact001651"
      unitRef="USDPShares">0.43</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-04-012025-03-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember"
      decimals="0"
      id="Fact001653"
      unitRef="USD">422456</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact001655"
      unitRef="Shares">600000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2024-11-30" id="Fact001657">P7Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact001659"
      unitRef="USDPShares">0.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="AsOf2024-11-30"
      decimals="INF"
      id="Fact001661"
      unitRef="Shares">152184</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001663">&lt;p id="xdx_89C_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z0kJvThGfjB1" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Warrant
activity during the years ended March 31, 2026 and 2025 is indicated below:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B7_zvKWr1W1ah95" style="display: none"&gt;SCHEDULE OF WARRANTS OUTSTANDING&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_custom--BrokerWarrantsMember_zdcD8hpqqJ65" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Broker
    Warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_custom--ConsultantWarrantsMember_zipoGj4lxBhg" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Consultant
    and Noteholder Warrants&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4B2_us-gaap--StatementEquityComponentsAxis_custom--WarrantsIssuedOnConversionOfConvertibleNotesMember_zGvZvK7PEnIe" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Warrants
    Issued on Convertible Notes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_4BD_zbcD8i8Pu3De" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20240401__20250331_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_zAOIMLlkdoci" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 36%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As at
    March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;208,927&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;253,994&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;868,098&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,331,019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_zwEinut82qeb" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired/cancelled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1670"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(15,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1672"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(15,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_zuOx0jnltAZe" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;600,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,200,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1677"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,800,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43B_c20250401__20260331_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_zsxATIRrCtYf" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;808,927&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,438,994&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;868,098&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,116,019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20250401__20260331_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_zLExyayE1Fd1" style="font-style: normal; display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;Beginning balance&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;808,927&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,438,994&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;868,098&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,116,019&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations_iN_di_z03Ag5H6omY4" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired/cancelled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1690"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1691"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1692"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1693"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_z8tV8RbCSQYc" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;147,150&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1696"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1697"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;147,150&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20250401__20260331_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_zW72oWUABIRh" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;As at March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;956,077&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,438,994&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;868,098&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,263169&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20250401__20260331_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_zyo4e6PRZeB9" style="font-style: normal; display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;956,077&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,438,994&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;868,098&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,263169&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_904_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--StatementEquityComponentsAxis__custom--BrokerWarrantsMember__srt--RangeAxis__srt--MinimumMember_zsDkmaDUU9j4" title="Exercise price"&gt;0.37&lt;/span&gt;
                                            to $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--StatementEquityComponentsAxis__custom--BrokerWarrantsMember__srt--RangeAxis__srt--MaximumMember_zGOgPkQQ1Dgg" title="Exercise price"&gt;37.56&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;$&lt;span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--StatementEquityComponentsAxis__custom--ConsultantAndNoteholderWarrantsMember__srt--RangeAxis__srt--MinimumMember_zdsKY4IVl1Sh" title="Exercise price"&gt;0.43&lt;/span&gt;
                                            to $&lt;span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--StatementEquityComponentsAxis__custom--ConsultantAndNoteholderWarrantsMember__srt--RangeAxis__srt--MaximumMember_zFgVV5eCMRIh" title="Exercise price"&gt;14.40&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20260331__us-gaap--StatementEquityComponentsAxis__custom--WarrantsIssuedOnConvertibleNotesMember_zByR3a6puuX3" title="Exercise price"&gt;4.18&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expiration
    Date&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_906_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20250401__20260331__us-gaap--StatementEquityComponentsAxis__custom--BrokerWarrantsMember_zZkfbny7FCf4" title="Expiration date"&gt;August
                                            2026 to October 2033&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20250401__20260331__us-gaap--StatementEquityComponentsAxis__custom--ConsultantAndNoteholderWarrantsMember_zigQ8MNP16k7" title="Expiration date"&gt;March
                                            2029 to December 2032&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20250401__20260331__us-gaap--StatementEquityComponentsAxis__custom--WarrantsIssuedOnConvertibleNotesMember_zNnaMtuzm7Gi" title="Expiration date"&gt;October
                                            2027&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;(g)
Stock based compensation&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2024-03-31_custom_BrokerWarrantsMember"
      decimals="INF"
      id="Fact001665"
      unitRef="Shares">208927</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2024-03-31_custom_ConsultantWarrantsMember"
      decimals="INF"
      id="Fact001666"
      unitRef="Shares">253994</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2024-03-31_custom_WarrantsIssuedOnConversionOfConvertibleNotesMember"
      decimals="INF"
      id="Fact001667"
      unitRef="Shares">868098</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2024-03-31"
      decimals="INF"
      id="Fact001668"
      unitRef="Shares">1331019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2024-04-012025-03-31_custom_ConsultantWarrantsMember"
      decimals="INF"
      id="Fact001671"
      unitRef="Shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
      contextRef="From2024-04-012025-03-31"
      decimals="INF"
      id="Fact001673"
      unitRef="Shares">15000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2024-04-012025-03-31_custom_BrokerWarrantsMember"
      decimals="INF"
      id="Fact001675"
      unitRef="Shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2024-04-012025-03-31_custom_ConsultantWarrantsMember"
      decimals="INF"
      id="Fact001676"
      unitRef="Shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2024-04-012025-03-31"
      decimals="INF"
      id="Fact001678"
      unitRef="Shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-03-31_custom_BrokerWarrantsMember"
      decimals="INF"
      id="Fact001680"
      unitRef="Shares">808927</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-03-31_custom_ConsultantWarrantsMember"
      decimals="INF"
      id="Fact001681"
      unitRef="Shares">1438994</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-03-31_custom_WarrantsIssuedOnConversionOfConvertibleNotesMember"
      decimals="INF"
      id="Fact001682"
      unitRef="Shares">868098</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact001683"
      unitRef="Shares">3116019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-03-31_custom_BrokerWarrantsMember"
      decimals="INF"
      id="Fact001685"
      unitRef="Shares">808927</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-03-31_custom_ConsultantWarrantsMember"
      decimals="INF"
      id="Fact001686"
      unitRef="Shares">1438994</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-03-31_custom_WarrantsIssuedOnConversionOfConvertibleNotesMember"
      decimals="INF"
      id="Fact001687"
      unitRef="Shares">868098</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2025-03-31"
      decimals="INF"
      id="Fact001688"
      unitRef="Shares">3116019</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2025-04-012026-03-31_custom_BrokerWarrantsMember"
      decimals="INF"
      id="Fact001695"
      unitRef="Shares">147150</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2025-04-01to2026-03-31"
      decimals="INF"
      id="Fact001698"
      unitRef="Shares">147150</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2026-03-31_custom_BrokerWarrantsMember"
      decimals="INF"
      id="Fact001700"
      unitRef="Shares">956077</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2026-03-31_custom_ConsultantWarrantsMember"
      decimals="INF"
      id="Fact001701"
      unitRef="Shares">1438994</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2026-03-31_custom_WarrantsIssuedOnConversionOfConvertibleNotesMember"
      decimals="INF"
      id="Fact001702"
      unitRef="Shares">868098</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact001703"
      unitRef="Shares">3263169</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2026-03-31_custom_BrokerWarrantsMember"
      decimals="INF"
      id="Fact001705"
      unitRef="Shares">956077</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2026-03-31_custom_ConsultantWarrantsMember"
      decimals="INF"
      id="Fact001706"
      unitRef="Shares">1438994</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2026-03-31_custom_WarrantsIssuedOnConversionOfConvertibleNotesMember"
      decimals="INF"
      id="Fact001707"
      unitRef="Shares">868098</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact001708"
      unitRef="Shares">3263169</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2026-03-31_custom_BrokerWarrantsMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001710"
      unitRef="USDPShares">0.37</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2026-03-31_custom_BrokerWarrantsMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001712"
      unitRef="USDPShares">37.56</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2026-03-31_custom_ConsultantAndNoteholderWarrantsMember_srt_MinimumMember"
      decimals="INF"
      id="Fact001714"
      unitRef="USDPShares">0.43</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2026-03-31_custom_ConsultantAndNoteholderWarrantsMember_srt_MaximumMember"
      decimals="INF"
      id="Fact001716"
      unitRef="USDPShares">14.40</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="AsOf2026-03-31_custom_WarrantsIssuedOnConvertibleNotesMember"
      decimals="INF"
      id="Fact001718"
      unitRef="USDPShares">4.18</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees
      contextRef="From2025-04-012026-03-31_custom_BrokerWarrantsMember"
      id="Fact001720">August
                                            2026 to October 2033</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees
      contextRef="From2025-04-012026-03-31_custom_ConsultantAndNoteholderWarrantsMember"
      id="Fact001722">March
                                            2029 to December 2032</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees
      contextRef="From2025-04-012026-03-31_custom_WarrantsIssuedOnConvertibleNotesMember"
      id="Fact001724">October
                                            2027</us-gaap:ClassOfWarrantOrRightReasonForIssuingToNonemployees>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="AsOf2016-02-02_custom_TwoThousandAndSixteenEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001726"
      unitRef="Shares">1241422</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2025-04-012026-03-31_custom_TwoThousandAndSixteenEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001728"
      unitRef="Shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-04-012025-03-31_custom_TwoThousandAndSixteenEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001730"
      unitRef="Shares">2836176</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_custom_TwoThousandAndSixteenEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001732"
      unitRef="USDPShares">0.5</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2025-04-012026-03-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember_custom_TwoThousandAndSixteenEquityIncentivePlanMember"
      decimals="0"
      id="Fact001734"
      unitRef="USD">25632</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="From2024-04-012025-03-31_us-gaap_SellingGeneralAndAdministrativeExpensesMember_custom_TwoThousandAndSixteenEquityIncentivePlanMember"
      decimals="0"
      id="Fact001736"
      unitRef="USD">1461698</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2026-03-31_us-gaap_StockOptionMember_custom_TwoThousandAndSixteenEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001738"
      unitRef="Shares">3048663</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2026-03-31_us-gaap_StockOptionMember_custom_TwoThousandAndSixteenEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001740"
      unitRef="USDPShares">1.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001742">&lt;p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zNlCnvfbTYae" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the stock option activities during the fiscal year ended March 31, 2026:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B5_zfN8fdZUZCxf" style="display: none"&gt;SCHEDULE OF STOCK OPTION ACTIVITIES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
                                            Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Term
                                            (years)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value&lt;sup&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 36%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zzddj5XrLfT1" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal" title="Number of options, beginning outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,067,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAIjmKSMZsF9" style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal" title="Weighted average exercise price, beginning outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.14&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z3Tk91tRkqwh" title="Weighted average remaining contractual term (years)"&gt;1.77&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEp_zwDlSUtvUMdl" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal" title="Aggregate intrinsic value, beginning outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,078,756&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustment
    for rounding effect of Reverse Split&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdjustmentForRoundingEffectOfReverseSplit_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zFy9mbPIMoBc" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Adjustment for rounding effect of Reverse Split"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1752"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAdjustmentForRoundingEffectOfReverseSplitInPeriodWeightedAverageExercisePrice_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zQ5H1RkaTsvf" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Adjustment for rounding effect of Reverse Split"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1754"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zVjEaTKUySU6" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1756"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zThdwn3jX1n6" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1758"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z6jf8MzfUoq9" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1760"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9om2UBLTajh" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1762"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zyl1nuuaj4cj" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(14,192&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zJ2pT6WG4Rm5" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1766"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zHpwBOXW8ixj" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(4,975&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zDELwJz3Dfci" style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1770"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    at March 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zI0vuBz3vQfj" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, ending outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,048,663&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zwxdDXfR33p9" style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, ending outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.13&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zS8nReOX4PSe" title="Weighted average remaining contractual term (years)"&gt;6.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEp_zKffgI1ga2d2" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Aggregate intrinsic value, ending outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested
    and expected to vest at March 31, 2026*&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zDetTzh0IdUf" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Vested and expected to vest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,048,663&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____ztQNBKZZ7ba9" style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Vested and expected to vest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.13&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zuYqmHWDQ6Vi" title="Weighted average remaining contractual term, Vested and expected to vest"&gt;6.01&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEpKg_____zD5lqmaLzwYd" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Aggregate intrinsic value, Vested and expected to vest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested
    and exercisable at March 31, 2026*&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zhtw4ZyZlxSd" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Vested and exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,749,295&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zWgkyofJaWQg" style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Vested and exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.14&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zU3k3wamSa3a" title="Weighted average remaining contractual term, Vested and exercisable"&gt;5.75&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20250401__20260331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEpKg_____z6CHObfNu54k" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Aggregate intrinsic value, Vested and exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F0C_z6BywhWyfaP6"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F12_zrtsjMsdDgz" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value
    of our common stock as of March 31, 2026 and fair value of common stock adjusted.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td id="xdx_F0F_zkREnKxyTlAd" style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F1D_z7q10pNCFHYd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
    includes &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBBQ1RJVklUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20250401__20260331__us-gaap--AwardTypeAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember_ztJVfYUhkkW" title="Options granted to employees"&gt;1,200,000&lt;/span&gt; options granted to employees from the 2023 Equity Incentive Plan, discussed below.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table summarizes the stock option activities during the fiscal year ended March 31, 2025:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Number
                                            of&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Options&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Exercise&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Price&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Weighted
                                            Average&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Remaining&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Contractual&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Term
                                            (years)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Aggregate&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Value&lt;sup&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 36%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjGJMqzus83l" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal" title="Number of options, beginning outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,239,873&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_ztbgpIUTF5wl" style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 12%; text-align: right; font-weight: normal" title="Weighted average exercise price, beginning outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.39&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; width: 12%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20230401__20240331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z7Otgh2jO8yi" title="Weighted average remaining contractual term (years)"&gt;5.35&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEp_zeBDLaPPzzYh" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right; font-weight: normal" title="Aggregate intrinsic value, beginning outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9,705,937&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Adjustment
    for rounding effect of Reverse Split&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdjustmentForRoundingEffectOfReverseSplit_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z3MIl9eK6kp9" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Adjustment for rounding effect of Reverse Split"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1808"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAdjustmentForRoundingEffectOfReverseSplitInPeriodWeightedAverageExercisePrice_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZi4X3tEIC0f" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Adjustment for rounding effect of Reverse Split"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1810"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zAY64GV5GULh" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,836,176&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zu9RSEe5JLDa" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Granted"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted2_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zjSiRRoALXIe" title="Weighted average remaining contractual term granted"&gt;0.02&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Cancelled&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zlXhKwINLnMd" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(931,000&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zim0SZj7lBp3" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Cancelled"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;9.32&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermCancelled_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zcUhWsuT9zAf" title="Weighted average remaining contractual term Cancelled"&gt;4.24&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_pid_di_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zZSyOCdxEeHj" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(57,582&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zEx5dX2a1X1" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Weighted average exercise price, Expired"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.56&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired2_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zgpU1TCvgfqb" title="Weighted average remaining contractual term, Expired"&gt;0.17&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_pid_di_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zANvfliwGEwb" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(19,637&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z5uJCvQX67Ca" style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right; font-weight: normal" title="Weighted average exercise price, Forfeited"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.37&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited2_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zkVdheeMUGr1" title="Weighted average remaining contractual term, Forfeited"&gt;2.34&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Outstanding
    at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zf7v9xy9yV2e" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, ending outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,067,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_zYZH6Wf9MI42" style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right; font-weight: normal" title="Weighted average exercise price, ending outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.14&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_z9q1l1XzsvPb" title="Weighted average remaining contractual term (years)"&gt;1.77&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEp_zW7iFkZtdGKg" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Aggregate intrinsic value, ending outstanding"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,078,756&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested
    and expected to vest at March 31, 2025*&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iE_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zQ7jSuTsMACd" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Vested and expected to vest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,067,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iE_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zoyZdUnVdfLa" style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right; font-weight: normal" title="Weighted average exercise price, Vested and expected to vest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.14&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____z6QY0bWBzXnb" title="Weighted average remaining contractual term, Vested and expected to vest"&gt;1.77&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iE_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEpKg_____zt4hntK0YMAa" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Aggregate intrinsic value, Vested and expected to vest"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,078,756&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Vested
    and exercisable at March 31, 2025*&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____z8JgIwyFAwLi" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Number of options, Vested and exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,611,411&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zZrqdNvDmtib" style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right; font-weight: normal" title="Weighted average exercise price, Vested and exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1.17&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKg_____zu0uW1tKYjtc" title="Weighted average remaining contractual term, Vested and exercisable"&gt;0.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_iE_c20240401__20250331__us-gaap--AwardTypeAxis__us-gaap--StockOptionMember_fKDEpKg_____zpbqEdxGGqW8" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Aggregate intrinsic value, Vested and exercisable"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;805,181&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;sup id="xdx_F02_zkreqy65znHh"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F14_zM1c8tp5zqqe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value
    of our common stock as of March 31, 2025 and fair value of common stock adjusted.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif"&gt;&lt;span id="xdx_F00_zBMTBKcBs96d" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span id="xdx_F13_zJCGXbg2wqxk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;This
    includes &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBBQ1RJVklUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA" id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20240401__20250331__us-gaap--AwardTypeAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember_zkZTkJcIwgCi" title="Options granted to employees"&gt;1,200,000&lt;/span&gt; options granted to employees from the 2023 Equity Incentive Plan, discussed below.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001744"
      unitRef="Shares">3067830</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001746"
      unitRef="USDPShares">1.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      id="Fact001748">P1Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001750"
      unitRef="USD">1078756</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2025-04-012026-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001764"
      unitRef="Shares">14192</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2025-04-012026-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001768"
      unitRef="Shares">4975</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2026-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001772"
      unitRef="Shares">3048663</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2026-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001774"
      unitRef="USDPShares">1.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2025-04-012026-03-31_us-gaap_StockOptionMember"
      id="Fact001776">P6Y3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2026-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001778"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2026-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001780"
      unitRef="Shares">3048663</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2026-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001782"
      unitRef="USDPShares">1.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="From2025-04-012026-03-31_us-gaap_StockOptionMember"
      id="Fact001784">P6Y3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2026-03-31_us-gaap_StockOptionMember"
      decimals="0"
      id="Fact001786"
      unitRef="USD">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2026-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001788"
      unitRef="Shares">2749295</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2026-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001790"
      unitRef="USDPShares">1.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2025-04-012026-03-31_us-gaap_StockOptionMember"
      id="Fact001792">P5Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2026-03-31_us-gaap_StockOptionMember"
      decimals="0"
      id="Fact001794"
      unitRef="USD">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2025-04-012026-03-31_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001798"
      unitRef="Shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2024-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001800"
      unitRef="Shares">1239873</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2024-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001802"
      unitRef="USDPShares">9.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2023-04-012024-03-31_us-gaap_StockOptionMember"
      id="Fact001804">P5Y4M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2024-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001806"
      unitRef="USD">9705937</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001812"
      unitRef="Shares">2836176</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001814"
      unitRef="USDPShares">0.5</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <BTCY:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted2
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      id="Fact001816">P0Y7D</BTCY:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermGranted2>
    <BTCY:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001818"
      unitRef="Shares">-931000</BTCY:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod>
    <BTCY:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001820"
      unitRef="USDPShares">9.32</BTCY:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice>
    <BTCY:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermCancelled
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      id="Fact001822">P4Y2M26D</BTCY:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermCancelled>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001824"
      unitRef="Shares">57582</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001826"
      unitRef="USDPShares">0.56</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <BTCY:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired2
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      id="Fact001828">P0Y2M1D</BTCY:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermExpired2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001830"
      unitRef="Shares">19637</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001832"
      unitRef="USDPShares">0.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <BTCY:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited2
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      id="Fact001834">P2Y4M2D</BTCY:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="AsOf2025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001836"
      unitRef="Shares">3067830</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001838"
      unitRef="USDPShares">1.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      id="Fact001840">P1Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="AsOf2025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001842"
      unitRef="USD">1078756</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="AsOf2025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001844"
      unitRef="Shares">3067830</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001846"
      unitRef="USDPShares">1.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      id="Fact001848">P1Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="AsOf2025-03-31_us-gaap_StockOptionMember"
      decimals="0"
      id="Fact001850"
      unitRef="USD">1078756</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="AsOf2025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001852"
      unitRef="Shares">2611411</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_us-gaap_StockOptionMember"
      decimals="INF"
      id="Fact001854"
      unitRef="USDPShares">1.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="From2024-04-012025-03-31_us-gaap_StockOptionMember"
      id="Fact001856">P0Y5M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="AsOf2025-03-31_us-gaap_StockOptionMember"
      decimals="0"
      id="Fact001858"
      unitRef="USD">805181</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="From2024-04-012025-03-31_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001862"
      unitRef="Shares">1200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001864">&lt;p id="xdx_899_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zhyUvzOEgKXb" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of each option granted is estimated at the time of grant using multi-nominal lattice model using the following assumptions,
for each of the respective years ended March 31&lt;b&gt;:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BB_zalpczyJFqyb" style="display: none"&gt;SCHEDULE OF FAIR VALUE OF OPTION GRANTED USING VALUATION ASSUMPTIONS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: justify; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Exercise
    price ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20250331__srt--RangeAxis__srt--MinimumMember_zPKvM8DvDAH5" title="Exercise price"&gt;0.43&lt;/span&gt;-&lt;span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_iI_pid_c20250331__srt--RangeAxis__srt--MaximumMember_zaJVIBXzfJUd" title="Exercise price"&gt;0.43&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: justify; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Risk
    free interest rate (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240401__20250331__srt--RangeAxis__srt--MinimumMember_zAGMUgD1t6Xd" title="Risk free interest rate"&gt;4.24&lt;/span&gt;-&lt;span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPure_c20240401__20250331__srt--RangeAxis__srt--MaximumMember_zBIUnSiBaWcc" title="Risk free interest rate"&gt;4.33&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: justify; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
    term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240401__20250331__srt--RangeAxis__srt--MinimumMember_zatYHNMxIsz1" title="Expected term"&gt;1.46&lt;/span&gt;-&lt;span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240401__20250331__srt--RangeAxis__srt--MaximumMember_zXmIqTJKCQ33" title="Expected term"&gt;5.00&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: justify; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
    volatility (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240401__20250331__srt--RangeAxis__srt--MinimumMember_zaMMQ3a1Lfvc" title="Expected volatility"&gt;113.97&lt;/span&gt;-&lt;span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20240401__20250331__srt--RangeAxis__srt--MaximumMember_zWXGHnY3KDz8" title="Expected volatility"&gt;142.22&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: justify; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
    dividend yield (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_pid_dp_uPure_c20240401__20250331_zQrqNu6gboMh" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal" title="Expected dividend yield"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: justify; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Fair
    value of option ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;-&lt;span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20250331__srt--RangeAxis__srt--MinimumMember_zvW1gWPaUtC" title="Fair value of option"&gt;1.097&lt;/span&gt;-&lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20250331__srt--RangeAxis__srt--MaximumMember_znyA1v23J1nk" title="Fair value of option"&gt;1.360&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: justify; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Expected
    forfeiture (attrition) rate (%)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;NA&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ExpectedForfeitureAttritionRates_pid_dp_uPure_c20240401__20250331_zSGT8GrZ65ik" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Expected forfeiture (attrition) rate"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;0.00&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2025-03-31_srt_MinimumMember"
      decimals="INF"
      id="Fact001866"
      unitRef="USDPShares">0.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
      contextRef="AsOf2025-03-31_srt_MaximumMember"
      decimals="INF"
      id="Fact001868"
      unitRef="USDPShares">0.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-04-012025-03-31_srt_MinimumMember"
      decimals="INF"
      id="Fact001870"
      unitRef="Pure">0.0424</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="From2024-04-012025-03-31_srt_MaximumMember"
      decimals="INF"
      id="Fact001872"
      unitRef="Pure">0.0433</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-04-012025-03-31_srt_MinimumMember"
      id="Fact001874">P1Y5M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="From2024-04-012025-03-31_srt_MaximumMember"
      id="Fact001876">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-04-012025-03-31_srt_MinimumMember"
      decimals="INF"
      id="Fact001878"
      unitRef="Pure">1.1397</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="From2024-04-012025-03-31_srt_MaximumMember"
      decimals="INF"
      id="Fact001880"
      unitRef="Pure">1.4222</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="From2024-04-012025-03-31"
      decimals="INF"
      id="Fact001882"
      unitRef="Pure">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_srt_MinimumMember"
      decimals="INF"
      id="Fact001884"
      unitRef="USDPShares">1.097</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="AsOf2025-03-31_srt_MaximumMember"
      decimals="INF"
      id="Fact001886"
      unitRef="USDPShares">1.360</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <BTCY:ExpectedForfeitureAttritionRates
      contextRef="From2024-04-012025-03-31"
      decimals="INF"
      id="Fact001888"
      unitRef="Pure">0.0000</BTCY:ExpectedForfeitureAttritionRates>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="AsOf2023-03-31_custom_TwoThousandAndTwentyThreeEquityIncentivePlanMember"
      decimals="INF"
      id="Fact001890"
      unitRef="Shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001892">&lt;p id="xdx_807_eus-gaap--IncomeTaxDisclosureTextBlock_ziOd3KusHRv1" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;10.
&lt;span id="xdx_82D_zHQdTvkZiXnd"&gt;INCOME TAXES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;i&gt;&lt;span style="text-decoration: underline"&gt;Income
taxes&lt;/span&gt;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
provision for income taxes differs from that computed at combined corporate tax rate of approximately 26% as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;i&gt;Income before income taxes&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #156082"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_89D_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z1YxLHDNp7" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;The components of loss before
income taxes by tax jurisdiction were as follows:&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B8_zRmi4r7YqQ74" style="display: none"&gt;SCHEDULE
OF COMPONENTS OF LOSS BEFORE
INCOME TAXES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250401__20260331_z9Z0yA6HkfCj" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March
                                            31, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240401__20250331_z0G3qexEBwsh" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March
                                            31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Jurisdiction&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hus-gaap--IncomeTaxAuthorityAxis__country--US_zUJ7SQXs7iq3" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,798,285&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,498,139&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hus-gaap--IncomeTaxAuthorityAxis__country--CA_zPxWJLJUgL4g" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;p style="margin: 0"&gt;Canada&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;(765,832&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;)&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;(923,040&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ztxNdxjowq3d" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;
    Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;p style="margin: 0"&gt;&lt;b&gt;(2,404,139&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;p style="margin: 0"&gt;&lt;b&gt;(8,421,179&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A8_z7PGxKGpert5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;Income tax expense (benefit)&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #156082"&gt;&lt;b&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p id="xdx_899_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zLZSK8cFFN42" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The provision (benefit) for income taxes differs
from the amount computed by applying the Company&#x2019;s combined federal and state statutory income tax rate of approximately 26% to loss before
income taxes as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BC_zkbi6kLxHfQe" style="display: none"&gt;SCHEDULE OF PROVISION (BENEFIT) FOR INCOME
TAXES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20250401__20260331_zqbh8woWYpMh" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;2026
    Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;2026
    &lt;span style="font-family: Times New Roman, Times, Serif"&gt;Rate&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20240401__20250331_zyqfsSAxYdae" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2025
    Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2025
    Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzaLw_zVHcCWPvYeI4" style="font-size: 10pt; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--TaxJurisdictionOfDomicileExtensibleEnumeration_dxL_c20250401__20260331_zlzPJWAL4sSk" title="::XDX::http%3A%2F%2Ffasb.org%2Fus-gaap%2F2026%23DomesticCountryMember"&gt;&lt;span id="xdx_900_eus-gaap--TaxJurisdictionOfDomicileExtensibleEnumeration_dxL_c20240401__20250331_zVSFIk34WUkl" title="::XDX::http%3A%2F%2Ffasb.org%2Fus-gaap%2F2026%23DomesticCountryMember"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1909"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1910"&gt;Tax at Statutory rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(625,076&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_dpi_uPure_ma123_c20250401__20260331_zB8t42BiN511" title="Tax at Statutory rate, percentage"&gt;(26.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(2,189,707&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_dpi_uPure_ma123_c20240401__20250331_zvEPc6vjnct9" title="Tax at Statutory rate, percentage"&gt;(26.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_maITEBzaLw_zSHL34EutkQa" style="font-size: 10pt; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;259,068&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_iN_dpi_uPure_ma123_c20250401__20260331_zQriP7NiV11d" title="Non-deductible expenses, percentage"&gt;10.8&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,322,198&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_iN_dpi_uPure_ma123_c20240401__20250331_zIHJqL7rGTxe" title="Non-deductible expenses, percentage"&gt;15.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzaLw_z7DGiXDJYB0g" style="font-size: 10pt; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Other temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(12,025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_iN_dpi_uPure_ma123_c20250401__20260331_zn4PKogrdks6" title="Other temporary differences, percentage"&gt;(0.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(988&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;_&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzaLw_zR3ac7rPNpMg" style="font-size: 10pt; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;378,033&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_dpi_uPure_ma123_c20250401__20260331_zNwN7Xjwunf1" title="Change in valuation allowance, percentage"&gt;15.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;868,497&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="display: none"&gt;&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzaLw_zzKHeMkTJjla" style="font-size: 10pt; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1933"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_dp_uPure_mt123_c20250401__20260331_ziHc3xFwWfTg" title="Income tax expense (benefit), percentage"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1934"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_dp_uPure_mt123_c20240401__20250331_z0l5ZkyMO05g" title="Income tax expense (benefit), percentage"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;
&lt;p id="xdx_8AC_zoTE1hUkPgQc" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zhSTjpLN6sye" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Deferred
tax assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B3_zpyDS82mUcZ9" style="display: none"&gt;SCHEDULE OF DEFERRED TAX ASSETS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20260331_zDXtI6J8gOxh" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;p style="font-style: normal; font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;As
                                            at&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="font-style: normal; font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;March
                                            31, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20250331_zuW280OXSQhj" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;p style="font-style: normal; font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;As
                                            at&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="font-style: normal; font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;March
                                            31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pp0p0_maDTANzytD_zBEVT3FNmxo5" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-capital
    loss carry forwards&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,550,273&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19,078,653&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTANzytD_zEj5Jd02a0Bb" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
    temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,646&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,803&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzytD_zvgH2VYhV3K2" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation
    allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(19,564,919&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(19,082,456&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzytD_z7vbbFVbfbYd" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1951"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1952"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AD_zdnlvAjGaxng" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026 and 2025, the Company decided that a valuation allowance relating to the above deferred tax assets of the Company was
necessary, largely based on the negative evidence represented by losses incurred and a determination that it is not more likely than
not to realize these assets, such that, a corresponding valuation allowance, for each respective period, was recorded to offset deferred
tax assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026 and 2025, the Company has approximately $&lt;span id="xdx_90A_eus-gaap--OperatingLossCarryforwards_iI_c20260331_z9lHvVmOmetd" title="Operating loss carry forwards"&gt;75,193,358&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--OperatingLossCarryforwards_iI_c20250331_znF2UMED9F4d" title="Operating loss carry forwards"&gt;73,379,434&lt;/span&gt;, respectively, of non-capital losses available to offset
future taxable income. &lt;span id="xdx_90D_ecustom--OperatingLossCarryforwardsExpirationDateDescription_c20250401__20260331_zqsiNPVJ8KRj" title="Operating loss carry forwards expiration date description"&gt;These losses will expire between 2035 to 2039.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of March 31, 2026, and 2025 the Company was not subject to any uncertain tax positions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001894">&lt;p id="xdx_89D_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_z1YxLHDNp7" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;The components of loss before
income taxes by tax jurisdiction were as follows:&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B8_zRmi4r7YqQ74" style="display: none"&gt;SCHEDULE
OF COMPONENTS OF LOSS BEFORE
INCOME TAXES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250401__20260331_z9Z0yA6HkfCj" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March
                                            31, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20240401__20250331_z0G3qexEBwsh" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;March
                                            31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Jurisdiction&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hus-gaap--IncomeTaxAuthorityAxis__country--US_zUJ7SQXs7iq3" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1,798,285&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(7,498,139&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_hus-gaap--IncomeTaxAuthorityAxis__country--CA_zPxWJLJUgL4g" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;p style="margin: 0"&gt;Canada&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;(765,832&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;)&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;(923,040&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ztxNdxjowq3d" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif"&gt;
    Loss before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;p style="margin: 0"&gt;&lt;b&gt;(2,404,139&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;p style="margin: 0"&gt;&lt;b&gt;(8,421,179&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;b&gt;)&lt;/b&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2025-04-012026-03-31_country_US"
      decimals="0"
      id="Fact001896"
      unitRef="USD">-1798285</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-04-012025-03-31_country_US"
      decimals="0"
      id="Fact001897"
      unitRef="USD">-7498139</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2025-04-012026-03-31_country_CA"
      decimals="0"
      id="Fact001899"
      unitRef="USD">-765832</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-04-012025-03-31_country_CA"
      decimals="0"
      id="Fact001900"
      unitRef="USD">-923040</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001902"
      unitRef="USD">-2404139</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact001903"
      unitRef="USD">-8421179</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001905">&lt;p id="xdx_899_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zLZSK8cFFN42" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The provision (benefit) for income taxes differs
from the amount computed by applying the Company&#x2019;s combined federal and state statutory income tax rate of approximately 26% to loss before
income taxes as follows:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span id="xdx_8BC_zkbi6kLxHfQe" style="display: none"&gt;SCHEDULE OF PROVISION (BENEFIT) FOR INCOME
TAXES&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_494_20250401__20260331_zqbh8woWYpMh" style="border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;2026
    Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;2026
    &lt;span style="font-family: Times New Roman, Times, Serif"&gt;Rate&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20240401__20250331_zyqfsSAxYdae" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2025
    Amount&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;2025
    Rate&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; padding-bottom: 1pt; font-size: 10pt; font-weight: bold"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_maITEBzaLw_zVHcCWPvYeI4" style="font-size: 10pt; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 36%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--TaxJurisdictionOfDomicileExtensibleEnumeration_dxL_c20250401__20260331_zlzPJWAL4sSk" title="::XDX::http%3A%2F%2Ffasb.org%2Fus-gaap%2F2026%23DomesticCountryMember"&gt;&lt;span id="xdx_900_eus-gaap--TaxJurisdictionOfDomicileExtensibleEnumeration_dxL_c20240401__20250331_zVSFIk34WUkl" title="::XDX::http%3A%2F%2Ffasb.org%2Fus-gaap%2F2026%23DomesticCountryMember"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1909"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1910"&gt;Tax at Statutory rate&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(625,076&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_dpi_uPure_ma123_c20250401__20260331_zB8t42BiN511" title="Tax at Statutory rate, percentage"&gt;(26.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(2,189,707&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_iN_dpi_uPure_ma123_c20240401__20250331_zvEPc6vjnct9" title="Tax at Statutory rate, percentage"&gt;(26.0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--IncomeTaxReconciliationNondeductibleExpense_maITEBzaLw_zSHL34EutkQa" style="font-size: 10pt; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;259,068&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90C_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_iN_dpi_uPure_ma123_c20250401__20260331_zQriP7NiV11d" title="Non-deductible expenses, percentage"&gt;10.8&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;1,322,198&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpense_iN_dpi_uPure_ma123_c20240401__20250331_zIHJqL7rGTxe" title="Non-deductible expenses, percentage"&gt;15.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eus-gaap--IncomeTaxReconciliationOtherAdjustments_maITEBzaLw_z7DGiXDJYB0g" style="font-size: 10pt; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Other temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(12,025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_iN_dpi_uPure_ma123_c20250401__20260331_zn4PKogrdks6" title="Other temporary differences, percentage"&gt;(0.5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;(988&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;_&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_maITEBzaLw_zR3ac7rPNpMg" style="font-size: 10pt; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;378,033&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90B_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_dpi_uPure_ma123_c20250401__20260331_zNwN7Xjwunf1" title="Change in valuation allowance, percentage"&gt;15.7&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;868,497&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="display: none"&gt;&lt;/span&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--IncomeTaxExpenseBenefit_iT_mtITEBzaLw_zzKHeMkTJjla" style="font-size: 10pt; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="padding-left: 10pt; font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;Income tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1933"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_90F_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_dp_uPure_mt123_c20250401__20260331_ziHc3xFwWfTg" title="Income tax expense (benefit), percentage"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1934"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: right"&gt;&lt;span style="font-size: 10pt"&gt;&lt;span id="xdx_907_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iT_dp_uPure_mt123_c20240401__20250331_z0l5ZkyMO05g" title="Income tax expense (benefit), percentage"&gt;0&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-size: 10pt; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;b&gt;&lt;/b&gt;&lt;/p&gt;
</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001907"
      unitRef="USD">-625076</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2025-04-01to2026-03-31"
      decimals="INF"
      id="Fact001912"
      unitRef="Pure">0.260</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact001908"
      unitRef="USD">-2189707</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="From2024-04-012025-03-31"
      decimals="INF"
      id="Fact001914"
      unitRef="Pure">0.260</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001916"
      unitRef="USD">259068</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2025-04-01to2026-03-31"
      decimals="INF"
      id="Fact001919"
      unitRef="Pure">-0.108</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact001917"
      unitRef="USD">1322198</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="From2024-04-012025-03-31"
      decimals="INF"
      id="Fact001921"
      unitRef="Pure">-0.157</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001923"
      unitRef="USD">-12025</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="From2025-04-01to2026-03-31"
      decimals="INF"
      id="Fact001926"
      unitRef="Pure">0.005</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact001924"
      unitRef="USD">-988</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001928"
      unitRef="USD">378033</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2025-04-01to2026-03-31"
      decimals="INF"
      id="Fact001931"
      unitRef="Pure">-0.157</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact001929"
      unitRef="USD">868497</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2025-04-01to2026-03-31"
      decimals="INF"
      id="Fact001936"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="From2024-04-012025-03-31"
      decimals="INF"
      id="Fact001938"
      unitRef="Pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001940">&lt;p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zhSTjpLN6sye" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Deferred
tax assets&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B3_zpyDS82mUcZ9" style="display: none"&gt;SCHEDULE OF DEFERRED TAX ASSETS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20260331_zDXtI6J8gOxh" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;p style="font-style: normal; font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;As
                                            at&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="font-style: normal; font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;March
                                            31, 2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20250331_zuW280OXSQhj" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;p style="font-style: normal; font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;As
                                            at&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="font-style: normal; font-family: Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;March
                                            31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--DeferredTaxAssetsOtherLossCarryforwards_iI_pp0p0_maDTANzytD_zBEVT3FNmxo5" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Non-capital
    loss carry forwards&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;19,550,273&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;19,078,653&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTANzytD_zEj5Jd02a0Bb" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Other
    temporary differences&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;14,646&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,803&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTANzytD_zvgH2VYhV3K2" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Valuation
    allowance&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(19,564,919&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(19,082,456&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzytD_z7vbbFVbfbYd" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Deferred
    tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1951"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1952"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOtherLossCarryforwards
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001942"
      unitRef="USD">19550273</us-gaap:DeferredTaxAssetsOtherLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOtherLossCarryforwards
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001943"
      unitRef="USD">19078653</us-gaap:DeferredTaxAssetsOtherLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001945"
      unitRef="USD">14646</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001946"
      unitRef="USD">3803</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001948"
      unitRef="USD">19564919</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001949"
      unitRef="USD">19082456</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001954"
      unitRef="USD">75193358</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001956"
      unitRef="USD">73379434</us-gaap:OperatingLossCarryforwards>
    <BTCY:OperatingLossCarryforwardsExpirationDateDescription contextRef="From2025-04-01to2026-03-31" id="Fact001958">These losses will expire between 2035 to 2039.</BTCY:OperatingLossCarryforwardsExpirationDateDescription>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001960">&lt;p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zjm2S0MYgu6f" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;11.
&lt;span id="xdx_828_zuQI2O8FMotl"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;There
are no claims against the Company that were assessed as significant, which were outstanding as at March 31, 2026 and, consequently, no
provision for such has been recognized in the consolidated financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001962">&lt;p id="xdx_807_eus-gaap--LesseeOperatingLeasesTextBlock_zJMl8UOwisS4" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;12.
&lt;span id="xdx_82F_zubPExF2yUD7"&gt;OPERATING LEASE RIGHT-OF-USE ASSETS AND LEASE OBLIGATIONS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has one operating lease primarily for office and administration.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
December 2021, the Company entered into a new lease agreement. The Company paid $&lt;span id="xdx_906_eus-gaap--LeaseDepositLiability_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--NewLeaseAgreementMember_zeXAn0V0JPT1" title="Lease deposit liability"&gt;85,000&lt;/span&gt; deposit that would be returned at the end of
the lease. In December 2022, the Company started a new lease with an additional suite in the same premise as the existing lease.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
measuring the lease obligations, the Company discounted lease payments using its incremental borrowing rate. The weighted-average-rate
applied is &lt;span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20260331_zL9muqgUXCkj" title="Weighted average rate"&gt;11.4&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--LeaseCostTableTextBlock_zidUPTys2nSf" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B5_zf5tA32ENyBf" style="display: none"&gt;SCHEDULE OF OPERATING LEASES OBLIGATIONS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Right
    of Use Asset&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Beginning
    balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingLeaseRightOfUseAsset_iS_c20250401__20260331_zw4mGKYB7T7" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal" title="Right of Use Asset, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;812,053&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLeaseRightOfUseAsset_iS_c20240401__20250331_zFWD5R8vuc9j" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal" title="Right of Use Asset, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,221,593&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;New
    leases&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--OperatingLeaseRightOfUseAssetNewLeases_c20250401__20260331_ztHrZEMlItbb" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Right of Use Asset, New leases"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1974"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--OperatingLeaseRightOfUseAssetNewLeases_c20240401__20250331_zvP9sA5pZeVi" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Right of Use Asset, New leases"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1976"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_di_c20250401__20260331_z8ibdG4zHrvc" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Right of Use Asset, Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(465,839&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_di_c20240401__20250331_zJzUtvSXBsre" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Right of Use Asset, Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(409,540&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ending
    balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLeaseRightOfUseAsset_iE_c20250401__20260331_zRen1Uw0SY5g" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Right of Use Asset, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;346,214&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseRightOfUseAsset_iE_c20240401__20250331_zgKwmjVjIve8" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Right of Use Asset, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;812,053&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Lease
    Liability&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Beginning
    balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingLeaseLiability_iS_c20250401__20260331_zVl9rfwVwyp6" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal" title="Lease Liability, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;929,116&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingLeaseLiability_iS_c20240401__20250331_ztOeRcyTvX1g" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal" title="Lease Liability, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,386,486&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;New
    leases&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--OperatingLeaseNewLeases_c20250401__20260331_zsNJTeEEDKX1" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Lease liability, New leases"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1990"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--OperatingLeaseNewLeases_c20240401__20250331_zXaGhoCNsbaj" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Lease liability, New leases"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1992"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment
    and interest accretion&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OperatingLeaseRepaymentAndInterestAccretion_iN_di_c20250401__20260331_zdCCG0YrDTbg" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Lease Liability, Repayment and interest accretion"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(531,286&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--OperatingLeaseRepaymentAndInterestAccretion_iN_di_c20240401__20250331_zh9IkJ75Bnt5" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Lease Liability, Repayment and interest accretion"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(457,370&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ending
    balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OperatingLeaseLiability_iE_c20250401__20260331_zaf2JkgqCa8b" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Lease Liability, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;397,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingLeaseLiability_iE_c20240401__20250331_zRCIVn23cWq7" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Lease Liability, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;929,116&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current
    portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OperatingLeaseLiabilityCurrent_iI_c20260331_zSWEQP7FY4Nj" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Current portion of operating lease liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;397,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseLiabilityCurrent_iI_c20250331_zehzpUZQZ5Og" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Current portion of operating lease liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;531,286&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Noncurrent
    portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_c20260331_zPycW3ayD73" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Noncurrent portion of operating lease liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2006"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_c20250331_zJpnAS1gkPk9" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Noncurrent portion of operating lease liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;397,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A7_zqvE5mRtG099" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
operating lease expense was $&lt;span id="xdx_90B_eus-gaap--OperatingLeaseExpense_c20250401__20260331__us-gaap--StatementOfIncomeLocationBalanceAxis__us-gaap--SellingGeneralAndAdministrativeExpenses_zYCLFUTHqSMd" title="Operating lease expense"&gt;627,728&lt;/span&gt; for the year ended March 31, 2026 (2025: $&lt;span id="xdx_906_eus-gaap--OperatingLeaseExpense_c20240401__20250331__us-gaap--StatementOfIncomeLocationBalanceAxis__us-gaap--SellingGeneralAndAdministrativeExpenses_z0Kc2tS2DD2j" title="Operating lease expense"&gt;587,045&lt;/span&gt;) and included in the selling, general and administrative
expenses. Operating cash flows from operating leases amounted to $&lt;span id="xdx_907_eus-gaap--ProceedsFromLeasePayments_c20250401__20260331_zTcsptU6nj79" title="Operating cash flows from operating leases"&gt;604,779&lt;/span&gt; and $&lt;span id="xdx_903_eus-gaap--ProceedsFromLeasePayments_c20240401__20250331_z7VUdWudMr6c" title="Operating cash flows from operating leases"&gt;587,164&lt;/span&gt; during the years ended March 31, 2026 and March
31, 2025, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;BIOTRICITY
INC.&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Notes
to Consolidated Financial Statements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Years
ended March 31, 2026 and 2025&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;(Expressed
in US Dollars)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zQIQ2zd1u7ze" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table represents the contractual undiscounted cash flows for lease obligations as at March 31, 2026:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zrTmFS2QiDFb" style="display: none"&gt;SCHEDULE OF CONTRACTUAL UNDISCOUNTED CASH FLOWS FOR LEASE OBLIGATION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Calendar
    year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20260331_zmwTAFUdOKTa" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzpEs_zfknQtlmk4md" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 80%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;411,170&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndBeyond_iI_maLOLLPzpEs_zmTjYhEcaAr9" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2027
    and beyond&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2022"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzpEs_z311pkc4QGx7" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    undiscounted lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;411,170&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zxSa54mNEIUl" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less
    imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,340&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OperatingLeaseLiability_iI_zSFNm8R35Yyh" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;397,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A0_zwoXT5dWvAD4" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseDepositLiability
      contextRef="AsOf2021-12-31_custom_NewLeaseAgreementMember"
      decimals="0"
      id="Fact001964"
      unitRef="USD">85000</us-gaap:LeaseDepositLiability>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="AsOf2026-03-31"
      decimals="INF"
      id="Fact001966"
      unitRef="Pure">0.114</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact001968">&lt;p id="xdx_892_eus-gaap--LeaseCostTableTextBlock_zidUPTys2nSf" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B5_zf5tA32ENyBf" style="display: none"&gt;SCHEDULE OF OPERATING LEASES OBLIGATIONS&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Right
    of Use Asset&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Beginning
    balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingLeaseRightOfUseAsset_iS_c20250401__20260331_zw4mGKYB7T7" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal" title="Right of Use Asset, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;812,053&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--OperatingLeaseRightOfUseAsset_iS_c20240401__20250331_zFWD5R8vuc9j" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal" title="Right of Use Asset, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,221,593&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;New
    leases&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--OperatingLeaseRightOfUseAssetNewLeases_c20250401__20260331_ztHrZEMlItbb" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Right of Use Asset, New leases"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1974"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--OperatingLeaseRightOfUseAssetNewLeases_c20240401__20250331_zvP9sA5pZeVi" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Right of Use Asset, New leases"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1976"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_di_c20250401__20260331_z8ibdG4zHrvc" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Right of Use Asset, Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(465,839&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_iN_di_c20240401__20250331_zJzUtvSXBsre" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Right of Use Asset, Amortization"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(409,540&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ending
    balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--OperatingLeaseRightOfUseAsset_iE_c20250401__20260331_zRen1Uw0SY5g" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Right of Use Asset, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;346,214&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseRightOfUseAsset_iE_c20240401__20250331_zgKwmjVjIve8" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Right of Use Asset, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;812,053&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Lease
    Liability&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 60%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Beginning
    balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--OperatingLeaseLiability_iS_c20250401__20260331_zVl9rfwVwyp6" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal" title="Lease Liability, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;929,116&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--OperatingLeaseLiability_iS_c20240401__20250331_ztOeRcyTvX1g" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal" title="Lease Liability, Beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,386,486&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;New
    leases&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--OperatingLeaseNewLeases_c20250401__20260331_zsNJTeEEDKX1" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Lease liability, New leases"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1990"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--OperatingLeaseNewLeases_c20240401__20250331_zXaGhoCNsbaj" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Lease liability, New leases"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1992"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Repayment
    and interest accretion&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_ecustom--OperatingLeaseRepaymentAndInterestAccretion_iN_di_c20250401__20260331_zdCCG0YrDTbg" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Lease Liability, Repayment and interest accretion"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(531,286&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--OperatingLeaseRepaymentAndInterestAccretion_iN_di_c20240401__20250331_zh9IkJ75Bnt5" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Lease Liability, Repayment and interest accretion"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(457,370&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ending
    balance at March 31&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--OperatingLeaseLiability_iE_c20250401__20260331_zaf2JkgqCa8b" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Lease Liability, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;397,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--OperatingLeaseLiability_iE_c20240401__20250331_zRCIVn23cWq7" style="border-bottom: Black 2.5pt double; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Lease Liability, Ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;929,116&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Current
    portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--OperatingLeaseLiabilityCurrent_iI_c20260331_zSWEQP7FY4Nj" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Current portion of operating lease liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;397,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--OperatingLeaseLiabilityCurrent_iI_c20250331_zehzpUZQZ5Og" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Current portion of operating lease liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;531,286&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Noncurrent
    portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_c20260331_zPycW3ayD73" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Noncurrent portion of operating lease liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2006"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_c20250331_zJpnAS1gkPk9" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Noncurrent portion of operating lease liability"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;397,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001970"
      unitRef="USD">812053</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="Fact001972"
      unitRef="USD">1221593</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001978"
      unitRef="USD">465839</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact001980"
      unitRef="USD">409540</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001982"
      unitRef="USD">346214</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001984"
      unitRef="USD">812053</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact001986"
      unitRef="USD">929116</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="Fact001988"
      unitRef="USD">1386486</us-gaap:OperatingLeaseLiability>
    <BTCY:OperatingLeaseRepaymentAndInterestAccretion
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact001994"
      unitRef="USD">531286</BTCY:OperatingLeaseRepaymentAndInterestAccretion>
    <BTCY:OperatingLeaseRepaymentAndInterestAccretion
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact001996"
      unitRef="USD">457370</BTCY:OperatingLeaseRepaymentAndInterestAccretion>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact001998"
      unitRef="USD">397830</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact002000"
      unitRef="USD">929116</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002002"
      unitRef="USD">397830</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact002004"
      unitRef="USD">531286</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact002008"
      unitRef="USD">397830</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2025-04-012026-03-31_us-gaap_SellingGeneralAndAdministrativeExpenses"
      decimals="0"
      id="Fact002010"
      unitRef="USD">627728</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="From2024-04-012025-03-31_us-gaap_SellingGeneralAndAdministrativeExpenses"
      decimals="0"
      id="Fact002012"
      unitRef="USD">587045</us-gaap:OperatingLeaseExpense>
    <us-gaap:ProceedsFromLeasePayments
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact002014"
      unitRef="USD">604779</us-gaap:ProceedsFromLeasePayments>
    <us-gaap:ProceedsFromLeasePayments
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact002016"
      unitRef="USD">587164</us-gaap:ProceedsFromLeasePayments>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact002018">&lt;p id="xdx_898_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zQIQ2zd1u7ze" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
following table represents the contractual undiscounted cash flows for lease obligations as at March 31, 2026:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BD_zrTmFS2QiDFb" style="display: none"&gt;SCHEDULE OF CONTRACTUAL UNDISCOUNTED CASH FLOWS FOR LEASE OBLIGATION&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Calendar
    year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20260331_zmwTAFUdOKTa" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_maLOLLPzpEs_zfknQtlmk4md" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 80%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 16%; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;411,170&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--LesseeOperatingLeaseLiabilityPaymentsDueYearTwoAndBeyond_iI_maLOLLPzpEs_zmTjYhEcaAr9" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2027
    and beyond&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2022"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_mtLOLLPzpEs_z311pkc4QGx7" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total
    undiscounted lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;411,170&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_zxSa54mNEIUl" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less
    imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;13,340&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OperatingLeaseLiability_iI_zSFNm8R35Yyh" style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;397,830&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002020"
      unitRef="USD">411170</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002024"
      unitRef="USD">411170</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002026"
      unitRef="USD">13340</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002028"
      unitRef="USD">397830</us-gaap:OperatingLeaseLiability>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact002030">&lt;p id="xdx_802_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_z7ju7skAj4F2" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;13.
&lt;span id="xdx_820_zKlVL7MQkDcb"&gt;PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Property and equipment consists of leasehold
improvements and office equipment, which are depreciated using the straight-line method over their estimated useful lives of &lt;span id="xdx_90F_eus-gaap--PropertyPlantAndEquipmentUsefulLife_iI_dtY_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zKfIVlSuSkB8" style="display: none" title="Leasehold improvements useful life"&gt;5&lt;/span&gt;
five years.&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span id="xdx_907_eus-gaap--PaymentsForProceedsFromProductiveAssets_do_c20250401__20260331_zIzrcIGdyWul" title="Purchase of property plant and equipment"&gt;&lt;span id="xdx_90A_eus-gaap--PaymentsForProceedsFromProductiveAssets_do_c20240401__20250331_zS7aLg2djyub" title="Purchase of property plant and equipment"&gt;No&lt;/span&gt;&lt;/span&gt; property and equipment additions were made during
the years ended March 31, 2026 and 2025.&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Depreciation expense for the years ended March 31,
2026 and 2025 was $&lt;span id="xdx_90A_eus-gaap--Depreciation_c20250401__20260331_zGc4S2LWzzmk" title="Depreciation expenses"&gt;5,953 &lt;/span&gt;and $&lt;span id="xdx_908_eus-gaap--Depreciation_c20240401__20250331_z1n4wBRJSDWf" title="Depreciation expenses"&gt;5,953&lt;/span&gt;, respectively.&lt;/p&gt;
&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_eus-gaap--PropertyPlantAndEquipmentTextBlock_z3Yi6fEJE0il" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zLdlv8HDrW3l" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Office&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;equipment&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Leasehold&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;improvement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 46%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iS_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zc9GN2VSeyDf" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right; font-weight: normal" title="Cost, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,839&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iS_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zsDrP3vEZfcc" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right; font-weight: normal" title="Cost, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,928&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iS_c20240401__20250331_zRb9Fj3lIjc6" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right; font-weight: normal" title="Cost, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,767&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentAdditions_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z5TzsSNlZMe1" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Office equipment, additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2050"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentAdditions_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zrc931NP93Ie" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Leasehold improvement, additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2052"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentAdditions_c20240401__20250331_zAUBjxSriQq" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2054"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance at March
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iS_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zNDVtB01Yv79" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Cost, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,839&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iS_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_znphSwJvx684" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Cost, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,928&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iS_c20250401__20260331_zEjO5iJ0KGT5" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Cost, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,767&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentAdditions_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zNmTfHFFb9A9" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Office equipment, additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2062"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentAdditions_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z9abtt1SBOfb" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Leasehold improvement, additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2064"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentAdditions_c20250401__20260331_z9jsiyXWUTH8" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Cost, additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2066"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance
    at March 31, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iE_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zMrrYiQMGXoc" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Cost, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,839&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iE_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zvY61r9HMKx4" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Cost, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,928&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iE_c20250401__20260331_zjqnHUPsUSV6" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Cost, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,767&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Accumulated
    depreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Office&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;equipment&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Leasehold&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;improvement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 46%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zeimsk0qMWP5" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right; font-weight: normal" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,042&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zMWxs8bFU8Tk" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right; font-weight: normal" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,173&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_c20240401__20250331_zlSCfsG35FPj" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 14%; font-weight: normal; text-align: right" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,215&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Depreciation_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zTu9PDkEuaq2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Office equipment, depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,367&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Depreciation_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zUqDhY7zJDfb" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Office equipment, depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,586&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Depreciation_c20240401__20250331_zLwI8ejHVlUb" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Office equipment, depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,953&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance at March
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zUrSnuPsAYn6" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;11,409&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zd7RrPNWFUWc" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;8,759&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_c20250401__20260331_zorYM9eStU85" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;20,168&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Depreciation_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zRNy32fV5dZc" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Office equipment, depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,367&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Depreciation_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zKDj2GkOx7sk" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Accumulated depreciation, depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,586&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Depreciation_c20250401__20260331_zwxo05XYIx5k" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Accumulated depreciation, additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,953&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance
    at March 31, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iE_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zkVuGaRxSqod" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Accumulated depreciation, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,776&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iE_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zgOUjON78R6d" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Accumulated depreciation, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,345&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iE_c20250401__20260331_z94EFyJ4nJ41" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Accumulated depreciation, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,121&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Net
    book value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zdEin23aUpmf" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Net book value, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;5,430&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zeiTENjXabMd" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Net book value, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;4,169&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20250331_zW3hMzi5empl" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Net book value, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;9,599&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance
    at March 31, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zwvKBHLc9Qe1" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Net book value, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2,063&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zxxvPlcsNCq5" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Net book value, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;1,583&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20260331_zb29t1PsSO7i" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;3,646&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_z5XW8uTH4sG6" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="AsOf2026-03-31_us-gaap_LeaseholdImprovementsMember"
      id="Fact002032">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PaymentsForProceedsFromProductiveAssets
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact002034"
      unitRef="USD">0</us-gaap:PaymentsForProceedsFromProductiveAssets>
    <us-gaap:PaymentsForProceedsFromProductiveAssets
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact002036"
      unitRef="USD">0</us-gaap:PaymentsForProceedsFromProductiveAssets>
    <us-gaap:Depreciation
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact002038"
      unitRef="USD">5953</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact002040"
      unitRef="USD">5953</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact002042">&lt;p id="xdx_898_eus-gaap--PropertyPlantAndEquipmentTextBlock_z3Yi6fEJE0il" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8B1_zLdlv8HDrW3l" style="display: none"&gt;SCHEDULE OF PROPERTY AND EQUIPMENT&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Office&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;equipment&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Leasehold&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;improvement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 46%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iS_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zc9GN2VSeyDf" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right; font-weight: normal" title="Cost, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,839&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--PropertyPlantAndEquipmentGross_iS_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zsDrP3vEZfcc" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right; font-weight: normal" title="Cost, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,928&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iS_c20240401__20250331_zRb9Fj3lIjc6" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right; font-weight: normal" title="Cost, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,767&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentAdditions_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z5TzsSNlZMe1" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Office equipment, additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2050"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentAdditions_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zrc931NP93Ie" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Leasehold improvement, additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2052"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentAdditions_c20240401__20250331_zAUBjxSriQq" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2054"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance at March
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iS_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zNDVtB01Yv79" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Cost, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,839&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iS_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_znphSwJvx684" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Cost, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,928&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_iS_c20250401__20260331_zEjO5iJ0KGT5" style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Cost, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,767&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentAdditions_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zNmTfHFFb9A9" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Office equipment, additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2062"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentAdditions_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z9abtt1SBOfb" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Leasehold improvement, additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2064"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentAdditions_c20250401__20260331_z9jsiyXWUTH8" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Cost, additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2066"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance
    at March 31, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iE_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zMrrYiQMGXoc" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Cost, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;16,839&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iE_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zvY61r9HMKx4" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Cost, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;12,928&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iE_c20250401__20260331_zjqnHUPsUSV6" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Cost, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;29,767&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Accumulated
    depreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Office&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;equipment&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Leasehold&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;improvement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; font-weight: normal"&gt;
    &lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;$&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; padding-bottom: 1pt; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 46%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    at March 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zeimsk0qMWP5" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right; font-weight: normal" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;8,042&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zMWxs8bFU8Tk" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right; font-weight: normal" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;6,173&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 2%; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_c20240401__20250331_zlSCfsG35FPj" style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 14%; font-weight: normal; text-align: right" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,215&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; width: 1%; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--Depreciation_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zTu9PDkEuaq2" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Office equipment, depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,367&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Depreciation_c20240401__20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zUqDhY7zJDfb" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Office equipment, depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,586&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--Depreciation_c20240401__20250331_zLwI8ejHVlUb" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Office equipment, depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,953&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance at March
    31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zUrSnuPsAYn6" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;11,409&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zd7RrPNWFUWc" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;8,759&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iS_c20250401__20260331_zorYM9eStU85" style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Accumulated depreciation, beginning balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;20,168&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Depreciation_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zRNy32fV5dZc" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Office equipment, depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;3,367&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--Depreciation_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zKDj2GkOx7sk" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Accumulated depreciation, depreciation"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;2,586&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--Depreciation_c20250401__20260331_zwxo05XYIx5k" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Accumulated depreciation, additions"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;5,953&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance
    at March 31, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iE_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zkVuGaRxSqod" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Accumulated depreciation, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;14,776&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iE_c20250401__20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zgOUjON78R6d" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Accumulated depreciation, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;11,345&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iE_c20250401__20260331_z94EFyJ4nJ41" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal" title="Accumulated depreciation, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;26,121&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Net
    book value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: right; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; text-align: left; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White; font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Balance
    at March 31, 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zdEin23aUpmf" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Net book value, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;5,430&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20250331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zeiTENjXabMd" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Net book value, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;4,169&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20250331_zW3hMzi5empl" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Net book value, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;9,599&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font-style: normal; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255); font-weight: normal"&gt;
    &lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;Balance
    at March 31, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zwvKBHLc9Qe1" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Net book value, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;2,063&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20260331__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_zxxvPlcsNCq5" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Net book value, ending balance"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;1,583&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_iI_c20260331_zb29t1PsSO7i" style="border-bottom: Black 1pt solid; font-style: normal; font-family: Times New Roman, Times, Serif; font-weight: normal; text-align: right" title="Net book value"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;3,646&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-style: normal; font-family: Times New Roman, Times, Serif; padding-bottom: 1pt; font-weight: normal; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-03-31_us-gaap_OfficeEquipmentMember"
      decimals="0"
      id="Fact002044"
      unitRef="USD">16839</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-03-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact002046"
      unitRef="USD">12928</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="Fact002048"
      unitRef="USD">29767</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-03-31_us-gaap_OfficeEquipmentMember"
      decimals="0"
      id="Fact002056"
      unitRef="USD">16839</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-03-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact002058"
      unitRef="USD">12928</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact002060"
      unitRef="USD">29767</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2026-03-31_us-gaap_OfficeEquipmentMember"
      decimals="0"
      id="Fact002068"
      unitRef="USD">16839</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2026-03-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact002070"
      unitRef="USD">12928</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002072"
      unitRef="USD">29767</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-03-31_us-gaap_OfficeEquipmentMember"
      decimals="0"
      id="Fact002074"
      unitRef="USD">8042</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-03-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact002076"
      unitRef="USD">6173</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2024-03-31"
      decimals="0"
      id="Fact002078"
      unitRef="USD">14215</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:Depreciation
      contextRef="From2024-04-012025-03-31_us-gaap_OfficeEquipmentMember"
      decimals="0"
      id="Fact002080"
      unitRef="USD">3367</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2024-04-012025-03-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact002082"
      unitRef="USD">2586</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2024-04-012025-03-31"
      decimals="0"
      id="Fact002084"
      unitRef="USD">5953</us-gaap:Depreciation>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-03-31_us-gaap_OfficeEquipmentMember"
      decimals="0"
      id="Fact002086"
      unitRef="USD">11409</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-03-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact002088"
      unitRef="USD">8759</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact002090"
      unitRef="USD">20168</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:Depreciation
      contextRef="From2025-04-012026-03-31_us-gaap_OfficeEquipmentMember"
      decimals="0"
      id="Fact002092"
      unitRef="USD">3367</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2025-04-012026-03-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact002094"
      unitRef="USD">2586</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="From2025-04-01to2026-03-31"
      decimals="0"
      id="Fact002096"
      unitRef="USD">5953</us-gaap:Depreciation>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2026-03-31_us-gaap_OfficeEquipmentMember"
      decimals="0"
      id="Fact002098"
      unitRef="USD">14776</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2026-03-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact002100"
      unitRef="USD">11345</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002102"
      unitRef="USD">26121</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-03-31_us-gaap_OfficeEquipmentMember"
      decimals="0"
      id="Fact002104"
      unitRef="USD">5430</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-03-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact002106"
      unitRef="USD">4169</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2025-03-31"
      decimals="0"
      id="Fact002108"
      unitRef="USD">9599</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2026-03-31_us-gaap_OfficeEquipmentMember"
      decimals="0"
      id="Fact002110"
      unitRef="USD">2063</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2026-03-31_us-gaap_LeaseholdImprovementsMember"
      decimals="0"
      id="Fact002112"
      unitRef="USD">1583</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="AsOf2026-03-31"
      decimals="0"
      id="Fact002114"
      unitRef="USD">3646</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2025-04-01to2026-03-31" id="Fact002116">&lt;p id="xdx_80E_eus-gaap--SubsequentEventsTextBlock_zkToFQLyT1X9" style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;14.
&lt;span id="xdx_829_zlwXN5UOzWRb"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During
the period from April 1 to July 14, 2026, the following events occurred:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: normal 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Company issued &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260401__20260714__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zVjLIGwrOAmf" title="Number of shares issued"&gt;805,609&lt;/span&gt;
    additional common shares to Series B preferred shareholders in order to supplement the &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250331__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOTW2zYRCTm9" title="Conversion of mezzanine equity into common shares"&gt;1,706,820&lt;/span&gt;
    shares to be issued  in relation to its conversion obligations for a conversion of &lt;span id="xdx_907_eus-gaap--ConversionOfStockSharesConverted1_c20250304__20250304__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zxDqKhMexYw8" title="Number of conversion of shares"&gt;25&lt;/span&gt;
    Series B preferred whose conversion period commenced on November 4, 2025. This conversion of preferred shares is intended to redeem or
    repay $&lt;span id="xdx_90F_eus-gaap--DebtInstrumentRepaidPrincipal_c20260401__20260714__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpEsKRzHXOD1" title="Repayment in pricipal amount"&gt;250,000&lt;/span&gt;
    in principal and $&lt;span id="xdx_90E_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_c20260714__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zjsAWTOKq2il" title="Accrued dividends"&gt;64,055&lt;/span&gt;
    in accrued dividends.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;On May 1, 2026, the Company entered into exchange agreements with holders
(the &#x201c;Exchange Holders&#x201d;) of an aggregate of &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260501__20260501__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeSharesAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zi8UB8nvCB44" title="Number of shares issued"&gt;14,144,325&lt;/span&gt; shares of the Company&#x2019;s common stock (the &#x201c;Exchange Shares&#x201d;),
options (the &#x201c;Exchange Options&#x201d;) to purchase &lt;span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260501__20260501__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeOptionsAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zHL1duqrsTf2" title="Number of shares issued"&gt;3,992,427&lt;/span&gt; shares of common stock of the Company, and warrants (the &#x201c;Exchange
Warrants,&#x201d; and together with the Exchange Shares and the Exchange Options, the &#x201c;Exchange Securities&#x201d;) to purchase &lt;span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260501__20260501__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeWarrantsAgreementMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zUaW6FFnVzp5" title="Number of shares issued"&gt;1,436,216&lt;/span&gt;
shares of common stock of the Company. The Exchange Holders include officers and directors of the Company. Pursuant to the exchange agreements,
the Exchange Holders exchanged their Exchange Securities for an aggregate of &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20260501__20260501__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zxKSLPTF04X1" title="Number of shares exchange"&gt;1,957,297&lt;/span&gt; shares of newly created Series C Preferred Stock
of the Company (on the basis of ten Exchange Securities for one share of Series C Preferred Stock). &#160;In connection with the exchange
agreements, on May 1, 2026, the Company filed a Certificate of Designation of Series C Preferred Stock with the Secretary of State of
Nevada. Pursuant to the Certificate of Designation, the Company designated &lt;span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20260501__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zpxwHl2WbCOc" title="Preferred stock, shares authorized"&gt;2,100,000&lt;/span&gt; shares as Series C Preferred Stock. &lt;span id="xdx_90D_eus-gaap--PreferredStockVotingRights_c20260501__20260501__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z3lLoOEFIvbj" title="Preferred stock, voting rights"&gt;Holders of Series
C Preferred Stock (the &#x201c;Series C Holders&#x201d;) will be entitled to 40 votes for each share of Series C Preferred Stock. Effective
upon the closing of any offering of equity securities in which the Company receives gross proceeds of at least $15 million (a &#x201c;Qualified
Financing&#x201d;), outstanding shares of Series C Preferred Stock will automatically convert into an aggregate of 59.6% of the Company&#x2019;s
outstanding shares of common stock (the &#x201c;Conversion Shares&#x201d;). In the event the Company issues warrants in such Qualified Financing,
Series C Holders will also receive warrants in the form issued in the Qualified Financing and in the same ratio to the Conversion Shares
as the warrant coverage in the Qualified Financing.&lt;/span&gt; &lt;span id="xdx_901_eus-gaap--PreferredStockConversionBasis_c20260501__20260501__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--TypeOfArrangementAxis__custom--ExchangeAgreementsMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z1dcFehwZjX9" title="Preferred stock, conversion basis"&gt;In the event the Company has not consummated a Qualified Financing by March 31, 2028,
Series C Holders will have the right to convert each share of Series C Preferred Stock to 10 shares of common stock. In connection with
the foregoing, the Company relied upon the exemption from registration under Section 4(a)(2) under the Securities Act of 1933, as amended,
for transactions not involving a public offering.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&#x25cf;&lt;/td&gt;
    &lt;td style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify"&gt;Following the filing of a preliminary Information Statement pursuant to
Section 14(c) of the4 Securities Exchange Act of 1934 to the holders of record as of the close of business on May 28, 2026 of the common
stock, the Series B Convertible Redeemable preferred stock and the Series C preferred stock of Biotricity, in June 2026, &lt;span id="xdx_90A_eus-gaap--StockholdersEquityReverseStockSplit_c20260528__20260528__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_z6ehvrfP9kSf" title="Reverse stock split"&gt;the Board of
Directors of Biotricity and 6 stockholders holding an aggregate of &lt;span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pid_c20260528__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zRbx2KHSJHF3" title="Preferred stock, shares issued"&gt;&lt;span id="xdx_90B_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260528__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zqrJAaUFZ6Ei" title="Preferred stock, shares outstanding"&gt;1,298,945&lt;/span&gt;&lt;/span&gt; shares of Series C Preferred stock issued and outstanding
as of May 28, 2026 representing 51,957,780 votes have approved and consented to an amendment to the articles of incorporation to effect
a future reverse stock split.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-04-012026-07-14_us-gaap_SeriesBPreferredStockMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002118"
      unitRef="Shares">805609</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2025-03-312025-03-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact002120"
      unitRef="Shares">1706820</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="From2025-03-042025-03-04_us-gaap_SeriesBPreferredStockMember"
      decimals="INF"
      id="Fact002122"
      unitRef="Shares">25</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:DebtInstrumentRepaidPrincipal
      contextRef="From2026-04-012026-07-14_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002124"
      unitRef="USD">250000</us-gaap:DebtInstrumentRepaidPrincipal>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="AsOf2026-07-14_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact002126"
      unitRef="USD">64055</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-05-012026-05-01_us-gaap_CommonStockMember_custom_ExchangeSharesAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002128"
      unitRef="Shares">14144325</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-05-012026-05-01_us-gaap_CommonStockMember_custom_ExchangeOptionsAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002130"
      unitRef="Shares">3992427</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-05-012026-05-01_us-gaap_CommonStockMember_custom_ExchangeWarrantsAgreementMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002132"
      unitRef="Shares">1436216</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="From2026-05-012026-05-01_us-gaap_PreferredStockMember_us-gaap_SeriesCPreferredStockMember_custom_ExchangeAgreementsMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002134"
      unitRef="Shares">1957297</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2026-05-01_us-gaap_PreferredStockMember_us-gaap_SeriesCPreferredStockMember_custom_ExchangeAgreementsMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002136"
      unitRef="Shares">2100000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockVotingRights
      contextRef="From2026-05-012026-05-01_us-gaap_PreferredStockMember_us-gaap_SeriesCPreferredStockMember_custom_ExchangeAgreementsMember_us-gaap_SubsequentEventMember"
      id="Fact002138">Holders of Series
C Preferred Stock (the &#x201c;Series C Holders&#x201d;) will be entitled to 40 votes for each share of Series C Preferred Stock. Effective
upon the closing of any offering of equity securities in which the Company receives gross proceeds of at least $15 million (a &#x201c;Qualified
Financing&#x201d;), outstanding shares of Series C Preferred Stock will automatically convert into an aggregate of 59.6% of the Company&#x2019;s
outstanding shares of common stock (the &#x201c;Conversion Shares&#x201d;). In the event the Company issues warrants in such Qualified Financing,
Series C Holders will also receive warrants in the form issued in the Qualified Financing and in the same ratio to the Conversion Shares
as the warrant coverage in the Qualified Financing.</us-gaap:PreferredStockVotingRights>
    <us-gaap:PreferredStockConversionBasis
      contextRef="From2026-05-012026-05-01_us-gaap_PreferredStockMember_us-gaap_SeriesCPreferredStockMember_custom_ExchangeAgreementsMember_us-gaap_SubsequentEventMember"
      id="Fact002140">In the event the Company has not consummated a Qualified Financing by March 31, 2028,
Series C Holders will have the right to convert each share of Series C Preferred Stock to 10 shares of common stock. In connection with
the foregoing, the Company relied upon the exemption from registration under Section 4(a)(2) under the Securities Act of 1933, as amended,
for transactions not involving a public offering.</us-gaap:PreferredStockConversionBasis>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="From2026-05-282026-05-28_us-gaap_PreferredStockMember_us-gaap_SeriesCPreferredStockMember_us-gaap_SubsequentEventMember"
      id="Fact002142">the Board of
Directors of Biotricity and 6 stockholders holding an aggregate of 1,298,945 shares of Series C Preferred stock issued and outstanding
as of May 28, 2026 representing 51,957,780 votes have approved and consented to an amendment to the articles of incorporation to effect
a future reverse stock split.</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2026-05-28_us-gaap_PreferredStockMember_us-gaap_SeriesCPreferredStockMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002144"
      unitRef="Shares">1298945</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2026-05-28_us-gaap_PreferredStockMember_us-gaap_SeriesCPreferredStockMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact002146"
      unitRef="Shares">1298945</us-gaap:PreferredStockSharesOutstanding>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact001750"
          xlink:label="Fact001750"
          xlink:type="locator"/>
        <link:footnote id="Footnote001795" xlink:label="Footnote001795" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value
    of our common stock as of March 31, 2026 and fair value of common stock adjusted.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001750"
          xlink:to="Footnote001795"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001778"
          xlink:label="Fact001778"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001778"
          xlink:to="Footnote001795"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001786"
          xlink:label="Fact001786"
          xlink:type="locator"/>
        <link:footnote id="Footnote001796" xlink:label="Footnote001796" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This
    includes <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBBQ1RJVklUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20250401__20260331__us-gaap--AwardTypeAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember_ztJVfYUhkkW"
  title="Options granted to employees">1,200,000</xhtml:span> options granted to employees from the 2023 Equity Incentive Plan, discussed below.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001786"
          xlink:to="Footnote001796"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001786"
          xlink:to="Footnote001795"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001794"
          xlink:label="Fact001794"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001794"
          xlink:to="Footnote001796"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001794"
          xlink:to="Footnote001795"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001780"
          xlink:label="Fact001780"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001780"
          xlink:to="Footnote001796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001782"
          xlink:label="Fact001782"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001782"
          xlink:to="Footnote001796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001784"
          xlink:label="Fact001784"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001784"
          xlink:to="Footnote001796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001788"
          xlink:label="Fact001788"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001788"
          xlink:to="Footnote001796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001790"
          xlink:label="Fact001790"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001790"
          xlink:to="Footnote001796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001792"
          xlink:label="Fact001792"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001792"
          xlink:to="Footnote001796"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001806"
          xlink:label="Fact001806"
          xlink:type="locator"/>
        <link:footnote id="Footnote001859" xlink:label="Footnote001859" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the fair value
    of our common stock as of March 31, 2025 and fair value of common stock adjusted.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001806"
          xlink:to="Footnote001859"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001842"
          xlink:label="Fact001842"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001842"
          xlink:to="Footnote001859"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001850"
          xlink:label="Fact001850"
          xlink:type="locator"/>
        <link:footnote id="Footnote001860" xlink:label="Footnote001860" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This
    includes <xhtml:span
  class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBBQ1RJVklUSUVTIChEZXRhaWxzKSAoUGFyZW50aGV0aWNhbCkA"
  id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_c20240401__20250331__us-gaap--AwardTypeAxis__custom--TwoThousandAndTwentyThreeEquityIncentivePlanMember_zkZTkJcIwgCi"
  title="Options granted to employees">1,200,000</xhtml:span> options granted to employees from the 2023 Equity Incentive Plan, discussed below.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001850"
          xlink:to="Footnote001860"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001850"
          xlink:to="Footnote001859"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001858"
          xlink:label="Fact001858"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001858"
          xlink:to="Footnote001860"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001858"
          xlink:to="Footnote001859"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001844"
          xlink:label="Fact001844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001844"
          xlink:to="Footnote001860"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001846"
          xlink:label="Fact001846"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001846"
          xlink:to="Footnote001860"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001848"
          xlink:label="Fact001848"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001848"
          xlink:to="Footnote001860"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001852"
          xlink:label="Fact001852"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001852"
          xlink:to="Footnote001860"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001854"
          xlink:label="Fact001854"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001854"
          xlink:to="Footnote001860"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001856"
          xlink:label="Fact001856"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001856"
          xlink:to="Footnote001860"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
